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ABSTRACT
This study investigated the mutagenicity of the major DNA adduct formed by
the human bladder carcinogen 4-aminobiphenyl (ABP), N-(deoxyguanosin-8-
yl)-4-aminobiphenyl (dG-C8-ABP), in the bacteriophage M13mpl9 single-
stranded (ss) genome replicated in Escherichia coli. To determine if DNA
adducts formed by ABP could induce mutations in the M13 ss genome, two
complementary mutational analyses in E. coli were undertaken. In the first
study, mutagenesis assays in the lacZ gene of globally ABP-modified M13mplO
ss and duplex (ds or RF) DNAs were conducted to determine which of the
known DNA adducts of ABP were likely to be mutagenic in the M13mplO ss
genome and to compare the ABP mutational spectrum in ss DNA to that
established in the lacZ gene of ABP-modified RF DNA. M13 globally ABP-
modified ss and RF DNAs were replicated in excision-repair proficient
(uvr*) and excision-repair deficient (uvr~) E. coli strains that were
induced or uninduced for SOS mutagenic processing functions. The results
showed ABP-DNA adducts in ss DNA were approximately 70-fold more mutagenic
and 50-fold more genotoxic than ABP lesions in ds DNA in SOS-induced uvr*
cells. ABP-DNA adducts in M13 ss DNA were dependent on the mucAB
processing genes for enhanced mutagenesis in SOS-induced cells. An
analysis of the ABP-induced mutations indicated that only base-pair
substitutions were detected in the lacZ gene of ABP-modified ss DNA. Over
80% of the mutations occurred at putative dG-ABP adducts. Among the base
changes, G -> T transversions were the predominant mutations followed by
G -> C transversions and then G -> A transitions.
In the second study, site-specific mutagenesis assays were conducted with
an M13 ss genome containing a single dG-C8-ABP lesion to determine the
genotoxic and mutagenic effects of the major ABP-DNA adduct. A -
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deoxytetranucleotide, 5'-d[pTpG-(ABP)pCpA]-3', containing a single
dG-C8-ABP adduct was synthesized, characterized and incorporated into an
M13mpl9 gapped duplex genome at a unique PstI site. The adduct was
situated in either the plus strand at position 6245, or in the minus strand
at position 6246 of the vector. The TG-(ABP)CA tetramer ligated into the
genome with an efficiency of 25%, compared to a 50% ligation efficiency for
a control genome. After in vivo replication of both the ABP-modified and
the control ss genomes in E. coli strains, DL7 (uvr+) and DL7/pGW16
(uvr+/mucAB), mutants were isolated to determine the mutation frequency and
the mutation specificity of the dG-C8-ABP lesion. The results of three
methods of mutant selection have indicated that the targeted mutation
frequency of a single dG-C8-ABP lesion, situated at the PstI site in an M13
ss genome, was approximately 0.01%. The primary mutation observed at this
site was the G -> C transversion. This mutation occurred with equal
frequency from putative adducts originating from either the plus strand or
from the minus strand of the genome.
These studies concluded that although the dG-C8-ABP was weakly mutagenic
under these experimental conditions, the contribution of this lesion to a
portion of the mutational spectrum induced by ABP in ss DNA is plausible.
Thesis supervisor: Professor John M. Essigmann
Title: Professor of Toxicology and Professor of Chemistry
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I. INTRODUCTION
Most, if not all, chemical carcinogens undergo metabolic or spontaneous
chemical activation to electrophilic derivatives that go on to form a
variety of addition products, or adducts, with the DNA of cells (Miller and
Miller, 1981). Most chemical adducts formed in DNA are removed by cellular
repair enzymes prior to replication of the genetic material; however,
defects in the repair or the removal of certain adducts occasionally result
in mutations. Many studies over the past decade have suggested that these
genetic changes activate cellular proto-oncogenes or inactivate tumor
suppressor genes (Weinberg, 1989; Vogelstein, 1990). These initial
mutagenic events are important because they may lead to neoplastic
transformation of cells which ultimately may result in carcinogenesis.
One important goal of mutagenesis studies using chemical carcinogens is
to evaluate the genotoxicity induced by a carcinogen in vivo. Results from
this type of evaluation will help to elucidate the mechanism and genetic
requirements for the mutational specificity of a carcinogen. More
specifically, these studies can serve as models for understanding the
cellular factors that cause cells to resist, or to succumb to, the
genotoxic properties of a toxic compound.
The objective of my research, which is documented in this dissertation,
was to investigate the mechanism of the repair and/or the mutagenesis of
the DNA adducts of the human bladder carcinogen, 4-aminobiphenyl (ABP).
The bacteriophage M13 was the model for study of ABP mutagenesis in two
- 11 -
complementary mutation analysis systems. In the first, forward mutation of
the full range of ABP adducts was studied in Escherichia coli using the
lacZa gene of M13 bacteriophage single-stranded (ss) DNA as the genetic
target; mutants were isolated and the molecular nature of the mutations
was determined. These data helped formulate hypotheses as to which DNA
adducts were the likely precursors to ABP-induced mutagenesis. The second
line of approach tested one of those hypotheses by introducing the major
DNA adduct of ABP into a known site in an M13 ss genome, followed by
replication of this uniquely-modified genome in E. coli. This approach
permitted an assessment of the mutational specificity of the major ABP-DNA
adduct as well as its contribution to the entire mutational spectrum
induced by ABP in E. coli.
The studies presented in this dissertation follow a collaboration
initially formed between our laboratory and Dr. Fred F. Kadlubar, renowned
for his expertise in the chemistry and pharmacokinetics of aromatic amines,
at the National Center for Toxicological Research (NCTR). Although this
research project has not investigated all aspects of the mutagenesis and
the repair of ABP-DNA adducts, it has led to a furthering of our
understanding of the genotoxicity of a chemical that is increasingly being
appreciated for its adverse impact on public health.
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II. LITERATURE SURVEY
Aromatic Amine Compounds and Carcinogenesis
This literature survey will review DNA adduct formation and mutagenesis
caused by an number of N-substituted aromatic compounds that have been
widely studied in the field of chemical carcinogenesis. The metabolism of
aromatic amine compounds and the role of these chemicals in carcinogenesis
will also be reviewed. The survey will focus on the following aromatic
amine compounds: 4-aminobiphenyl, benzidine (BZ), N-acetyl-2-aminoflourene
(AAF), 2-aminofluorene (AF) and 2-naphthylamine (2-NA). The structures of
these aromatic amine compounds and their applications in industry or their
occurrence in the environment are shown in Figure 1.
History of Industrial Exposure to Aromatic Amines
The aromatic amines and related compounds are known to be potent
carcinogens (IARC, 1972; 1987). Among these, 4-aminobiphenyl, has been
shown to be a potent bladder carcinogen in humans (Melick et al., 1955;
1971). ABP was manufactured and used in this country as an antioxidant in
the rubber manufacturing industry from 1935 until 1954 (Garner et al.,
1984). Its production and use was ceased when it was implicated as the
etiological agent in bladder cancer induced in industrially exposed workers
(Melick et al., 1955). The results of the study performed by Melick and
coworkers demonstrated that a striking 19 of 171 (11%) workers exposed to
- 13 -
Figure 1.
Structures of Aromatic Amine Compounds and their Industrial Use or
Occurrence in the Environment (from King, 1982).
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Aromatic amine compound Use / Occurrence
ABP in industrial use had developed bladder tumors. A follow-up study of
315 exposed workers revealed that approximately 17% of this larger group
had developed bladder cancers (Melick et al., 1971). These data were
compiled from individuals exposed at two plants owned by the only company
that was known to produce and use ABP compounds in this country (Garner et
al., 1984).
In addition to ABP, other aromatic amines, such as 2-naphthylamine
(2-NA) have also been implicated in industrial cases of bladder cancer,
which were originally believed to be due to exposure to aniline (Case et
al., 1954). The aromatic amine, benzidine (BZ), was used in the production
of dyes in the chemical industry for nearly 100 years. Although the
incidence was lower, bladder tumors due to industrial exposure to BZ was
also reported (Case et al., 1954). Benzidine is an intermediate in the
production of several widely used carcinogenic dyes: Direct Black 38,
Direct Blue 6 and Direct Brown 95 (Garner et al., 1984). A related
aromatic compound, developed as a potential insecticide, that has been
extensively studied but never used is N-acetyl-2-aminofluorene (AAF). AAF
and cogeners were found to be carcinogenic in experimental animals prior to
their synthesis in large-scale quantities that would have resulted in
industrial, and then general population, exposure (Wilson et al., 1941).
Animal Models for Aromatic Amine Carcinogenesis
In addition to the role of aromatic amines in the development of human
cancers, the carcinogenic potency of these compounds have been extensively
investigated in experimental animals. The first report that provided
- 16 -
evidence for the carcinogenicity of aromatic amines in experimental animals
was conducted by Hueper and coworkers (1938). The results of this study
clearly demonstrated that dogs given 2-NA developed bladder cancer.
Subsequently, many studies were conducted with animals to test the
carcinogenicity as well as to elucidate the mechanisms of carcinogenesis by
ABP and related aromatic amines. Prior to the implication of ABP in the
etiology of industrial bladder cancer in this country, the carcinogenic
potential of ABP was demonstrated in both experimental rats and dogs by
Walpole and coworkers in Great Britain (1952; 1954). The results suggested
that the dog was the most susceptible animal to develop bladder cancer
compared to other animals such as rats or rabbits (Walpole et al., 1954;
Block et al. 1978). Rabbits develop bladder cancers although at a lower
incidence than in dogs (Radomski, 1979) and rats were observed to primarily
form mammary and liver tumors when given ABP (Dooley et al., 1988).
The results of later studies with 2-NA indicated that, overall, this
compound is most carcinogenic in the dog, followed by rabbits, guinea pigs
and hamsters, with the rat being the least susceptible to 2-NA
carcinogenesis (Radomski, 1979). BZ and its derivatives cause mammary
tumors (Morton et al., 1981) and urothelial tumors in rats (Wang et al.,
1990). The carcinogenic nature of AAF was initially demonstrated in rats
through studies conducted by Wilson et al. (1941). Subsequently, AAF was
found to be carcinogenic in dogs, in which it induces liver and bladder
tumors; rats and hamsters develop a variety of tumors, including liver and
bladder neoplasms, and rabbits form bladder and uterine tumors when treated
with AAF or its metabolites (King, 1982).
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The carcinogenic potency of ABP to induce bladder tumors in dogs is
greater than those of 2-NA, BZ or AAF; in rats, however, AAF appears to be
the most potent hepatocarcinogen followed by ABP, 2-NA and BZ (Radomski,
1979; Garner et al., 1984).
Based on the experimental and clinical evidence provided by many
researchers, most carcinogenic aromatic amines have been removed from
industrial use. This point not withstanding, the prevalence of bladder
cancer in certain areas of the world has been well documented (Parkes and
Evans, 1984). The aromatic amines continue to be in the environment, and
thus exposure of humans to these compounds is an everyday occurrence for
many individuals (Kadlubar et al., 1988c).
Environmental Exposure to Aromatic Amine Compounds
Aromatic Amines in Tobacco Smoke
As indicated above, ABP is no longer used in industry, but recent
studies have shown that ABP may still pose a carcinogenic risk from its
presence as an environmental contaminant. One known contemporary route of
ABP exposure is through cigarette smoke (Bryant et al., 1987). Many
carcinogens, including aromatic amines such as ABP and 2-NA (both of which
are known bladder carcinogens) have been detected in cigarette smoke. ABP
is present in the mainstream smoke produced from blond tobacco cigarettes
at 2.4 ng per cigarette. In cigarettes containing black tobacco the amount
of ABP is 4.6 ng in the mainstream smoke and 143 ng in the sidestream smoke
(Patrianakos and Hoffman, 1979).
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Cigarette smoking has long been associated with an increased risk for
bladder cancer (Mommsen and Aagaard, 1983; Vineis et al., 1984; Vineis et
al., 1988), lending further, albeit indirect, evidence for the significance
of the aromatic amines, including ABP, as agents that might be responsible
for the myriad of toxic effects of smoking. Among bladder cancer patients,
smokers of black tobacco (air-cured) had a 2-3 fold increased risk of
bladder cancer compared to blond (flue-cured) tobacco cigarette smokers
(Vineis et al., 1988). These results correlate with the finding that black
tobacco contains a higher concentration of carcinogens as compared to blond
tobacco (Patrianakos and Hoffman, 1979).
Smoking-Related ABP-Hemoglobin Adducts
One measure of exposure to ABP from tobacco smoke is the analysis of
ABP and related compounds in the bloodstream of cigarette smokers. The
results of early studies by the Tannenbaum laboratory have determined that
smokers, compared to nonsmokers, have an increased level of ABP residues in
their blood as measured by ABP bound to hemoglobin (Hb) to form ABP-Hb
adducts (Bryant et al., 1987). A mean value of 154 pg of ABP/per g of Hb
in blood samples from smokers versus 28 pg ABP/g Hb for nonsmokers was
determined in this study. A later report by the same group indicated that
after withdrawl from cigarette smoking, the levels of the ABP-Hb adduct in
smokers declined to the levels observed in nonsmokers (Maclure et al.,
1990). This study clearly demonstrated that Hb adducts of ABP were formed
from exposure to cigarette smoke. In studies comparing adduct levels among
individuals that smoked different types of tobacco, it was determined that
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the levels of ABP-hemoglobin adducts in smokers of black tobacco were
higher than the ABP-Hb adducts formed from smokers of blond tobacco (Bryant
et al., 1988). Again, this finding is consistent with the higher
concentration of carcinogens in black tobacco cigarette smoke compared to
blond tobacco smoke (Patrianakos and Hoffman, 1979), as well as to the
increased risk for bladder cancer in smokers of black tobacco versus blond
tobacco smokers (Vineis et al., 1988).
Recent studies have demonstrated that ABP can pass across the human
placenta in pregnant women and bind to fetal hemoglobin to form ABP-Hb
adducts (Coghlin et al., 1991). The results of this study definitively
showed that levels of ABP-Hb adducts were higher in both the maternal blood
samples as well as the fetal blood samples from smokers compared to
nonsmokers. A important finding reported in many studies, was that ABP-Hb
adducts were present in minor, but perhaps significant amounts in blood
samples from nonsmokers as well (Bryant et al., 1987; Kadlubar, 1988b).
Thus, it appears that ABP exposure continues today to a large number of
people both directly and passively with exposure to cigarette smoke and
perhaps other environmental sources. The measurement of ABP-Hb adducts in
blood samples from individuals can be used as a biomarker as well as a
dosimeter for exposure to ABP and other relevant environmental carcinogens.
Exposure to Related Aromatic Amine Compounds
Aside from tobacco smoke, exposure to aromatic amines and related
compounds may also result from other sources. For example, the
carcinogens, AF, ABP, and 2-NA have been reported to be found in coal-
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0
derived synthetic fuels (Guerin and Buchanan 1987). The recent manufacture
and use of benzidine-based dyes has also been documented (Schulte et al.,
1988; Mirokova and Lalchev, 1990). The presence of the structurally
related compounds, the heterocyclic amines, have been detected in cooked or
fried high-protein foods such as meat and fish (Sugimura and Sato, 1983).
Heterocyclic amines have been demonstrated to be activated to DNA binding
compounds similarly to aromatic amines (Kato and Yamazoe, 1990; Turesky et
al., 1991). These, in addition to as yet unknown sources of aromatic
amines and related compounds, are believed to be important in the etiology
of human cancer (Parkes and Evans, 1984; Weisburger, 1988; Kadlubar et al.,
1988c).
Metabolism of Aromatic Amine Compounds
Susceptibility to Carcinogenesis by Aromatic Amines
Although many individuals are exposed to aromatic amines and related
compounds on a frequent basis, there may be other factors such as genetic
susceptibility and pharmacokinetics in the metabolism of these chemicals
which may be important in the etiology of aromatic amine carcinogenesis.
One of the goals of recent studies has been to establish a relationship
between inter-individual metabolism of carcinogenic agents and subsequent
tumor formation as a result of exposure to these agents in various
individuals (Kadlubar et al., 1988c). Enzymatic capabilities in the
detoxification or in the activation of carcinogenic compounds appear to
play an important role in species or organ specificity of aromatic amine-
induced carcinogenesis (Harris, 1989).
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Aromatic amines induce tumors infrequently at sites of administration.
Usually these compounds affect distal tissues, mainly liver, intestine, and
bladder indicating that metabolic activation of aromatic amines is
essential for their carcinogenicity (Miller, 1970). The use of
experimental animals as models for the study of the metabolism of aromatic
amine carcinogens in humans has led to a further understanding of the
mechanisms of metabolic activation and metabolic detoxification of these
compounds (Miller, 1978).
The Role of N-Acetylation Reactions in the Metabolism of Aromatic Amines
It is generally accepted that the carcinogenic basis of aromatic amines
and related compounds depend on the metabolic activation of these compounds
by the host organism (Miller and Miller, 1981). Various pathways including
N-hydroxylation, N-acetylation and N-deacetylation are important in the
activation of aromatic amines to tumorigenic agents (King and Glowinski,
1983; Gorrod and Manson, 1986). The capacity for N-acetylation by liver
N-acetyltransferases involved in the metabolism of aromatic amines is
hypothesized to be important in species and organ specificity of
tumorigenesis by these compounds (King and Glowinski, 1983).
Studies attempting to establish the relationship between acetylation of
aromatic amines, acetylator phenotype, and target organ tumorigenesis have
suggested that acetylation leads to activation of carcinogens in species
prone to arylamine-hepatocarcinogenesis whereas in species susceptible to
arylamine-induced bladder cancer, acetylation represents a detoxification
pathway (Hein, 1988; Kadlubar et al., 1988c; Flammang et al., 1989).
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Interspecies differences have been observed in the metabolism and the
carcinogenic effects of aromatic amines in various tissues (Radomski,
1979). In rats, which are known to possess N-acetylation
enzymes, liver tumors are evident after treatment with ABP or its
derivatives (Miller et al., 1961). In dogs, bladder tumors from aromatic
amines are predominant, which may be due to the fact that these animals do
not acetylate ABP metabolites and therefore are not susceptible to tumors
in the liver, where N-acetylation reactions occur (Poupko et al., 1983).
In vitro studies using dog liver microsomes demonstrated enzymatic
deacetylation of N-acetylated-ABP compounds. This metabolic pathway may
render dogs susceptible to liver and bladder tumors from acetylated
aromatic amines such as AAF and bladder tumors from deacetylated aromatic
compounds such as ABP (Lower and Bryan, 1976). The ability to N-acetylate
aromatic amine bladder carcinogens is believed to be an important
detoxification step in the metabolism of ABP; however, with compounds such
as BZ, N-acetylation represents a activation step (Morton et al., 1979;
Weber and Hein, 1985).
In addition to the enzymatic capacity for N-acetylation by liver N-
acetyltransferses, genetic differences in the rates of N-acetylation of
various aromatic amines have also been observed in rabbits (McQueen et al.,
1982; Ilett et al., 1991), and mice (Mattano et al., 1988). Cell culture
studies with rabbit hepatocytes indicate that rabbits that were shown to
have high rates of acetylation, designated the fast acetylator phenotype,
were more susceptible to the genotoxic effects of AF and BZ than were the
slow acetylator phenotypes (McQueen et al., 1982; 1983). Recently, it has
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been demonstrated that liver or colon cytosol preparations from rabbits
with the rapid acetylator phenotype when incubated with either N-OH-ABP or
N-OH-AAF and DNA resulted in significantly higher DNA binding than
preparations from slow acetylator rabbits (Ilett et al., 1991). A higher
carcinogen-DNA adduct level in certain tissues could suggest an increased
susceptibility of arylamine carcinogenesis in these organs.
The aromatic amine N-acetyltransferase also shows a genetic
polymorphism in humans; thus affecting the rates of N-acetylation of
various aromatic amine carcinogens (Flammang et al., 1988; Land et al.,
1989). Fast acetylator phenotypes are homozygous dominant or heterozygous
for two alleles of the gene for the N-acetyltransferase; slow acetylators
are homozygous recessive for the two alleles (Hein, 1988). Recently, the
two alleles found in slow acetylators have been identified as Ml and M2.
These are associated with a decrease in the levels of the
N-acetyltransferase enzyme rather than the presence of a defective enzyme
(Blum et al., 1991).
The ability to acetylate aromatic amines may or may not predispose
humans to carcinogenesis from exposure to these compounds. An early study
by Cartwright et al. (1982) demonstrated that among industrial workers
exposed to aromatic amines, 22 of 23 individuals that developed bladder
cancer were of the slow acetylator phenotype. In the same study, these
investigators also reported that among individuals that were not
occupationally exposed to aromatic amines, there was no association with
bladder carcinomas and acetylator phenotype. The results of later studies
have indicated a correlation between acetylator phenotype and bladder
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cancer risk, with an increased number of bladder cancers observed in
individuals with a slow acetylator phenotype (Mommsen et al., 1985; Mommsen
and Aargard, 1986).
Other studies have investigated the relationship between acetylation
phenotype and colorectal carcinoma. A higher proportion of rapid
acetylator phenotypes among colorectal cancer patients compared to matched
controls was reported in one study (Ilett et al., 1987). Recent studies,
however, have shown very little correlation between the fast acetylator
phenotype and the susceptibility to colorectal carcinoma (Kirlin et al.,
1991).
Further studies in this area may unravel this complex issue; however,
the basic conclusions from these studies indicate that individuals with the
fast acetylator phenotype may be more susceptible to liver and colon
carcinogenesis, whereas slow acetylator phenotypes appear to be prone to
bladder carcinogenesis. Inter-individual differences observed in the
metabolism of the carcinogens, ABP, AAF, AF or BZ may lead to differences
in the nature of the tumorigenicity induced by these compounds.
Recent studies have investigated the relationship between cigarette
smoking, acetylation phenotype and the formation of carcinogen adducts in
human urothelial cells and blood samples. In the genetically determined
slow acetylators, there was an increase in the levels of ABP-Hb adducts
present in blood samples that correlated with the type of tobacco smoked by
the individual (Vineis et al., 1990). The results of the study suggested
that the slow acetylator phenotype could be at a higher risk for arylamine-
induced bladder cancer due to the increased exposure to ABP as evidenced by
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the higher number of ABP-Hb adducts formed in these individuals. Recent
reports have documented a correlation between carcinogen-protein binding to
carcinogen binding of cellular DNA (reviewed in Skipper and Tannenbaum,
1990). Inter-individual differences in the metabolic activation of
carcinogenic compounds and the formation of carcinogen-DNA adducts have
been reported (Harris, 1989).
Metabolic Activation of Aromatic Amines by N-Hydroxylation
In addition to the importance of N-acetylation in the metabolism and
tissue susceptibility to tumorigenesis by aromatic amines, in most species,
metabolic activation of these compounds by N-oxidation by P-450 mixed-
function oxidases is believed to be a critical step in the conversion of
the promutagen to the proximate carcinogen (Cramer et al., 1960; Radomski
et al., 1973; Miller and Miller, 1981).
The initial step of metabolic activation of aromatic amines such as ABP
is through N-oxidation to a more hydrophilic species,
N-hydroxy-4-aminobiphenyl (N-OH-ABP) (Figure 2) (Miller et al., 1961;
Hammons et al., 1985; Guengerich and Shimada, 1991). The detoxification
reactions of ABP that occur mainly via liver N-acetyltransferases compete
with the formation of N-OH-ABP by liver monooxygenases. Detailed
investigations have demonstrated that purified liver cytochrome P-450
isoenzymes are active in the oxidation of ABP to N-OH-ABP (Masson et al.,
1983; Guengerich et al., 1988). Recently, in humans, N-hydroxylation of
ABP was demonstrated to be catalyzed predominantly by the liver cytochrome
P-450 IA2 enzyme (Butler et al., 1989a; 1989b).
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0
Figure 2.
Proposed Pathways of Metabolic Activation of ABP by N-hydroxylation or
Detoxification of ABP by N-acetylation in Humans (based upon Beland and
Kadlyjbar, 1986).
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The metabolism of related aromatic amines has been studied in parallel
with ABP. The carcinogen AAF is activated in vivo in two steps:
N-hydroxylation of AAF by P-450 enzymes results in formation of N-OH-AAF,
this is followed by esterification by N-acetyltransferases or
sulfotransferases to form the highly reactive N-acetoxy-AF or the sulfuric
acid ester, respectively (Kriek and Westra, 1979; Miller and Miller, 1981).
Alternatively, N-OH-AAF could be deacetylated by liver enzymes to form the
reactive N-hydroxy-AF compound (King and Glowinski, 1983).
In most species, BZ compounds are N-acetylated to N-acetylbenzidine
(ABZ) by liver N-acetyltransferases before N-hydroxylation by P-450 enzymes
occurs (Morton et al., 1979). ABZ and DABZ have been shown to be better
substrates than BZ for the liver P-450 enzymes (Hammons et al., 1985).
Genetic variations in the ability to activate arylamines through
N-oxidation by the cytochrome P-450 enzymes has been observed in humans
(Butler et al., 1989a). A combination of the rapid arylamine oxidizer/slow
acetylator phenotype has been suggested to be more susceptible to
arylamine-urinary bladder carcinogenesis (Kadlubar et al., 1990). An
individual with this phenotype may not be able to rapidly detoxify aromatic
amines such as ABP. Consequently, the fast oxidation of these compounds
would result in them being transported via the circulation to the bladder
where they could form adducts with cellular DNA. A recent study
demonstrated that a combination of a slow acetylator phenotype with a fast
metabolic oxidizer phenotype formed the highest number of ABP-Hb adducts
(Bartsch et al., 1990). Since i-oxidation is a critical initial step in
the activation of arylamines which leads to the formation of Hb adducts,
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the presence of these adducts could be used as a biomarker of exposure to
aromatic amine carcinogens.
Metabolism of Aromatic Amines in In vitro Cell Systems
The metabolic activation of aromatic amines has been studied in both
animal models and cell culture systems. Studies using isolated liver
microsomes from different species have demonstrated that N-hydroxylation by
hepatic monooxygenases is an important step in the metabolic pathway for
most animals (McMahon et al., 1980). Bladder epithelial (urothelial) cells
from rats, cattle and dogs have been shown to have the capacity to
N-hydroxylate aromatic amines (Poupko et al., 1983). The results of in
vitro studies with isolated hepatocytes from different species have shown
that the extent of N-hydroxylation of ABP correlates with the occurrence of
N-hydroxylated-ABP compounds in the urine of the same species (Jatoe and
Gorrod, 1987).
Other studies have shown that N-hydroxylated metabolites of ABP and AF
were effective in inducing more unscheduled DNA synthesis in cultured dog
urothelial cells compared to rats or rabbits (Wang et al., 1985; Wang et
al., 1988a, 1988b). The results of these studies correlate with earlier
investigations which indicate that dogs are more susceptible than rats or
rabbits to arylamine-bladder carcinogenesis (Radomski, 1973).
The carcinogen-induced cytotoxicity of the N-hydroxylated
metabolites of ABP has been demonstrated in experiments performed with
cultured human uroepithelial cells (HUC) (Reznikoff et al., 1986). The
findings confirm that N-hydroxylation of ABP is an essential step in the
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activation of this compound to a carcinogenic agent. More recent
experiments using HUC have shown that N-OH-ABP can be metabolized to ABP
and 4-acetylaminobiphenyl (AABP) (Swaminathan and Reznikoff, 1988;
Swaminathan, 1988). These results indicate that N-OH-ABP could be
activated by urothelial N-acetyltransferases, indicating a role for the
bladder in the metabolism of ABP and related derivatives.
The activation of ABP to reactive metabolites in target tissues has
been investigated using purified bladder microsomal preparations (Poupko et
al., 1983). The results indicate that species differences exist in the
activation of ABP by bladder mucosa. Monooxygenases capable of activating
ABP were not found in the dog bladder, suggesting that hepatic N-oxidation
is a more relevant route for ABP metabolism in dogs.
In addition to N-oxidation in the liver as an activation step, recent
evidence suggests metabolism of ABP can occur in the target organ, dog
bladder, via the peroxidase-mediated pathway. In vitro studies have
demonstrated peroxidative activation of ABP and other bladder carcinogens
by prostaglandin H synthase (PHS), an enzyme present in dog urothelium
(Kadlubar et al., 1982b). Peroxidase activation of ABP has been observed in
studies with human bladder and dog bladder explants incubated with ABP
(Kadlubar et al., 1988a). Activation of BZ by PHS has been demonstrated in
dog urothelial cells (Wise et al., 1984) as well as in human bladder
microsomal preparations (Flammang et al., 1989).
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Metabolism of ABP in Dogs
Activation and metabolism of ABP has been studied using dogs as a model
because of similarities to humans in the pathogenesis of bladder
carcinogenesis (Block et al., 1978; Beland et al., 1983). In dogs, after
initial hepatic N-oxidation of ABP to N-OH-ABP, some of this species
becomes conjugated to a glucuronide moiety in the liver, and either the
resulting conjugate, N-hydroxy-ABP-N-glucuronide or the unconjugated
N-OH-ABP is transported to the bladder for subsequent elimination (Radomski
et al., 1977; Poupko et al., 1979; Kadlubar et al., 1977; Kadlubar et al.,
1991).
Initial studies had suggested that the majority of the N-hydroxy-ABP is
conjugated to the glucuronide; however, recent evidence indicates that the
most of the N-OH-ABP is filtered into the bladder as the free
hydroxylamine, while the glucuronide conjugate represents only 0.3% of the
total ABP entering the bladder lumen (Figure 3) (Kadlubar et al., 1988b;
Kadlubar et al., 1991). In dogs as well as in humans, it is believed that
some fraction of the N-glucuronide moiety may break down in the bladder to
form N-OH-ABP. The hydroxylamine compound is believed to undergo a change
to form a reactive metabolite presumed to be an aryl-nitrenium ion, which
binds to nucleic acids in bladder epithelial cells (Kadlubar et al., 1977;
Kadlubar et al., 1991).
Recent evidence has shown that urine voiding interval is an important
factor in the susceptibility to bladder tumorigenesis by ABP in dogs.
Higher levels of urothelial DNA adducts of ABP were obtained from animals
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a
Figure 3.
A Model for the Metabolism and Distribution of Metabolites of ABP and the
Formation of ABP-DNA and ABP-Hemoglobin Adducts in Dogs (adapted from
Kadlubar et al., 1991).
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that were subjected to longer intervals before urine voiding (Kadlubar et
al., 1987, Kadlubar et al., 1988b; Kadlubar et al., 1991). These studies
provide evidence that in the dog bladder, ABP-DNA adducts are formed from
N-OH-ABP as a function of urine retention time more than as a function of
urine pH.
The metabolism of other bladder carcinogens has also been studied in
dogs. Since BZ is a bladder carcinogen, and dogs have been found to be
unable to acetylate arylamines (Poirier et al., 1963; Lower and Bryan,
1976), other routes of BZ metabolism in dogs have been investigated. One
predominant route of activation of BZ is through peroxidative metabolism in
extrahepatic tissues by PHS (Kadlubar et al., 1982b; Wise et al., 1984). A
recent study investigated the possible pathways of tumor induction by BZ in
dogs (Lakshmi et al., 1990). The authors concluded that in vivo oxidation
by PHS is a likely route of BZ metabolism in dogs (Lakshmi et al., 1990).
Formation of DNA Adducts of Aromatic Amine Compounds
Once chemical carcinogens are metabolized, these metabolites can react
with different sites in cellular DNA to form a variety of carcinogen-DNA
adducts (Miller and Miller, 1981). Chemical-DNA lesions that are not
repaired by cellular enzymes may serve as precursors to mutations during
replication of DNA (Loeb, 1989). Inter-individual variation in the
metabolism of chemical carcinogens, in the spectrum of formation of
chemical-DNA adducts of carcinogens, as well as in the repair of
carcinogen-DNA lesions play a significant role in individual susceptibility
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to cancer development (Harris, 1989; 1991). Knowledge of the individual's
genetic predisposition to cancer as well as improved methods in the
detection of carcinogen-DNA adducts may provide the best methods for risk
assessment (Kadlubar et al., 1988c).
The study of DNA adduct formation by ABP and related carcinogens has
been well studied both in vitro with cell culture systems and in vivo with
experimental animals. The formation of DNA adducts of ABP may represent an
initial step in the formation of tumors induced by ABP. One study has
demonstrated that ABP can be transferred from the blood into the milk of
lactating female rats; this may represent a significant source of exposure
to the nursing offspring of these rats (La Voie et al., 1989). As might be
expected, liver ABP-DNA adducts were detected in the nursing pups as a
result of this ABP exposure. Another study using the technique of 32P-
Postlabeling of DNA demonstrated that ABP can traverse the placenta of
pregnant mice and form DNA adducts in fetal organs (Lu et al., 1986).
The assay of carcinogen-DNA adducts as biomarkers for exposure has been
demonstrated successfully using a noninvasive procedure to analyze the DNA
originating from exfoliated urothelial cells (Talaska et al., 1990). A
very recent study has detected the levels of ABP-DNA adducts to be 2-20
fold higher in the exfoliated urothelial cells from smokers versus
nonsmokers (Talaska et al., 1991b). In addition, this report indicated a
positive correlation with the presence of urothelial DNA adducts and the
mutagenicity of urine in bacterial mutagenesis assays.
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Spectrum of ABP-DNA Adduct Formation
The formation of DNA adducts of ABP has been extensively studied in
dogs as the model system, because of similarities to man in the development
of bladder tumors after exposure to ABP and other aromatic amines (Beland
and Kadlubar, 1986).
There are three major DNA adducts formed in vivo when ABP is
administered to dogs (Kadlubar et al., 1982a; Beland and Kadlubar, 1985).
For ABP adduct analysis, the DNA from dog bladder was isolated, and both
the extent of binding and the adduct profile were determined. The
urothelial DNA was enzymatically hydrolyzed and the resultant nucleosides
were analyzed by high pressure liquid chromatography (HPLC). The adducts
were identified as N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP),
N-(deoxyguanosin-N 2-yl)-4-aminobiphenyl (dG-N 2 -ABP), and
N-(deoxyadenosin-8-yl)-4-aminobiphenyl (dA-C8-ABP); these adducts represent
approximately 75%, 15%, and 10% of the binding in vivo to DNA, respectively
(Figure 4).
An analysis of both dog urothelial and liver DNA indicated that ABP-DNA
adduct binding increased between 1 and 2 days after ABP administration and
remained constant for another 5 days (Beland et al., 1983; Beland and
Kadlubar, 1985) in both liver and bladder DNA. In dogs, only the bladder
and not the liver has been reported to be a target for tumor formation by
ABP (Radomski, 1979).
A similar distribution of binding in vitro was observed when
Salmonella typhimurium was treated with (N-OH-ABP) or when N-OH-ABP was
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Figure 4.
Structures of the DNA Adducts of 4-Aminobiphenyl
(from Beland and Kadlubar, 1985).
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reacted, at pH 5, with calf thymus DNA (Figure 4) (Kadlubar et al., 1982a;
Beland et al., 1983; Beland and Kadlubar, 1985).
In addition to ABP and N-OH-ABP, other reactive ABP compounds have been
used to form ABP-DNA adducts (Figure 5) (Beland et al., 1983; Lasko et al.,
1988). When the reactive metabolite of ABP, N-acetoxy-N-trifluoroacetyl-
ABP (N-OAc-TFAABP) was reacted with DNA, the major adduct was determined to
be the dG-C8-ABP adduct (Lasko et al., 1988; Beland et al., 1990; Tamura
and King, 1990).
In an experiment performed with HUC cytosol fractions incubated with
N-OH-ABP, acetyl-CoA and calf thymus DNA, the major ABP-DNA adduct formed
was identified as the dG-C8-ABP adduct (Swaminathan and Reznikoff, 1988).
The results of this study demonstrate the potential capacity of the human
bladder in ABP metabolism and DNA adduct formation.
Recent studies have demonstrated that the predominant carcinogen-DNA
adduct detected in biopsy tissue samples from urinary bladders of cigarette
smokers was identical to a synthetic ABP-deoxyguanosine (dG) adduct,
dG-C8-ABP, based on chromatographic data (Talaska et al., 1991a). In
addition, the dG-C8-ABP adduct detected in exfoliated urothelial cells from
dogs given ABP was chromatographically identical to that found in
exfoliated urothelial cells from smokers (Talaska et al., 1990; Talaska et
al., 1991b).
The crucial step in the activation of ABP and resulting DNA adduct
formation is by N-oxidation catalyzed by the P-450 oxygenases; however,
studies have demonstrated that purified PHS enzyme from dog urothelium was
also able to activate ABP to form DNA adducts (Kadlubar et al., 1988a).
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Figure 5.
Structures of Reactive ABP Compounds.
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The major adduct formed, preliminarily identified as an iminoquinone, was
different from those formed from reaction with N-OH-ABP. In addition, in
vivo studies with bladder explants from humans and dogs have shown that the
peroxidase-derived adduct formed predominantly in these tissues (Kadlubar
et al., 1988a). However, in dogs given a single dose of ABP, the
iminoquinone formed to a minor extent; even after multiple dosing this
adduct was apparently not evident.
DNA Adducts of Related Aromatic Amine Compounds
The arylamide of ABP, 4-acetylaminobiphenyl (AABP) forms primarily
mammary tumors in rats (Shirai et al., 1981). When the hydroxamic acid of
AABP, N-OH-AABP, was reacted with rat liver DNA, the binding level of this
compound was considerably lower than the binding of the related aromatic
amide, N-hydroxy-2-acetylaminofluorene (N-OH-AAF) (Kriek, 1969; Beland and
Kadlubar, 1985). The lower number of adducts formed by AABP could be one
explanation for the finding that AAF is a more potent liver carcinogen than
AABP (Miller et al., 1961; Beland and Kadlubar, 1985). The DNA adducts
formed by AABP have been characterized: 80% of the adducts were determined
to be the deacetylated adduct, dG-C8-ABP, and the remaining were the
acetylated dG-C8-AABP adduct, and a minor 3-N2-dG-AABP adduct (Kriek and
Westra, 1979; Gupta and Dighe, 1984).
AAF is an extensively studied carcinogen that induces liver tumors in
rats (Wilson et al., 1941). In rat liver both the acetylated AAF adduct,
N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene, dG-C8-AAF, and the
corresponding deacetylated adduct, N-(deoxyguanosin-8-yl)-2-aminofluorene,
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dG-C8-AF, as well as a minor 3-(deoxyguanosin-N2-yl)-AAF, dG-N2-AAF, are
formed (Figure 6) (Kriek and Westra, 1979). In rats, the deacetylated
adduct accounts for 80% of the binding after a single dose of AAF or N-OH-
AAF (Kriek, 1969). The acetylated adduct, dG-C8-AAF has a half-life of 7
days, while the deacetylated adduct, dG-C8-ABP was relatively persistent in
rat liver DNA (Visser and Westra, 1981). The formation of acetylated
adducts of AAF probably arises through the sulfotransferase pathway while
the deacetylated adducts form through N,O acyltransfer or deacetylation of
N-OH-AAF (Miller and Miller, 1981; King and Glowinski, 1983). Reaction of
DNA with the ultimate carcinogenic metabolite,
N-acetoxy-N-acetylaminofluorene (AAAF), produces the dG-C8-AAF adduct and
the minor dG-N 2 -AAF (Miller and Miller, 1981; Beland and Kadlubar, 1985).
The reaction of N-OH-AF with DNA predominantly results in formation of the
dG-C8-AF adduct (Tang and Lieberman, 1983).
When the related aromatic amine 2-NA is reacted with DNA in vitro,
three adducts have been detected: a dG-C8-2-NA adduct, a dG-N2-2-NA adduct,
and a dA-N6 -2-NA adduct (Kadlubar et al., 1980). The dG-C8-2-NA was found
to be the most persistent adduct in bladder DNA, and, for this reason, some
workers have suggested it may be responsible for the carcinogenic effect of
2-NA (Beland and Kadlubar, 1985).
Acetylated BZ derivatives have shown to be N-hydroxylated and then
N-acetylated to form a DNA binding species (Morton et al., 1979; Martin et
al., 1982). The major DNA adduct formed in rats given BZ, or ABZ was
N-(deoxyguanosin-8-yl)-N'acetylbenzidine, dG-C8-ABZ. Two major BZ-DNA
adducts through the PHS peroxidative metabolic pathway have been identified
- 44 -
0
Figure 6.
Structures of the DNA adducts of N-acetyl-2-aminofluorene.
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(Yamazoe et al., 1988). The major one, N-deoxyguanosin-8-yl)-benzidine
(dG-C8-BZ), and a minor one, N,3-(deoxyguanosin-N7 ,Cs-yl)-benzidine were
detected in incubations of DNA with the peroxidase enzyme.
Aromatic Amines and DNA Interaction Studies
Although a spectrum of carcinogen-DNA adducts can form both in vivo and
in vitro from the reaction of aromatic amines with DNA, it may be the
persistence of the unremoved adducts in the DNA, and the nature of the
chemical-DNA adduct structure that are the primary determinants of the
biological effects of the adducts. The effects of these carcinogen lesions
in vivo probably depends on changes induced by the adducts in DNA
conformation that affect the structure and function of DNA.
As shown in many studies, when ABP binds to DNA the major adduct formed
is the dG-C8-ABP adduct. Binding studies of ABP to DNA have shown that the
dG-C8-ABP adduct resides in the major groove of DNA where it does not cause
much distortion and may not affect the base-pairing properties of the
adducted base (Broyde et al., 1985). A later study conducted by Abuaf et
al. (1987) has demonstrated that the binding of ABP to DNA induces a slight
B-Z transition in a poly (dG-dC) sequence. In general, it has been
suggested that ABP-DNA adducts cause minimal perturbation in DNA structure,
which may possibly permit these adducts to escape recognition by cellular
repair enzymes.
Compounds such as AAF, cause a major local distortion in DNA structure
when bound to DNA as the acetylated adduct, dG-C8-AAF (Hingerty and Broyde,
1982). The binding of AAF to poly (dG-dC) DNA induces a transitional
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change in the B-DNA conformation to a left-handed Z-DNA structure and
rotates the adducted dG-C8-AAF base from an anti to a syn conformation
about the N-glycosidic bond (Grunberger and Santella, 1981). A recent
study done by Koehl et al. (1989), investigated the effect of the position
of an AAF-DNA adduct within a DNA sequence that was determined from
mutagenesis studies to be a mutation-prone sequence. This study found that
the location of the AAF-adduct in the hot-spot sequence affected the local
structure of the DNA, inducing it from a B-DNA conformation to a Z-like DNA
structure. The results, however, do not correlate with the mutation data
within the hot-spot sequence (Burnouf et al., 1989).
In contrast to the acetylated AAF adduct, initial studies indicated
that much less of a conformational change was observed to occur with the
major AAF adduct formed in DNA in vivo, the deacetylated DNA adduct,
dG-C8-AF (Broyde and Hingerty, 1983). A more recent study investigated the
conformational changes induced in DNA by a dG-C8-AF adduct (Norman et al.,
1989). This study found that the dG-C8-AF adduct causes more of a
structural distortion in DNA than previously observed. In the sequence in
which it was situated, the dG-C8-AF adduct was found to form a more stable
base-pair (bp) with deoxyadenosine (dA) than with deoxycytosine (dC). This
favorable base-pairing structure was postulated to be responsible for the
predominant G -> T mutation formed by this adduct in vivo (Bichara and
Fuchs, 1985; Carothers et al., 1988).
Another study compared the presence of either an dG-C8-ABP or a
dG-C8-AF adduct in a pentadecamer ras gene sequence (Marques and Beland,
1990). The results of this study indicated that in this sequence the
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structural perturbations induced by these two carcinogen adducts were
similar; distortion of the DNA helix was minimal.
It has been suggested that the conformational properties of ABP-DNA adducts
compared to AAF or AF adducts may contribute to the similarities and/or
differences in the biological consequences of these compounds (Shapiro et
al., 1986).
Although ABP adducts form bulky lesions in DNA, if they are not removed
by cellular enzymes, they may pose a threat to the replication machinery of
the cell and possibly result in mutations during replication. The results
of DNA conformation studies have proposed that low energy syn conformers of
ABP that form due to rotation of the ABP adducted-base-sugar bond may be
mutagenic during DNA synthesis at the replication fork (Broyde et al.,
1985).
Replication and Repair of Aromatic Amine-Modified DNA
DNA Replication in E. coli
DNA replication in E. coli is normally an error-free process, with the
error frequencies in the duplication of the E. coli genome recorded at 10~9
to 10-10 per replicated base. The high fidelity of DNA replication is
achieved by three steps in the synthesis of DNA: (1) the correct selection
and incorporation of the complementary base during 5'-3' DNA synthesis; (2)
3'-5' exonucleolytic editing of an incorrectly inserted base at the end of
the DNA chain; and (3) the post-replication repair of DNA (Echols and
Goodman, 1990).
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In E. coli, DNA polymerase III holoenzyme is the major enzyme
responsible for DNA replication. DNA polymerase I plays a role in the
repair of damaged DNA and DNA polymerase II is believed to be involved in
the mutagenic response in E. coli (Echols and Goodman, 1990). The results
of in vitro assays have shown that an altered form of pol I, pol I*, may be
involved in SOS-induced mutagenesis (Lackey et al., 1982). Mutagenic
lesions in DNA can fall in two, but not necessary exclusive, categories:
(1) replication-blocking lesions, such as UV photodimers which inhibit DNA
replication; and (2) error-promoting lesions, such as alkylated bases which
allow replication but promote mispairing of these bases during DNA
synthesis (Walker, 1984; Echols and Goodman, 1990).
Nucleotide Excision Repair System of E. coli and its Influence on Aromatic
Amine-DNA Adducts
Most bulky, helix-distorting DNA lesions such as those formed by UV
radiation and aromatic amines such as AAF are replication-blocking lesions.
If they are not repaired by cellular enzymes, they may be lethal to the
genome of the cell. In bacteria, the nucleotide excision repair system has
been shown to remove a variety of chemical-DNA adducts from DNA (van
Houten, 1990). The E. coli excision repair system is controlled by three
genes: uvrA, uvrB, and uvrC (Grossman and Yeung, 1990). The products of
these genes control the initial step of the repair of DNA damaged by UV
radiation and bulky chemicals such as AAF. The corresponding repair
proteins, UvrA, UvrB and UvrC act together with UvrD (helicase) to excise a
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12-13 nucleotide sequence of the damaged region of the DNA (Sancar and
Sancar, 1988; Selby and Sancar, 1990).
The most widely studied aromatic amine-DNA adducts have been those
formed by AAF. Both the acetylated as well as the deacetylated adducts
have been recognized and repaired by the E. coli excision repair system
(Tang and Lieberman, 1983; Pierce et al., 1989; Seeberg and Fuchs, 1990).
The rates of removal of the acetylated adducts have been faster than that
of the deacetylated adducts probably owing to structural differences in DNA
perturbations induced by these adducts.
The availability of E. coli strains which are proficient, uvr+, or
deficient, uvr~, in the nucleotide excision repair functions has enabled
workers to study the repair and mutagenesis of bulky adducts such as UV
lesions and AAF-DNA adducts in E. coli (Howard-Flanders et al., 1966).
In Vitro Replication Assays on Aromatic Amine-modified Templates
DNA replication assays conducted in vitro with both AAF and AF adducts
have shown that the AAF adducts block or terminate DNA synthesis by DNA
polymerases (Moore et al., 1980; Fuchs et al., 1983; Sahm et al., 1989).
Experiments with double-stranded DNA modified with AAAF have shown that DNA
adducts formed by this compound block DNA synthesis at the replication fork
where the adducted-DNA is single-stranded, thus probably resulting in
lethality or mutation at that site (Armier et al., 1988).
In contrast, accurate translesion synthesis of the AF adduct
predominantly occurs during in vitro synthesis on AF-modified templates
(Michaels et al., 1987; Strauss and Wang, 1990; Michaels et al., 1991).
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Other studies have observed mutations formed during in vitro assays with
AF-modified templates (Sahm et al., 1989). The majority of the mutations
were -1 deletion of G's and G -> T transversions at putative dG-AF adducts.
Mechanisms of Mutagenesis by Chemical-DNA Adducts
Mutations in DNA can occur as a result of mispairing of modified DNA
bases during DNA replication or ineffective repair of DNA adducts prior to
or during DNA synthesis. An incorrect purine-pyrimidine bp can lead to
transition mutations, while a purine-purine bp can lead to a transversion
mutation (Topal and Fresco, 1976; Topal, 1988). These incorrect base pairs
can form through both chemical as well as structural perturbations of the
DNA (Loechler, 1988).
Mutations that occur during DNA replication could arise not only from
mispairing of adducted DNA bases but also from structural changes in the
normal base-sugar conformation induced by DNA adducts. A change in
conformation from anti to syn about the N-glycosidic bond between the base
and the deoxyribose moiety can permit mispairing of G.m with the imino
tautomeric forms of either A or G, or mispairing of Asm with the imino
tautomers of either G or A, thus resulting in mutations (Topal and Fresco,
1976; Swenson and Kadlubar, 1981). Speculations about the mispairing
possibilities of aromatic amine-adducted bases have led to predictions that
C8 and N2 -substituted guanines can result in G -> T or G -> C transversions
and GB-substituted adenines may cause A -> C or A -> T transversions
(Beland and Kadlubar, 1985; Loechler, 1988). In E. coli, most bulky
adducts formed by aromatic amines such as ABP at dG bases are repaired
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efficiently by the cellular repair systems; however, unrepaired adducts
could lead to mutations during DNA replication. Many studies have been
carried out in E. coli investigating the mutagenic specificity as well as
the mutational specificity of the DNA adducts formed by carcinogens in
these cells (Miller, 1983).
The SOS System of E. coli
E. coli has two major independent regulatory systems than can be
induced in response to DNA damage: (1) the SOS system which is controlled
by the RecA and LexA proteins, and (2) the adaptive response controlled by
the Ada protein (Walker, 1984). In E. coli, the first evidence of a
cellular response to damaging agents was provided in a study conducted by
Weigle (1953). The results of the experiment indicated that exposure of
the host bacterial cell to a low fluence of UV radiation prior to infection
with a UV-irradiated bacteriophage not only led to a substantial increase
in the survival of the UV-damaged phage but was required for a high level
of phage mutagenesis. This cellular phenomenon was later found to be
inducible by UV irradiation of E. coli and was responsible for both the
mutagenic reactivation of UV-irradiated phage and for error-prone repair of
bacterial DNA (Defais et al., 1971). The cellular phenomenon was
eventually promoted as the "SOS hypothesis" by Radman (1975).
The designation "SOS" suggested that damage to bacterial DNA or the
inability to replicate DNA initiated a signal that caused the derepression
of various gene functions all of which led to the enhanced likelihood of
survival for the cell or its phages (Witkin, 1976). The hypothesized
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mechanism of the SOS mutagenic pathway is that DNA replication is inhibited
by lesions in the template strand so that a base cannot be added opposite
the lesion during DNA synthesis (Strauss, 1989). As result of the
induction of the SOS gene products, DNA polymerase activity is altered so
that synthesis past the lesion occurs. This increased processivity comes
with a cost, however, in that there is an increase in the frequency of
mutations (Strauss, 1989).
The induction of the SOS response leads to various cellular repair and
mutagenic activities. The functions involve different types of DNA repair,
including postreplication recombinational repair, double strand break
repair, and long patch excision repair. The SOS response alters various
aspects of DNA replication, the most important of which is allowing the
replication complex to insert nucleotides opposite noncoding template
lesions known as the UmuDC-dependent error-prone translesion activity which
is responsible for SOS mutagenesis (Walker, 1984; Witkin, 1991).
Mutagenesis by UV lesions or bulky chemical adducts in E. coli is
dependent on the SOS error-prone system. The SOS response consists of the
derepression of approximately 20 din or "damage-inducible" genes that are
regulated by the RecA and LexA proteins. The expression of these genes are
important in the excision-repair of bulky adducts (uvrA, B, and C gene
products) and the mutagenic processing of damaged DNA (functions of the
umuDC operon) (Walker, 1985).
SOS induction and mutagenesis is comprised of two RecA-mediated
pathways of translesion synthesis and replication restart, both of which
involve alterations in DNA replication mediated by RecA and the UmuC-UmuD'
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proteins (Echols and Goodman, 1990). Recently much progress has been made
to elucidate the role of the various proteins in the regulation and
expression of the SOS response. The major regulator in the SOS system
appears to be the RecA protein, which is now presumed to have three roles
in SOS mutagenesis (Echols and Goodman, 1990).
The first role of RecA is in regulation of the expression of the SOS
genes. It is believed that DNA damage generates a signal, presumably
single-stranded regions of DNA, to which RecA binds along with another
cofactor, probably dATP. This binding complex results in an altered form
of the RecA protein designated RecA*. RecA* facilitates the proteolytic
autocleavage of the LexA protein, which is the repressor of the genes of
the SOS regulon, including the recA gene itself as well as the umuDC genes
(Sweasy et al. 1990). When DNA repair is completed or replication of DNA
is resumed, RecA is no longer activated, LexA is no longer cleaved and the
repression of the SOS genes is restored (Witkin, 1991). Recent evidence
suggests that the UmuD protein may also be important in the decay of the
SOS response (Battista et al., 1990b).
In its second role, RecA protein has been shown to activate proteins by
facilitating the autocleavage of the UmuD protein to the form, UmuD', which
is the form active in SOS mutagenesis (Burckhardt et al., 1988; Nohmi et
al., 1988; Shinagawa et al., 1988). Only UmuD' has been shown to be
functional in SOS-induced mutagenesis (Nohmi et al., 1988). One current
hypothesis is that UmuC and UmuD' form a complex and may facilitate
elongation of DNA by polymerase III past a DNA lesion (Battista et al.,
1990a). Recent evidence suggests that the intact UmuD protein is a
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negative regulator of its cleaved product, the UmuD' protein (Battista et
al., 1990b). These workers demonstrated that UmuD-UmuD' heterodimers form
in vitro and postulated that these complexes lead to the decline of the SOS
response in E. coli.
A third direct role for RecA in SOS mutagenesis has been hypothesized
(Battista et al., 1990a; Sweasy et al., 1990). Studies have indicated that
RecA may inhibit the 3'-5' proofreading exonuclease of the epsilon subunit
of the DNA polymerase III complex (Lu et al., 1986; Witkin, 1991). Two
possible mechanisms have been suggested for the role of RecA in SOS
mutagenesis (Echols and Goodman, 1990). RecA may be involved in
translesion mutagenic replication, or replicative bypass I, in which RecA
protein binds to a DNA lesion facilitating polymerase III bypass of the
damaged base. Alternatively, RecA may be involved in replication restart,
or replicative bypass II, in which pol III might bypass the lesion by
copying the undamaged strand (Dutriex et al., 1989; Woodgate et al., 1989).
Elucidation of the biochemical mechanisms of RecA, UmuD and UmuC in SOS
mutagenesis using purified proteins remains to be established.
Analogues of the umuc and umuD mutagenic processing genes of E. coli
have been found in naturally occurring plasmids found in bacteria. A
derivative of the Salmonella typhimurium plasmid R46, plasmid pKM101, which
encodes the mucA and mucB genes, has been used in the Ames assay to enhance
the susceptibility of cells to mutagenesis (McCann et al., 1975; Walker,
1978). The products of the mucA and mucB genes are important in the
mutagenesis resulting from bulky DNA adducts in bacteria (Walker, 1984).
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Plasmid pGW16, a mutant of pKM101, has been shown to induce high mutation
rates in E. coli (Walker, 1978; Lasko et al., 1988; Little et al., 1991).
Mutagenesis Studies with Aromatic Amines in Bacteria
The early mutagenesis studies with aromatic amines were carried out in
S. typhimurium, a strain that is sensitive to aromatic amines that are
carcinogenic for humans and animals. Subsequently, mutation assays were
conducted in E. coli to evaluate the genotoxicity of a wide range of
chemicals. The bacterial studies were then used as models to develop
mutagenesis studies with mammalian cell culture systems.
Mutagenesis Assays in S. typhimurium
The initial S. typhimurium mutation assays were developed in the
laboratory of Ames and colleagues (Ames et al., 1975; McCann et al., 1975).
Within a short time the investigators had demonstrated that 85% of the
carcinogens tested were found to be bacterial mutagens in their
experimental system.
The mutagenicity of ABP and related aromatic amines has been
investigated using the S. typhimurium assays (McCann et al., 1975). In
these assays the his gene of S. typhimurium is used as the target for
mutation. The S. typhimurium strains used are described as follows: TA1538
is a frameshift tester strain; its derivative, TA98, harbors the plasmid
pKM101. TA1535, another tester strain, is used to detect bp substitution
mutations at a G-C bp target and TA100 is a derivative of this strain
containing pKM101 (Maron and Ames, 1984). The presence of pKM101 in
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S. typhimurium tester strains has been observed to enhance the SOS-
dependent mutagenesis by various chemicals (McCann et al., 1975; Walker,
1978).
Either ABP in the presence of a metabolic activating system (liver S-9
fraction), or N-OH-ABP caused mutations in S. typhimurium strains TA1538,
TA98 and TA100, but not TA1535 (El-Bayoumy et al., 1981; Beland et al.,
1983). Mutagenesis by ABP was highest towards TA98 with the S-9 activating
system and AF was found to be mutagenic in TA98, TA1538 and TA100 (Scribner
et al., 1979). Connor and coworkers (1983) found ABP, AF and AAF to be
mutagenic in TA98 with the S-9 enzyme fraction with the order of
mutagenicity being AF > AAF > ABP > AABP. In TA100, AF was approximately
equivalent to ABP.
For BZ, either N-acetylation or peroxidative metabolism could produce
reactive metabolites that were mutagenic in bacteria (De France and
Josephy, 1987). The requirement for acetylation enzymes in the metabolic
activation of BZ was demonstrated using the S. typhimurium/hepatocyte assay
(Neis et al., 1984). In this study BZ was found to be mutagenic in the
S. typhimurium/rat hepatocyte system; however, ABP was more mutagenic with
S. typhimurium and only with the S-9 enzyme fraction from hepatocytes.
Acetylation is a metabolically activating step in BZ metabolism; however,
it is a detoxification step in ABP metabolism (Kadlubar et al., 1982b; Hein
1988).
In assays conducted with S. typhimurium TA104, a strain carrying
pKM101, which can be used to detect mutations at an A-T bp target (Levin et
al., 1984), ABP treatment resulted in increased reversion to his
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prototrophy (Lasko et al., 1988). Together, the results from the
S. typhimurium studies demonstrate that mutagenesis by ABP and related
aromatic amines is enhanced in the presence of SOS-processing functions
with frameshift mutations and base-pair substitution mutations occurring at
both C-C and A-T bp targets.
Mutagenesis Studies in E. coli
The mutagenicity of ABP and related aromatic amines has also been
studied using various mutation assays in E. coli. N-OH-ABP was observed to
be a direct-acting mutagen in E. coli WP2uvrA, an excision-repair deficient
strain. An increased level of mutation was observed in the same cells that
contained the plasmid pKM101 (Pai et al., 1985).
A recent study investigated AAF mutagenesis directly in the lacI gene
of E. coli (Schaaper et al., 1990). These investigators treated bacterial
cells with AAAF and analyzed the mutations formed in vivo. The mutations
were found to be a mixture of both base-substitution and frameshifts,
suggesting that the mutations formed probably arise from both the
acetylated (AAF) adducts as well as the deacetylated (AF) adducts. The
latter was suggested to be formed from deacetylation of AAAF in the
bacterium prior to reaction with DNA (Schaaper et al., 1990).
Mutagenesis Assays Using Plasmid or Viral-Based Vectors
Extensive studies have been conducted with aromatic amines using
plasmid or viral-based vector systems in mutagenesis assays in E. coli.
This section will first review the biology of M13 bacteriophage, the vector
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used in viral-based assays reported in this dissertation as well as in many
other studies. Subsequently, mutagenesis studies in E. coli with aromatic
amine-modified M13 vectors or extrachromosomal plasmids modified with
aromatic amines will be reviewed.
The M13 Bacteriophage Experimental System
M13 Life Cycle
M13 is a single-stranded filamentous bacteriophage that infects E. coli
cells containing an F factor plasmid (Figure 7). M13 adsorbs to the F
pilus on male bacteria and releases its DNA into the cytoplasm of the cell.
After infection, once the single-stranded viral DNA (the plus strand) is
inside the cell, the complementary strand (the minus strand) is synthesized
using the host cell replication enzymes to form the duplex replicative form
(RF) DNA. After the RF is formed, M13 protein synthesis takes place. The
M13 genome encodes ten essential genes required for phage viability as well
as an intergenic region (IR), which bears the origins of replication. The
RF DNA is converted to viral DNA by the rolling circle method of
replication after M13 gene II protein nicks the plus strand of the duplex.
When the intracellular pool of RF molecules has accumulated to about
100-200 copies, DNA synthesis is focused on producing viral strands. The
M13 gene V protein sequesters the newly synthesized viral strands and
together with M13 gene VIII product, which forms the major coat protein of
the bacteriophage, the viral DNA is packaged, and extruded out of the cell
as phage particles (Ray, 1978; Rasched and Oberer, 1986). M13
bacteriophage does not lyse its host but infected cells grow more slowly
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Figure 7.
The Life Cycle of Bacteriophage M13. Phage infection of an M13 host strain
occurs via the pilus. Alternatively, M13 ss or RF DNA can be taken up by
the cell via a calcium chloride/heat shock transfection procedure. Details
are described in text (adapted from Bradley, 1991).
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than uninfected cells. Infectivity with M13 can be high, leading to a
phage titre of 1012 phage particles or plaque-forming units/mL (PFU/mL) of
bacterial culture (Messing, 1983).
13 as a Cloning Vector
The M13 RF genome has been modified to form cloning vectors (the Ml3mp
series) that contain within the IR region, a portion of the lac gene
regulatory system (operator and promoter), a part of the lacZ gene (the a
fragment) and a series of unique restriction sites that can be used for
insertion of DNA fragments (Messing et al., 1977) (Figure 8). When M13mp
phage, M13 ss or RF DNA is inside an appropriate host cell (lacZ 2M15), a-
complementation can occur between the lacza gene in the M13 genome and the
lacZ AM15 deletion of the lacZ gene carried on an F episome (F') in the
host bacterium (Langley et al., 1975; Welply et al., 1981). The lac operon
can be induced by IPTG (isopropyl-#-D-thiogalactopyranoside), a synthetic
inducer that binds the Lac repressor, thus permitting transcription of
lacza mRNA from M13 RF DNA. The gene product of the a gene fragment, the
NH2 portion of the protein, complements the COOH portion of the protein
produced from the w fragment of the lacZ gene on the F' in the host cell.
This results in expression of a biologically active protein,
p-galactosidase, an enzyme that cleaves lactose or a synthetic substrate
such as X-gal (5-bromo-4-chloro-3-indolyl-#-D-galactopyranoside) into its
respective subunits (Messing, 1983). Normal beta-galactosidase production
results in cleavage of a chromogenic substrate such as X-gal (an indicator
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Figure 8.
The M13 Cloning Vectors used in the study of 4-aminobiphenyl mutagenesis in
E. coli. M13mplO single-stranded and double-stranded DNA were used in the
random mutagenesis experiments. Two derivatives of M13mp19+ double-
stranded DNA were used in the site-specific mutagenesis experiments.
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dye) to yield an indigo compound that produces blue plaques on an indicator
plate containing M13 host cells, X-gal and IPTG.
The 113 IacZ Gene Mutation Assay
The M13 phage genome can be used as a facile and useful system for
mutagenesis studies (Kunkel, 1984; Loechler et al., 1984). The lacza gene
in the M13mp genome serves as the target for mutation
in this system. M13 phage DNA (ss DNA) or M13 RF DNA (double-stranded or
ds DNA) can be treated with chemical agents, introduced into host cells,
replicated in vivo and then analyzed for mutations. When M13 is plated on
appropriate host cells, such as E. coli GW5100 (lacZ AM15), X-gal and IPTG,
plaques with a blue phenotype (wild-type) are produced after infection by
M13 phage. Mutations in the lacza gene that affect the biological
properties of #-galactosidase result in proteins that are either slow to
cleave X-gal, producing light-blue plaques, or inactive proteins that yield
colorless plaques on indicator plates (Figure 9).
The lacZ forward mutation assay has been used to evaluate the
mutagenicity of ABP-DNA adducts (Lasko et al., 1988); AF-DNA adducts (Gupta
et al., 1988) and AAF-DNA adducts (Gupta et al., 1991) in the lacza gene of
randomly modified M13 ss or ds genomes. This forward mutation assay can be
used to detect many bp substitution mutations as well most insertions and
deletions (Kunkel et al., 1984).
For site-specific mutagenesis assays, DNA adducts of ABP (Lasko et al.,
1988), AF and AAF (Reid et al., 1990) have been situated in the cloning
region of the lacZ gene at a site where bp substitution mutations should
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Figure 9.
The M13 lacZa gene Mutation Assay. The #-galactosidase alpha protein
synthesized from the lacZ gene of the M13 genome complements the #-
galactosidase omega protein produced from the M13 host bacterial cell to
form an active #-galactosidase polypeptide. Four #-galactosidase
polypeptides aggregate into a tetramer to form an active 6-galactosidase
enzyme (adapted from Lasko, 1986).
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not disrupt normal production of A-galactosidase; however, insertions,
deletions or in-frame termination codons would affect the normal expression
of the lacZ gene.
Mutagenesis Studies with Aromatic Amine-Modified DNA in E. coli
Assays with Globally-Modified Vectors
The mutational spectrum of ABP and the survival of ABP-modified M13mplO
RF DNA in E. coli have been assayed in a random mutagenesis experiment
conducted in our laboratory (Lasko et al., 1988). This study demonstrated
that survival of ABP-modified M13mpl duplex genomes in excision-repair
proficient strains (uvr+) was higher than in excision-repair deficient
cells (uvrA or uvrc). When M13 ds DNA, randomly adducted with ABP, was
transfected into uvr* cells containing pGW16, there was a 40-fold increase
in mutagenesis above background in an SOS-processing environment. The
primary mutations observed in the lacZ gene were found at dG sites with
G:C -> T:A and the G:C -> A:T mutations representing the majority of the
sequence changes (Lasko et al., 1988).
A later study compared the genotoxic effects of DNA adducts formed by
AABP and ABP to DNA adducts formed by AAF and AF in a plasmid pBR322 assay
system (Tamura and King, 1990). These workers were investigating the
influence of the excision repair of deacetylated and acetylated DNA adducts
on plasmid survival. The results indicated that there was no significant
difference in the genotoxic effects between AABP and ABP on the survival of
adducted plasmid DNA in E. coli. In addition, AABP-DNA adducts were as
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genotoxic as ABP-adducted plasmid DNA in uvr+ strains compared to uvr~
strains. In contrast, the AAF-DNA adducts were more genotoxic than the AF-
DNA adducts in plasmids replicated in either uvr* or uvr~ strains. The
authors postulated that structural differences between AABP and AAF adducts
were responsible for the differences in genotoxicity induced by the two
adducts.
In studies done with reactive metabolites of AAF, an AAAF-treated
plasmid was demonstrated to be highly mutagenic in E. coli (Koffel-Schwartz
et al., 1984). The reaction of the ultimate carcinogen, AAAF, with DNA
produces primarily acetylated dG-C8-AAF adducts. The majority of mutations
induced by this carcinogen were SOS-dependent frameshifts in the
tetracycline gene of pBR322. These mutations fell into two categories: -1
frameshifts at repetitive dG sequences; and -2 G-C frameshift mutations at
Nar I, 5'-GGCGCC-3' sequences, which were umuDC-independent (Koffel-
Schwartz et al., 1984). In addition, there was no direct association
between the preferential sites of AAF-DNA modification and the AAF mutation
spectrum (Fuchs, 1983). The results suggest that there are mutation-prone
sequences in which the binding of the carcinogen to the DNA may induce a
conformational change such that the lesion becomes a target for the enzymes
or proteins involved in the processing of the lesion into a mutation
(Bichara and Fuchs, 1985). A recent study using an AAAF-modified M13
double-stranded vector showed that AAF adducts induced both -1 G
frameshifts and various bp substitution mutations in the lacZ gene target
of M13 with approximately equal frequency (Gupta et al., 1991). The
authors suggest that differences in the types of vectors used in the
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mutation assays as well as the different mutational targets may contribute
to the differences in the observed mutations from the plasmid system of
Fuchs and coworkers (Koffel-Schwartz et al., 1984).
By contrast, mutations caused by the reactive AF metabolite, N-OH-AF,
which forms primarily the deacetylated adduct, dG-C8-AF, in a plasmid
vector were predominantly G:C -> T:A bp substitution mutations (Bichara and
Fuchs, 1985). Mutagenesis by AF was shown to be dependent on the SOS umuDC
gene functions of E. coli. The requirement for SOS induction for a
significant increase in mutation frequency with an N-OH-AF treated M13mplO
duplex genome was demonstrated in a study conducted by Ross et al. (1988).
The results of this study showed that without prior SOS induction of the
host cell, mutation frequency of the adducted DNA did not significantly
increase above background. Another study compared N-OH-AF mutagenesis
induced in M13mp8 ss and ds DNA (Gupta et al., 1988). In this assay, the
mutation frequency of M13 ss DNA modified with N-OH-AF increased 10-fold
above background in SOS-induced cells. In AF-modified ds DNA the increase
in mutation frequency was less than in ss DNA. Presumably, adducts in ss
DNA are more mutagenic than adducts in ds DNA owing to the increased
capacity for ds DNA repair by the host cellular enzymes (Lindahl, 1979).
Differences in the types of DNA-adducts formed by different aromatic
amines and the alterations in DNA structure induced by these aromatic
compounds may account for the differences in mutagenicity of these
compounds and types of mutations observed in bacterial test systems.
Together, the results from experiments conducted in E. coli suggest that
the gene products of the SOS system are important for the mutagenicity of
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DNA adducts formed by ABP and related aromatic amines as well as for the
survival of aromatic amine-modified ss and ds genomes. The results from
random mutagenesis experiments have been invaluable in the data they have
provided regarding both the mutation frequency induced by various aromatic
amines in similar assay systems as well as the mutational specificity of
the different aromatic amine compounds.
Although the mutational spectrum induced by a carcinogen is
informational, it is often difficult to assign a particular mutational
change to a specific carcinogen-DNA lesion. Advances made in the field of
single-lesion mutagenesis have enabled investigators to make hypothesis
about individual chemical-DNA adducts and test these hypothesis in the same
plasmid and viral systems used to study random mutagenesis induced by these
chemical carcinogens (Wood and Essigmann, 1991).
Assays with Site-Specifically Modified Vectors
It recently has become possible to study the biological effects of a
single DNA lesion situated in a vector that is replicated in vivo. Early
work in this field was conducted in E. coli, a host cell that is easy to
propagate and manipulate in culture. These accomplishments were made
possible by, (1) the availability of plasmids and viral genomes that could
be easily genetically engineered for the study of single-lesion mutagenesis
and (2) advances in the chemical synthesis of deoxyoligonucleotides
containing single chemical-DNA adducts (Basu and Essigmann, 1988).
Various methods have been described to construct genomes containing
single chemical-DNA lesions (Singer and Essigmann, 1991). One method
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involves ligating a site-specifically modified oligonucleotide into a
gapped duplex viral genome to create a singly-adducted vector (Green et
al., 1984; Naser et al., 1988). A second technique utilizes a primer
extension method to create a genome from a modified oligonucleotide
annealed to viral or plasmid genome (Chambers et al., 1985; Kodadek and
Gamper, 1988). The first relies on the placement of the adduct within a
restriction site in the genome, whereas the second method can be used to
situate the adduct at almost any site in the genome.
Initially, DNA adducts induced by alkylating agents were studied
because of the ease in which they could be synthesized and situated in
genetic vectors. The DNA adduct, 06-methlyguanine, is a minor product
formed by alkylating agents in DNA. The initial site-specific experiments
investigating the mutagenicity of the 06-methlyguanine adduct were
conducted by Loechler et al. (1984) and were followed by a number of
studies that employed different methods for studying in vivo mutagenesis
induced by alkyl-DNA adducts in plasmid or viral genomes (Chambers et al.,
1985; Bhanot and Ray, 1986; Hill-Perkins et al., 1986; Ellison et al.,
1989; Klein et al., 1990; Dosanjh et al., 1991).
The possible mutagenic roles of the specific DNA adducts of aromatic
amines and amides have also been extensively studied in E. coli (Lasko et
al., 1988; Moriya et al., 1988; Burnouf et al., 1989; Reid et al. 1990).
In a site-specific mutagenesis experiment, a single dG-C8-ABP adduct, when
present in a double-stranded M13mplO genome, was observed to be not
mutagenic even though ABP was mutagenic in the same duplex genome in random
mutagenesis experiments (Lasko et al., 1988). A bias against replication
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of the ABP-adducted strand of the singly-modified vector was suggested as
one explanation for this unexpected observation. In fact, this hypothesis
has been promoted based on a study conducted with a ds plasmid modified
with AAAF (Koffel-Schwartz et al., 1987). The investigators reported a
profound replication bias towards the unadducted strand when DNA adducts
were present on only one strand of a ds plasmid. The results of this study
are important because it suggests that adducts present in one strand of
duplex DNA may be rapidly repaired or bypassed in vivo and hence these data
may explain our observation of little or no mutagenesis in the
site-specific mutagenesis study (Lasko et al. 1988).
After these experiments were published, other results from our
laboratory found that adducts in ss DNA were more mutagenic than in ds DNA
(Basu et al., 1988; Bradley, 1991). To circumvent the dilemma of studying
single lesions in duplex vectors, researchers have placed UV lesions or put
uracil residues in DNA to inactivate one strand of a duplex genome or
plasmid vector thereby forcing replication onto the adducted strand during
in vivo synthesis of the singly-adducted vector (Burnouf et al., 1989; Reid
et al., 1990). Studies conducted in our laboratory have found that the use
of bacteriophage M13 is advantageous in that the ds as well as the ss DNA
forms of this bacteriophage can be manipulated and used to study single-
lesion mutagenesis (Basu et al., 1988; Lasko et al., 1988; Wood et al.,
1990).
Site-specific mutagenesis experiments with AAF adducts have
investigated the effect of a single dG-AAF adduct in a mutation prone
sequence in a plasmid vector replicated in bacterial cells (Burnouf et al.,
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1989). The position of the adduct within the 5'-GGCGCC-3' sequence
significantly contributed to the mutagenicity of the lesion in vivo. The
results observed from this investigation indicated that mutagenesis induced
by the adduct was SOS-dependent and the primary mutational change was a -2
frameshift, which is consistent with the mutational spectrum of AAF
observed by this same group (Koffel-Schwartz et al., 1984).
Another laboratory has investigated the genotoxic effect of either the
dG-C8-AAF or the dG-C8-AF adduct in an M13 vector replicated in bacterial
cells (Romano et al., 1988; Gupta et al., 1989; Reid et al., 1990).
Although the investigators report that the mutation frequency was increased
due to the presence of the adduct, most of the actual mutations observed
were not targeted to the site of the lesion in the vector (Gupta et al.,
1989). In fact the AAF adduct was found to be less mutagenic than the AF
adduct. The latter was found to induce -1 frameshift mutations in ds DNA
and bp substitutions in ds DNA containing uracil residues in the strand
opposite the adduct (Reid et al., 1990). In addition, the induced
mutations were observed to be different in SOS-induced and non-SOS-induced
backgrounds. An earlier study investigating a single dG-C8-AF adduct in
M13 DNA had also noted that this lesion induces -1 deletion mutations,
albeit in a non-SOS dependent manner (Mitchell and Stohrer, 1986). The
results of these studies do not correlate with the random mutagenesis
experiments with AF-modified DNA (Bichara and Fuchs, 1985). Differences in
the experimental systems used to assay the AF- and AAF-adducted genomes may
explain the different results observed by these groups (Burnouf et al.,
1989; Reid et al., 1990).
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While the assays using plasmid and viral-based assays were being
conducted, plasmids referred to as shuttle vectors were being developed to
study mutagenesis in both bacterial and mammalian cells. One of the first
studies investigating aromatic amine-DNA adducts using shuttle vectors was
conducted by Moriya et al. (1988). These workers found that a single
dG-C8-AAF lesion situated in a duplex vector was mutagenic at a high
frequency when assayed in bacteria without SOS-induction; the primary
mutation observed was the G -> C transversion. Once again, however, the
type of mutation observed is not what was expected based upon the
mutational spectrum induced by AAF in bacteria (Koffel-Schwartz et al.,
1984).
Mutagenesis Studies with Aromatic Amines in Mammalian Cells
Assays with Endogenous Genes of Mammalian Cells
Mutagenesis studies have also been conducted in mammalian cells with
aromatic amine-modified shuttle vectors as well in the endogenous genes of
mammalian cells in culture.
In mammalian cells, ABP, AAF and BZ in the presence of an activating
liver S-9 fraction, were found to induced TK~/~ mutations in the
L5178YTK+/- mouse lymphoma forward mutation assay (Oberly et al., 1984).
AAF was demonstrated to be mutagenic in the dihydrofolate reductase gene of
cultured Chinese hamster ovary cells (Carothers et al., 1988). The
majority of the induced mutations were base-substitutions in the dhfr gene.
The investigators found that the majority of the adducts that were analyzed
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after treatment of CHO cells in vivo with AAF were the deacetylated,
dG-C8-AF adducts (Carothers et al., 1988).
Although the AAF results in mammalian cells do not agree with the
results observed in bacteria (Koffel-Schwartz et al., 1984), they are
consistent with the theory that mammalian cells may possess deacetylase
enzymes that remove the acetyl group from AAF prior to reaction with DNA or
perhaps after adduction with DNA. This theory has been offered as an
explanation for the results observed in an early study conducted by Moriya
et al. (1988), in which a site-specifically dG-C8-AAF modified shuttle
vector was replicated in COS-1 monkey cells with a high mutation frequency.
The mutational changes induced by the lesion were G -> C and G -> T
transversions that occurred with approximately equal frequency. Although,
N-acetyltransferases that catalyze N,O-acyltransfer of acetylated compounds
have been detected in mammalian cells (Mattano et al., 1988), and could
explain the observations of Carothers et al. (1988); there is no
experimental evidence, however, to support the existence of an adduct
deacetylase.
Assays with Aromatic Amine-Modified Shuttle Vectors
The mutagenic effects of AAF and AF have been extensively studied in
shuttle vector systems by Maher and colleagues (Maher et al., 1989; Mah et
al., 1989; Mah et al., 1991). The mutations produced by an AF-modified
plasmid replicated in a human kidney cell line were primarily base-
substitution mutations, with G:C -> T:A being the predominant mutation (Mah
et al., 1989). A recent study conducted by this group compared mutagenic
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efficiencies between AAF and AF adducts in a shuttle vector replicated in
human cells (Mah et al., 1991). The results indicated a similar mutation
spectrum for both AAF and AF adducts, predominantly bp substitutions;
however, the authors were able to demonstrate that the AAF adducts in the
DNA were not deacetylated to AF adducts when the shuttle vector was
replicated in vivo.
The mutagenesis results observed by Maher and coworkers correlate with
the earlier findings of Carothers et al. (1988) and Moriya et al. (1988);
however, the mutational data for AAF observed in studies conducted in
mammalian cells do not agree with the results observed in bacterial cells
(Koffel-Schwartz et al., 1984). Differences in the mutagenic processing of
AAF and AF adducts between bacterial and mammalian cells or the effect of
unknown adduct repair mechanisms in mammalian cells may account for the
differences observed in these two systems.
Aromatic Amines and Oncogene Activation
The accurate repair of carcinogen-DNA adducts in the endogenous genes
of mammalian cells is crucial. Mutations caused either during repair or
replication of carcinogen-adducted DNA can be important if they cause DNA
sequence changes that result in the activation of proto-oncogenes (Topal,
1988). Activating mutations in oncogenes have been suggested to initiate
neoplastic changes in the phenotype of the normal cell to a pre-cancerous
type (Weinberg, 1989).
Two early studies investigated activated oncogenes in cell lines
derived from human bladder tumors (Tabin et al., 1982; Reddy et al., 1982).
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These studies demonstrated that activated oncogenes were found in both the
EJ and T24 human bladder carcinoma cell lines; in both cases the genetic
change that led to the activation was a G -> T point mutation at the second
position of the 12th codon, GGC, of the oncogene (Tabin et al., 1982; Reddy
et al., 1982). Characterization of the oncogene revealed that it was a
member of the H-ras family, oncogenes found in many types of tumors (Fujita
et al., 1984).
One of the first studies that many workers have interpreted to show
that chemical carcinogens can activate oncogenes in vivo was conducted by
Zarbl et al. (1985). The results of this study demonstrated that mammary
tumors induced in rats by the chemical carcinogen, N-methyl-N-nitrosourea,
show a G -> A mutation at the second position of the 12th codon, GGA, of
the H-ras gene. While it has not been directly shown that an 0-alkyl DNA
adduct caused the mammary tumor formation (other models are possible), it
is noteworthy that the type of mutation induced by 06-methylguanine in vivo
(Loechler et al., 1984; Ellison et al., 1989) matches that observed in
mammary tumors by Zarbl and coworkers.
The discovery of the H-ras oncogenes combined with the knowledge that
activation of these genes can occur by single bp mutations has been viewed
to lend support to the somatic mutation theory of cancer and the important
role of chemical carcinogens in the process of tumorigenesis (Brookes,
1989). It is emphasized, however, that other models for tumorigenesis by
chemical carcinogens are possible (R. Cha, unpublished observations).
In addition to the G -> T mutations found at the second position of the
12th codon, GGC, of the H-ras gene in bladder tumors, A -> T mutations at
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the 61st codon, CAG, have been reported (Nishimura and Sekiya, 1987;
Lawley, 1990). C -> C and C -> T changes at the first position of 12th
codon, GGT, of the K-ras gene have also been observed in bladder tumor
cells.
Studies investigating the mechanism of aromatic amine-induced
carcinogenesis have taken two approaches to identifying activating oncogene
mutations. In the first approach, Vousden and colleagues have transfected
a plasmid containing the human H-ras gene treated in vitro with AAAF into
NIH 3T3 cells (Vousden et al., 1986). The activating oncogene mutations
found were primarily C:G -> A:T and G:C -> T:A transversions at the first
and third positions, respectively, of the 61st codon, CAG, of the ras gene.
Another study investigated AAF-induced tumors in mice (Wiseman et al.,
1986). These investigators treated animals with N-OH-AAF and analyzed the
activating mutations by the NIH 3T3 assay. Of 7 AAF-induced hepatomas, 7
were found to contain a C:G -> A:T mutation at the first position of the
61st codon, CAA, of the H-ras gene.
A recent study demonstrated that BZ cogeners can activate ras oncogenes
in rats treated with these compounds (Reynolds et al., 1990). The majority
of the activating mutations that occurred in the ras gene represented three
groups: G:C -> A:T mutations at the first and second positions of the 12th
codon, GGA; G:C -> C:G mutations at the first position of codon 13, GGC,
and C:G -> A:T mutations at the first position of the 61st codon, CAA, of
the H-ras gene.
In addition to the involvement of ras oncogenes in carcinogenesis, the
presence of mutated or deleted forms of tumor suppressors genes such as the
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p53 gene in human cancers has been documented (Vogelstein, 1990). A recent
study has demonstrated mutations in the p53 gene in 61% of bladder tumors
that were analyzed (Sidransky et al., 1991). The types of base changes
that could have led to the alterations in the p53 gene include G -> C, G ->
A, and G -> T mutations.
The results of these studies suggest a good correlation between the
types of mutational changes induced by chemical carcinogens observed in
mutagenesis studies and the changes that have been observed to activate
proto-oncogenes or inactivate tumor suppressor genes in vivo. These
studies validate the use of in vitro assays to determine the mutagenic
potential as well as the mutational specificity of a chemical carcinogen.
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III. MATERIALS AND METHODS
Chemicals
4-Nitrobiphenyl, acetic anhydride and trifluoroacetic anhydride were
purchased from Aldrich Chemical Co. N-Hydroxy-aminobiphenyl (2,2'-[ 3H],
92 mCi/mmol) was purchased from Midwest Research Institute. Reagents for
synthesis of deoxyoligonucleotides were obtained from Applied Biosystems.
HPLC solvents were from Omnisolv. Adenosine triphosphate (ATP), Sepharose
CL-4B chromatography resin and ethidium bromide were purchased from Sigma
Chemical Co. DNA-grade hydroxylapatite (HAP), 5-Bromo-4-chloro-3-indolyl
#-D-galactopyranoside (X-Gal) and isopropyl #-D-thiogalactopyranoside
(IPTG) were purchased from Boehringer Mannheim Biochemicals. Radionuclides
[y32P]-ATP (6000 Ci/mmole) and [a 3 5S]-ATP (600 Ci/mmole) were obtained from
Dupont/New England Nuclear and Amersham Corporation, respectively.
Acrylamide, Bio-Gel A agarose resin, and polyacrylamide resin P4 were from
Bio-Rad Laboratories.
DNA Standards and Primers
The 8-32 base oligonucleotide molecular weight markers were purchased
from Pharmacia LKB Biotechnology. The lambda HindIII digest DNA markers
were purchased from Gibco Bethesda Research Laboratories (BRL). The M13
lacZ gene 17-base sequencing primer was synthesized at the Whitehead
Institute for Biomedical Sciences (Cambridge, MA). The M13 cloning region
15-base primer was purchased from New England Biolabs. The M13 "-40"
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17-base sequencing primer was purchased either from Pharmacia LKB
Biotechnology or the United States Biochemical Corporation. The 15-base
oligonucleotides used for the hybridization analysis were synthesized in
the Biopolymers Laboratory (MIT). DNA sequencing reagents were purchased
from either Amersham, Pharmacia LKB Biotechnology or the United States
Biochemical Corporation.
Enzymes
Exonuclease III (ExoIII) was purchased from Gibco BRL. DNA restriction
enzymes PstI, SmaI, and BgiII were purchased from Boehringer-Mannheim
Biochemicals or New England Biolabs. E. coli DNA polymerase I (Klenow
fragment), calf intestinal alkaline phosphatase (CIP), bacteriophage T4
polynucleotide kinase (T4 PNK), and T4 DNA ligase were purchased from
Boehringer Mannheim Biochemicals. Bacteriophage T4 polynucleotide kinase
was also obtained from New England Biolabs. T7 DNA polymerase, E. coli DNA
ligase and nuclease P1 were purchased from Pharmacia LKB Biotechnology.
Sequenase T7 DNA polymerase enzyme version 2.0 was obtained from the United
States Biochemical Corporation. Snake venom phosphodiesterase (type II)
was purchased from Sigma Chemical Co.
Bacterial Strains
The cell strains used in this study were derivatives of the E. coli
AB1157 (lac+, uvr+) strain, constructed in our laboratory (Lasko et al.
1988), and are listed as follows: excision repair-proficient E. coli DL7
cells ((AB1157, lac AU169, uvr*); and the isogenic excision-repair
deficient E. coli DL6 cells (AB1886, lac AU169, uvrA) (Table 1).
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Table 1.
Bacterial Strains
E. coli strain Relevant genotype Source
DL7
DL6
DL5
DL4
DL7/pGW1 6
MM294A
GW5100
NR8044
AB11157; lacAU169 ; uvr +
AB1886; /acAU169 ; uvrA
AB1885; lacAU169 ; uvrB
AB1884; lacAU169 ; uvrC
AB1157; lacAU169 ; uvr*;
(pGW16: mucA; mucB)
lac +
JM103 P1 -; lacZAM15;
M13 plating strain;
amber suppressor (supE)
IacZAM15 ; M13 plating strain;
opal suppressor
D. Lasko
D. Lasko
D. Lasko
D. Lasko
D. Lasko
K. Backman
L. Marsh
R. Dunn
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In addition, DL7 and DL6 cells induced for SOS functions by UV-irradiation
(Defais et al., 1976; Lasko et al., 1988) and DL7 cells containing the
mutagenesis enhancing plasmid, pGW16 (a derivative of pKM101; Walker,
1978), were used for transfection of ABP-modified M13 genomes.
Bacteriophage Vectors
The bacteriophage M13mplO stock used for producing the M13 single-
stranded and replicative form DNAs for generating the randomly ABP-modified
genomes was purchased from Pharmacia LKB Biotechnology. The initial
bacteriophage stocks of M13mpl9 insert genomes, M13mpl9(+6) and
M13mpl9(+10), used to make the gapped heteroduplexes vectors for the site-
specific mutagenesis studies were a gift from M. Benasutti and E. Loechler
(Boston University, Boston, MA) (see Figure 8).
Bacterial Culture Media
Media supplies for cell growth were from Difco laboratories. Luria-
Bertani (LB) media (1% tryptone, 0.5% yeast extract, 1.0% NaCl; Maniatis,
1982) was used to grow E. coli DL7, DL6 and DL7/pGW16 cells for
transformation by M13 ss and RF DNAs. E. coli DL7 and derivatives were
propagated on LB plates containing 1.5% Bacto-agar. SOC medium (2%
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM
MgS0 4, 20 mM glucose; Hanahan, 1985) was used for E. coli cells after the
electrotransformation protocol. The M13 host cells were propagated on M13
minimal A (Miller, 1972) plates containing 0.01% thiamine. Single colonies
of M13 host plating strains were grown in 2X YT media (1.6% tryptone, 1.0%
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yeast extract, 1.0% NaCl; Messing, 1983). M13 bacteriophage-infected or
M13 DNA-transfected cells were plated in B Broth soft agar (1.0% tryptone,
0.8% NaCl, 0.6% Bacto-agar; Messing, 1983) containing X-gal (0.5 pg/pL) and
IPTG (0.2 pg/pL) with fresh E. coli M13 host cells on B broth indicator
plates (1.0% tryptone, 0.8% NaCl, 2.0% Bacto-agar).
Preparation of M13 Bacteriophage DNA
Large-Scale Isolation of 13 RF and SS DNA
M13 bacteriophage ss DNA was prepared by a modified protocol of Messing
(1983). For large-scale isolation of M13 ss and RF DNAs, one liter (L)
cultures of an M13 plating bacteria strain (approximately 106 cells/mL)
were inoculated with an amplified M13 bacteriophage stock (approx. 1010
PFU/mL) and grown overnight in 2X YT medium at 37 *C. The following day
the bacterial/phage culture was spun in 250-ml centrifuge bottles in a
Sorvall centrifuge to pellet the bacterial cells. The pelleted cells were
saved to isolate the M13 RF DNA. M13 ss DNA was harvested from the
supernatant by PEG 8000/NaCl (20% PEG, 2.5M NaCl) precipitation. The
precipitated phage was resuspended in TE (10 mM Tris-Cl, 1.0 mM EDTA pH
8.0), extracted with phenol buffered with 0.1 M Tris-Cl (pH 8.0) (lX),
phenol-chloroform (1:1) (3X), chloroform (lX) and finally the phage ss DNA
was precipitated with ethanol and resuspended in TE. The ss DNA was
further purified over a HAP column equilibrated in phosphate buffer (0.14 M
KHzPO4 ; 0.14 M K2HPO4 ) and stored in TE at 4 *C.
M13 RF DNA was isolated from the phage-infected bacterial cells using a
modified version of the Triton-lysis procedure (Lasko et al., 1986;
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Sambrook et al., 1989). Briefly, the cell pellet from a 1 L
phage/bacterial culture was resuspended in Sucrose-Tris-saline buffer, and
lysed in a 0.5% Triton-Tris-EDTA-SDS solution. The lower molecular weight
nucleic acids were purified from the chromosomal DNA and the cell debris,
which were pelleted in an ultracentrifugation spin. The closed circular RF
DNA was further separated from nicked DNA and RNA by centrifugation
overnight in cesium chloride-ethidium bromide gradient conditions. The RF
DNA was removed from the gradient tubes, extracted with butanol to remove
the ethidium bromide, subsequently dialyzed against 1X TE to remove the
CsCl, and stored in TE at 4 'C.
Small-scale Isolation of H13 RF and SS DNA
For analysis of M13 mutant phage samples, small-scale preparations of
M13 ss and RF DNA were made. Briefly, 1.5 mL of 2X YT was inoculated 1:100
with an late-log phase culture of E. coli GW5100 and a single M13 phage
plaque and grown in a culture tube for 3 hours (hr) on a tube rollerdrum at
37 *C. The cells were pelleted in 1.5 mL microfuge tubes and saved to
isolate M13 RF DNA as described below. M13 ss DNA was isolated from the
bacteriophage in the bacterial culture supernatant by a modified protocol
of Messing (1983). Briefly, the phage supernatant was respun in a
microfuge to pellet any remaining cells and added to a tube containing 1/5
volume 20% PEG, 2.5 M NaQAc (pH 7.0) and incubated at 4 *C. Following this
incubation, the solution was centrifuged to precipitate the phage;
subsequently, the PEG solution was removed and the phage pellet was
resuspended in TE. The sample was extracted 1X with phenol, 1X with
chloroform and precipitated with 1/10 volume 3 M NaOAc (pH 5.2) and 2.5
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volumes of ethanol. After incubation at -70 'C, the DNA was precipitated
by centrifugation, the pellet was washed 2X with 70% ethanol, dried and
resuspended in TE.
M13 RF DNA was isolated from phage-infected cells according to a
modified alkaline lysis protocol (Sambrook et al., 1989). The cell pellet
was resuspended in 10 mM Tris-EDTA, 100 mM NaCl buffer and recentrifuged to
remove any residual supernatant. The cells were again resuspended in 50 mM
glucose, 25 mM Tris-Cl, and 10 mM EDTA (pH 8.0) and placed on ice. A 0.2 N
NaOH, 1.0% SDS lysis solution was added to the cell suspension and the
tubes were gently mixed and placed on ice until the solution was clear.
Subsequently, a 5 M potassium acetate solution was added to the tubes, the
samples were mixed well, and kept on ice. Following the incubation on ice,
the tubes were centrifuged to pellet the cell debris and the large
chromosomal DNA. The supernatant was removed and extracted 1X with
phenol:chloroform:isoamyl alcohol (25:24:1) and the aqueous layer was
precipitated with 2.5 volumes of ethanol at 25 *C. The samples were
centrifuged at 4 *C, and washed with 70% ethanol. The DNA was dried and
resuspended in 100 pL of TE. The RNA was precipitated from the solution by
adding a equal volume of 10 M lithium chloride, incubating the tubes on
ice, followed by centrifugation to pellet the large RNAs. The supernatant
was precipitated with 2.5 volumes of ethanol and precipitated at -20 *C.
The DNA/ethanol solution was centrifuged to isolate the DNA; the pellet was
washed with 70% ethanol, dried and resuspended in TE.
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Mutagenesis and Toxicity of Ultraviolet Light to M13 Genomes
The aim of the UV mutagenesis assays was to determine the optimal
amount of UV required for induction of mutagenic SOS functions in both
excision repair proficient and excision repair deficient bacterial strains.
To achieve this goal, UV survival assays were conducted first, by direct
irradiation of E. coli cells and determining cell survival and second, by
transfecting irradiated M13 DNA into cells that were UV irradiated or not
irradiated for induction of SOS functions.
Genotoxicity of UV irradiation in E. coli
For UV survival studies, E. coli strains DL7, DL7/pGW16, and DL4 cells
were irradiated for various times with UV irradiation from a 254 nm light
source. UV fluence rate was measured with a UVX radiometer; typical rates
were 1.0-1.2 Joules/meter 2.second (J/m 2 .s). Briefly, 100 mL of sterile LB
media was inoculated with 1 mL of an overnight culture of E. coli DL7,
DL7/pGW16 or DL4 cells and grown in 500-mL baffled culture flasks until
mid-log phase, usually 1-2 x 108 cells/mL. Cells were then placed on ice
and harvested in 250 mL Sorvall bottles (Oak-Ridge type) by spinning at
5000g (7000 rpm) in a Sorvall RC2B centrifuge. The supernatant was
discarded and the cell pellet was resuspended in 100 mL of sterile, cold 10
mM MgSO 4 . At this step, all but one-fifth of the cells was removed for UV
irradiation for induction of host SOS gene functions. The uvr* cells, DL7
and DL7/pGW16, were exposed in 25 ml aliquots in sterile 150 mm petri
dishes to a range of UV doses from 8-50 seconds (s) to a 15 W General
Electric germicidal lamp at a UV fluence rate of 1.1 J/m 2*s. DL4 (uvrC)
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cells were resuspended in cold LB media and irradiated as above to a range
of UV doses from 2-12 secs. Aliquots of cells were removed and plated on
LB plates to determine cell survival before and after different amounts of
UV irradiation.
Mutagenesis Induced by UV Lesions in M13 DNA
To assess the genotoxic and mutagenic effects of UV lesions in E. coli,
M13mplO or Ml3mpl8 bacteriophage ss DNAs were UV irradiated and then
transfected into competent E. coli cells that were UV irradiated or not
irradiated to induce SOS functions. After irradiation of the bacterial
cells, both the UV-treated and control cells were added in separate flasks
to an equal volume of 2X LB and incubated at 37 *C for 40 minutes (min),
during which time expression of SOS gene products occurred (Defais et al.,
1976). The uvrC cells were added to an equal volume of LB and incubated at
37 *C for 20 min. After the SOS incubation period, the cells were placed
on ice and harvested by centrifugation for 10 min at 5000g. The cells were
then made competent for uptake of DNA by the calcium chloride method
(Mandel and Higa, 1970; Cohen et al., 1972; Maniatis, 1982). Briefly, the
cell pellets were resuspended in an equal volume of sterile, cold 30 mM
CaCl2 and placed on ice for 20 min. The cell suspension was again
centrifuged at 5000g for 5 min and the pellet was resuspended in 1/20
volume of cold 30 mM CaCl2, placed on ice and used as soon as possible for
the transfection of modified DNAs. Typically, for each transfection, 2 pg
of M13 ss DNA was irradiated for 60 s with a 254 run lamp at a UV fluence of
1.1 J/m2.s and mixed with 300 pL of E. coli calcium chloride-competent
cells. For control transfections, 0.1 pg of M13 ss DNA was transfected
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into 300 pL competent bacteria. Transfection samples were then held on ice
(0 *C) for 15-30 min, heat-shocked at 42 *C for 90 s and subsequently
plated with M13 host cells on B Broth indicator plates, containing X-gal
and IPTG. Mutant phage, detected as light blue and colorless among wild-
type blue plaques, were enumerated to determine the mutation frequency.
These UV mutation experiments were conducted first, to determine if the
M13 bacteriophage ss genome was an adequate vector in which to study
mutagenesis; and second, to assess if the UV irradiation conditions were
sufficient to induce the SOS mutagenic processing functions of the host
cells.
Mutagenesis Assays with Globally ABP-Modified M13 Genomes
ABP mutagenesis assays in the lacZ gene of randomly ABP-modified M13
DNA were performed to determine which of the known DNA adducts of ABP were
likely to be mutagenic in the M13 ss genome and to compare the mutational
spectrum in ss DNA with the results observed in our laboratory with ABP-
modified ds DNA (Lasko et al., 1988). Cells of different repair
backgrounds were used for the mutation assays with globally modified DNAs
to investigate which bacterial genes are important in the repair or
mutagenesis of ABP-DNA lesions.
ABP Modification of M13 Genomes
Modification of M13 ss and RF DNAs was conducted with activated N-OAc-
TFAABP, in the laboratory of F. Kadlubar (NCTR). N-OAc-TFAABP was
synthesized from N-hydroxy-ABP (2,2'-[ 3H]) by the method of Lee and King
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(1981). M13mplO ss DNAs (7244 bases) were randomly adducted with 20 mM
N-OAc-TFAABP (specific activity 7.85 mCi/mmole). Reaction conditions were
300 pg/mL M13 ss DNA in TE (pH 8.0) at 37 *C for 1 hr. Amounts of N-OAc-
TFAABP to add to the reaction were calculated to achieve levels of
modification of 1 to 20 lesions per genome. M13mp10 RF DNAs (7244 bp) were
modified in a similar reaction at a concentration of 200 pg/ml to achieve
levels of 10 to 100 adducts per duplex genome. DNA buffer controls (b.c.)
using ethanol instead of ABP were used to assess the effect of reaction
conditions on the DNA. Two hundred to three hundred pg of ds and ss DNA
were used and a total of three dose points including a b.c. was done for
each modification experiment. The DNA samples were purified by n-butanol
and phenol extractions to remove unreacted N-OAc-TFAABP and the modified
DNAs were stored in ethanol at -70 *C. As a standard, calf thymus DNA
modified with N-OAc-TFAABP under similar conditions, was hydrolyzed and
analyzed by HPLC to determine the distribution of adducts and the adduct
profile of DNA binding by this activated ABP compound.
The extent of modification (the number of [ 3H]-ABP residues bound to
DNA) was determined by measuring the amount of radioactive material present
in a known amount of DNA and calculating the number of adducts present.
The number of apurinic (AP) sites possibly caused by the reaction
conditions was assessed by the method of Drinkwater et al. (1980) and as
described in Lasko et al. (1988). Modified RF DNA was treated with ExoIII
under conditions where it acts as an AP endonuclease (in the presence of
Ca 2 ). The percent of conversion of supercoiled RF DNA (form I) to nicked
circular RF DNA (form II) or linear RF DNA (form III) was determined using
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positive/negative film and densitometric evaluation. The mean number of
strand breaks (m) is estimated from the relation m - -lnf1 where f, is the
amount of the DNA that remains as Form I after treatment with Exo III. The
number of AP sites was estimated in this manner. M13 ABP-modified ss DNA
was treated with alkali, 0.1 N NaOH, and electrophoresed in 1.0% agarose
gels (lX TBE) stained with ethidium bromide to assess the integrity of the
M13 ss DNA and estimate the number of putative AP sites that may have
formed after the ABP reaction conditions.
Transfection of Globally ABP-modified M13 DNAs into E. coli
M13 ss and RF DNAs randomly modified with ABP were transfected into E.
coli cells where they were subjected to the repair and replication systems
of the host (Figure 10). The E. coli cells used for the transfection were
made competent for uptake of exogenous DNA by the calcium chloride protocol
as follows. Typically, 100 mL of sterile LB media was inoculated with 1 mL
of an overnight culture of E. coll DL7, DL7/pGW16 or DL6 cells and grown in
500-mL culture flasks until mid-log phase, usually 1-2 x 108 cells/mL.
Cells were then placed on ice and harvested in 250 mL Sorvall bottles by
spinning at 5000g in a Sorvall centrifuge. The supernatant was discarded
and the cell pellet was resuspended in 100 mL of sterile, cold 10 mM MgS0 4.
At this step, half of the cells was removed for UV irradiation in order to
induce the host SOS gene functions. The uvr* cells, DL7 and DL7/pGW16, were
exposed for 40 secs to a 15 W General Electric germicidal lamp at a UV
fluence rate of 1.1 J/m 2 s in 25 ml aliquots in sterile 150 mm petri
dishes. After irradiation, both the UV-treated and control cells were
added in separate flasks to an equal volume of 2X LB and incubated at 37 *C
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Figure 10.
Mutagenesis Assays in the lacZ gene of bacteriophage M13. ABP-modified M13
single- and double-stranded DNAs were transfected into competent E. coli.
Transfectants were plated on indicator plates with M13 host bacterial
cells. Mutants were scored as light-blue or colorless plaques among blue
wild-type plaques. Mutation Frequency was determined by dividing the
mutant plaques by the total number of plaques.
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for 40 min for expression of SOS gene products. DL6 (uvrA) cells were
resuspended in cold LB media and irradiated as above for 6 secs and added
to an equal volume of LB and incubated at 37 *C for 20 min. An aliquot of
the cells was removed before and after UV treatment to compare cell
survival before and after UV exposure. After the SOS incubation period,
the cells were placed on ice and harvested by centrifugation for 10 min at
5000g. The cells were made competent by the calcium chloride method as
described above. The competent cells were placed on ice and used as soon as
possible for the transfection of modified DNAs.
M13 RF and ss DNAs were transfected into competent DL7, DL7/pGW16, or
DL6 cells. For ABP-modified ss DNA, 50 ng of the b.c. DNA, 100-750 ng of
modified ss DNA or 1 ng of control ss DNA in a total volume of 100 pL and
approximately 200 pL (4.0 x 108) of cells was used for each transfection.
Forty ng of RF-modified DNA and 1 ng of b.c. DNA were used per
transfection. The cell-DNA mixture was incubated in culture tubes on ice
for 30-60 min and then heat-shocked at 42 *C for 90 s. Aliquots of the
transfection mixture were then plated with host bacteria (E. coli GW5100)
on IPTG, X-gal indicator B broth plates. Transfection efficiency or
survival of the modified genomes was determined by enumerating infective
centers produced after plating the transfection mixture and comparing this
number to the actual amount of DNA used per transfection.
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Mutant Isolation and DNA Sequencing Methods
Mutations in the lacZa gene can be detected as colorless or pale-blue
plaques compared to blue (wild-type) plaques. The mutation frequency was
determined by dividing the number of mutant phage by the total number of
infective centers obtained after the transfection. Putative mutant phage
were plaque-purified by restreaking on new plates and small-scale
preparations of M13 ss DNA were obtained for sequence analysis. M13 ss
DNAs were sequenced by the dideoxy method (Sanger et al., 1977) to analyze
the types of mutations induced by ABP-DNA lesions. A synthesized 15-base
primer (Kunkel, 1984) that anneals to position 6407-6422 of the M13mplO
genome was used to sequence the 300 bp lacZa target in the M13 genome
(Figure 11). Sequencing reactions were performed with a reagent kit and
[a 35S]-ATP according to the protocol provided by the manufacturer. The
reactions were electrophoresed in 6% or 8% polyacrylamide (19:1
acrylamide:bisacrylamide), IX TBE gels containing 7M urea (Maniatis et al.,
1982). After electrophoresis, gels were fixed in 10% methanol, 10% glacial
acetic acid and dried at 80 *C on a gel dryer. Exposures to Kodak X-Ray
film were carried out for 16-24 hours at room temperature. The sequencing
data was used to formulate a mutation spectrum for ABP in the lacZ gene of
M13.
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Figure 11.
The lacZa gene target of M13mplO. The cloning region polylinker and the 93
bp deletion present in the host bacteria (lacz AM15) are denoted (adapted
from Lasko et al., 1988).
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Site-Specific Mutagenesis Assays with Singly ABP-Modified M13 Genomes
Subsequent to obtaining the mutational spectrum for ABP in M13 ss DNA,
the next step was to determine the mutagenic specificity of the major
deoxyguanosine adduct of ABP, dG-C8-ABP, in M13 ss DNA. This experiment
would establish the contribution of this lesion to the entire mutational
spectrum. In order to do this, I have constructed a site-specifically
modified M13 genome containing a single dG-C8-ABP lesion. This genome was
made by ligating either an ABP-adducted tetranucleotide,
5'-d[pTpG-(ABP)pCpA]-3', or the corresponding unmodified tetramer,
5'-d[pTpGpCpA]-3', both of which were synthesized in our laboratory, into a
unique PstI restriction enzyme site in a gapped heteroduplex M13 vector.
The details of the synthesis and characterization of TG-(ABP)CA (MIT), the
construction of site-specifically ABP-modified genomes using the
tetranucleotide, TG-(ABP)CA, the transfection of modified genomes into
E. coli cells, and the mutant selection protocols are described in the
following sections.
Synthesis, Purification and Characterization of a Tetranucleotide
Containing the Major DNA Adduct of ABP
Synthesis of the deoxytetranucleotide 5'-d[TpG-(ABP)pCpA]-3'
The deoxytetranucleotide, 5'-d[TpGpCpA]-3', synthesized by the
cyanoethyl phosphoramidite method, was modified with N-acetoxy-4-
aminobiphenyl (N-OAc-ABP), an electrophilic derivative, to yield ABP-
adducted d[TGCA] (Figure 12). The N-OAc-ABP used in the synthesis of
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Figure 12.
Synthesis of the Tetranucleotide 5'-pTpG-(ABP)pCpA-3' (MIT). The
tetranucleotide 5'-TGCA-3' was reacted with N-acetoxy-4-aminobiphenyl to
yield the ABP-adducted tetranucleotide, 5'-TG-(ABP)CA-3.'. Details are
provided in the text.
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5'-d[TpG-(ABP)pCpA]-3' was prepared by reduction of 4-nitrobiphenyl (NO-
ABP) to N-OH-ABP and subsequently N-acetylated in a reaction with
pyruvonitrile and triethylamine that was incubated at 45 *C for 1 hr. A 10
pmol portion of TGCA dissolved in a mixture of chloroform : ethyl alcohol
H20 and triethylamine was allowed to react with five sequential additions
of solid N-OAc-ABP (total 3.78 mmol) at 25 *C. After 3 hr, the reaction
was diluted with dichloromethane and water, the aqueous layer was collected
and washed with dichloromethane and finally the sample was concentrated to
dryness in vacuo.
Purification and Characterization of 5'-d[TpG-(ABP)pCpA]-3'
The crude mixture from the reaction of TGCA with N-OAc-ABP was purified
by a preparative reversed phase HPLC system equipped with a Hewlett Packard
1040A diode-array detector using a linear gradient from 0-50% acetonitrile
in 0.1 M ammonium acetate pH 5.8. The tetranucleotides d[TGCA] and
d[TG-(ABP)CA] were further analyzed on a Phenomenex Ultramex 5-pm C1.
column (25 x .46 cm) using a reversed phase HPLC Beckman system. After
HPLC purification the tetramers were desalted using the same HPLC column
and a linear H2 0, CH3CN gradient. The tetramers were characterized during
HPLC purification by UV spectroscopy at 260 nm and 310 nm (to detect
aromatic amine-substituted DNA molecules) using the diode array detector to
confirm the structural integrity of the ABP-adducted tetramer.
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Nucleotide Composition Analysis
After the tetranucleotides were purified, both the modified and
unmodified tetramers were enzymatically digested to their respective
nucleosides, which were then analyzed by HPLC to confirm the nucleoside
composition. Digestion was performed sequentially with nuclease P1 for 12
hr at 37 *C in 10 mM ZnS0 4 , 30 mM NaQAc (pH 5.2) then snake venom
phosphodiesterase for 3-4 hr at 37 0C in 100 mM Tris-Cl (pH 8.0), 100 mM
MgCl 2 - The products of the digestion were analyzed on a C18 reversed phase
column using a gradient from 0-50% CH3CN in 0.1 M NH40Ac pH 7.2.
Electrophoretic Gel Analysis of Tetranucleotides
In conjunction with the HPLC purification, both the unmodified and ABP-
modified oligonucleotides were 5'-end labeled with [732 P]-ATP to yield
(5'-32P)-d[TpGpCpA]-3' and (5'-32 P)-d[TpG-(ABP)pCpA]-3', respectively. The
tetranucleotides were then denatured at 100 0C and electrophoresed on 23%
polyacrylamide gels to assess the purity and integrity of the samples. In
separate reactions the ABP-adducted and control tetranucleotides were
subjected to the same conditions used to denature the modified and
unmodified genomes. After treatment at 100 *C for 5 min, the
oligonucleotides were analyzed by UV spectroscopy and HPLC to assess the
chemical stability of the tetramers under these conditions.
After characterization of 5'-TG-(ABP)CA-3' and 5'-TGCA-3', the
5'-phosphorylated tetranucleotides were ligated into M13 gapped duplex
vectors to produce the site-specifically modified and unmodified genomes,
respectively.
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Construction of a Site-specifically Modified M13 Genome Containing the
Major dG-C8-ABP Adduct at a Unique PstI Restriction Enzyme Site
Preparation of M13 Gapped Heteroduplex Vectors
A site-specifically ABP-modified M13 genome was constructed by ligating
a 5'-phosphorylated ABP-adducted tetranucleotide into a four-base gap in a
gapped heteroduplex vector (M13GHD) that had a nick in the strand opposite
that containing the gap. Using the same protocol a control genome was
constructed with the unmodified tetranucleotide. The M13 gapped duplexes
were made from a pair of M13mpl9 derived vectors according to a
modification of the protocol of Green et al. (1984). In a typical
reaction, 50 pg of an M13mpl9 genome denoted as M13mpl9(+6) was linearized
by SmaI restriction enzyme digestion and annealed to 50 pg of a genome,
M13mpl9(+10), containing a unique PstI site that had been linearized at a
unique BglII and 5'-dephosphorylated with calf alkaline intestinal
phosphatase (CIP). The gapped duplex reaction was first incubated at
100 *C for 5 min, then 65 *C for 30 min and then slowly cooled to room
temperature. After the reaction, an aliquot of the mixture was run on a
0.8% agarose gel (stained with ethidium bromide to visualize the DNA) to
determine the percent of formation of M13GHD. This method could two
produce two forms of the gapped heteroduplexes, vectors containing a unique
4-base gap at the PstI site in the plus strand of the M13 duplex and a nick
at the BglII site in the minus strand or vectors containing the 4-base gap
in the minus strand of the M13 genome and the nick present in the plus
strand of the viral genome. The phosphorylated tetranucleotides could be
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ligated into the four-base gap in either form of the gapped duplex vectors
(Figure 13). The M13GHD vectors were made fresh and stored in aqueous
solution at 4 0C until the ligation experiment.
Phosphorylation and Characterization of 5'-TpG-(ABP)pCpA-3' and
5'-TpGpCpA-3'
The tetranucleotides used in the construction of the singly-adducted
genomes were 5'-phosphorylated and then ligated into the gapped
heteroduplex vectors. For the pilot experiments, typically, 100 pmoles
(133 ng) of the ABP-modified tetranucleotide, 5'-d[TpG-(ABP)pCpA]-3' or 100
pmoles (118 ng) of the unmodified tetramer, 5'-d[TpGpCpA]-3' were
5'-phosphorylated with 100 pCi of [y32P]-ATP (6000 Ci/mmol) using T4
polynucleotide kinase in 50 mM Tris-Cl, 10 mM MgCl2 , 5 mM DTT (pH 7.4) and
unlabeled ATP at a five-fold molar excess in a 10 pL reaction. Samples
were incubated at 37 *C for 45 min after which the reaction was terminated
at 65 *C for 15 min. Following the reaction, an aliquot of the
phosphorylation reaction, usually one pmole, was analyzed on a 23%, 7 M
urea, 1X TBE denaturing polyacrylamide gel. The radiolabeled tetramers
were visualized as bands on the gel by autoradiography of the wet gel to X-
ray film or exposure to a solid phosphor screen. Analysis of the phosphor
screen was carried out on a Molecular Dynamics phosphorimager. Using the
autoradiograph as a marker, the labeled tetramer bands were sliced from the
gel and counted (Cerenkov) in a Beckman scintillation counter. In this
manner, the specific activity of the tetranucleotide could be determined as
cpm per pmole of oligonucleotide.
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Figure 13.
Construction of a site-specifically modified genome containing a single
N-(deoxyguanosin-8-yl)-4-aminobiphenyl adduct at a unique PstI site in an
M13mpl9+ genome. M13mpl9(+10) RF DNA was linearized at a unique BglII site
and 5'-dephosphorylated with calf alkaline intestinal phosphatase (CIP).
This M13-BglII/CIP RF DNA was heat denatured and renatured with M13mpl9(+6)
RF DNA that was digested with Smal to produce two forms of the M13mp19
gapped heteroduplex vectors (Ml3GHD). A 5'phosphorylated dG-C8-ABP-
modified tetranucleotide, 5'-pTpG-(ABP)pCpA-3', was ligated into a four-
base gap of a unique PstI restriction site of the M13GHD. M13 genomes
containing the dG-C8-ABP adduct in either the plus strand (+) at position
6245, or the minus (-) strand at 6246 were produced from the ligation with
a nick at the BglII site in the strand opposite that containing the adduct.
In parallel, a control genome was constructed with an unmodified
tetranucleotide, 5'-pTpGpCpA-3'. Subsequently, the modified and the
unmodified genomes could be heat denatured to produce the singly ABP-
adducted ss genome, M13-TG-(ABP)CA, and the control ss genome, M13-TGCA.
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Ligation of Tetranucleotides into Gapped Heteroduplex Vectors
Subsequently, in parallel reactions, the ABP-adducted and the control
[32 P]-phosphorylated tetramers were ligated at a five-hundred-fold molar
excess into 0.2 pmole (1 pg) of the gapped duplex genome. Ligation
reactions were performed with either E. coll DNA ligase for 16 hr at 12*C
in 20 mM Tris-Cl (pH 7.5), 4 mM MgCl2, 10 mM (NH 4 ) 2 SO 4 , 0.1 M KC1
containing 0.1 mM NAD+ or Bacteriophage T4 DNA ligase for 16 hr at 16*C in
50 mM Tris-Cl (pH 7.8), 10 mM MgCl2 , 10 mM DTT, and 1 mM ATP). Following
the ligation reaction, the ligated genomes were purified from
unincorporated tetramers by chromatography through a 0.7 cm x 20 cm column
containing Sepaharose CL 4B or BioRad Bio-Gel A desalting gel. In some
instances, prior to column chromatography, the ligation mixture was spun in
a Centricon-10 microconcentrator (Amicon Corporation) to remove the excess
of unincorporated radiolabeled tetramer. The presence of the [I- 32 P]-ATP
label was used to monitor the ligated genomes during purification by column
chromatography and subsequent gel analysis.
Characterization of Site-specifically ABP-modified M13 Genomes
The efficiency of ligation of the ABP tetramer, 5'-pTpG-(ABP)pCpA-3'
into the gapped duplexes was determined by calculating the specific
activity of the site-specifically modified genomes in cpm per pmol of
genome. The ligation efficiency represents the percent of M13GHD that had
incorporated a phosphorylated ABP-tetramer. This value is compared to the
ligation efficiency of the control tetramer, 5'-pTpGpCpA-3', into the
gapped duplex vector.
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The ABP-modified genome was characterized with restriction endonuclease
digests to confirm the location of the adduct in the genome as well as to
observe if the presence of the adduct inhibited PstI restriction enzyme
cleavage at the PstI site. The unmodified genome was digested in parallel
as a control reaction. Restriction digests and uncut samples were then
analyzed in 0.8% agarose gels containing ethidium bromide. After
electrophoresis, the gels were photographed and then dried at 60 *C on a
gel dryer and exposed to X-ray film overnight with an intensifying screen
or exposed to a phosphor screen to visualize the radiolabeled genomes.
In addition, the radiolabeled, nicked, duplex M13 genomes were
denatured with heat (100 *C for 5 min) and electrophoresed in 1.0% agarose
gels that were stained with ethidium bromide following gel electrophoresis.
This analysis was used to determine the actual percentage of the ligation
sample that represented viable ss DNA.
Transfection Assays with a Singly-ABP-adducted M13 Genome in E. coli
The site-specifically ABP-modified genomes and control genomes used for
the mutagenesis experiments were constructed prior to each experiment as
described above. Mutagenesis experiments involved replicating both the
control bacteriophage genome, M13-TGCA, and the adducted genome,
M13-TG-(ABP)CA, into E. coli DL7 (uvr+) cells or E. coli DL7/pGW16
(uvr*/mucAB) cells that were induced for SOS functions by UV-irradiation
(Figure 14). The transfectants were plated on an E. coli M13 host strain
and the progeny phage were analyzed to determine the genotoxic and
mutagenic effects of a single ABP lesion in this cell system. In parallel
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Figure 14.
Site-specific mutagenesis assays with the ABP-modifed single-stranded
genome, M13TG-(ABP)CA, and the control genome, M13TGCA. Genomes were
transfected by electroporation into cells that were induced or not induced
for SOS functions. Transfectants were plated to determine transfection
efficiency of the site-specifically modified genome. Progeny phage were
plated, mutants were isolated and sequenced to determine the mutation
frequency as well as the mutation specificity of the dG-C8-ABP adduct.
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experiments, UV irradiated E. coli DL7/pGW16 cells were transfected with
UV-irradiated Ml3mpl8 ss DNA to assess if the UV irradiation conditions
were adequate for induction of SOS functions.
Preparation of and UV Irradiation of Cells
The cells used for these mutagenesis experiments were grown, UV treated
and prepared for DNA transfection as follows. One mL of an overnight
culture of E. coli DL7 cells or E. coli DL7/pGW16 cells was diluted into
100 mL of LB medium and grown separately in 500-ml baffled flasks until in
mid-log phase, usually 1-2 x 108 cells/ml. The cells were placed on ice
for 5 min and then spun in 250 ml Sorvall bottles at 50OOg (7000 rpm, 10
min) in a Sorvall centrifuge to pellet the cells. After the supernatant
was removed the cells were resuspended in an equal volume of sterile, cold
10 mM MgS0 4 .
At this step, the DL7 cells were kept on ice and the DL7/pGW16 cells
were removed to be UV-irradiated for induction of SOS gene functions.
DL7/pGW16 cells were exposed for 40 s to a 15 W General Electric germicidal
lamp at a UV fluence rate of 1.1 J/m2-s in 25 ml aliquots in sterile 150 mm
petri dishes. An aliquot of the cells was removed before and after UV
treatment to compare cell survival before and after UV exposure. After
irradiation, both the UV-treated and control cells were added in separate
flasks to an equal volume of 2X LB and incubated at 37 *C for 40 min for
expression of SOS gene products. After the recovery, both flasks of cells
were placed on ice and prepared and washed with H20 to remove particulates
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that can interfere with the electrotransformation protocol that was used
for transfection of M13 DNA (Dower et al., 1988).
Briefly, 200 mL of cells were spun in two 250 mL Sorvall bottles as
described above. The supernatant was removed and the cells were
resuspended in a total of 100 mL of sterile, ice-cold H20, pooled and spun
at 50OOg (7000 rpm, 15 min). The H20 was removed carefully and the cell
pellet was then resuspended in 25 mL of sterile H20 and transferred to a 50
mL sterile Sorvall tube and spun at 50OOg (7000 rpm, 15 min). The H20 was
removed from the tubes with a sterile 25 mL pipet and the cell pellet was
finally resuspended with H2 0 (if required) in a total volume of 200 pL and
placed on ice to be used as soon as possible.
Preparation of M13 Genomes for Transfection
While growing the cells, the control and adducted genomes were prepared
for the transfection. Both sets of duplex vectors were digested with SmaI
and only the ABP-modified genomes were treated with PstI to ensure that any
PstI sensitive material was removed from the sample. The digested samples
were extracted with phenol:chloroform 1X, chloroform 1X, then purified and
desalted with 3 washes of TE in a Centricon-10 microconcentrator. Prior to
each transfection, the duplex genomes were heat denatured at 100 *C for 5
min to generate ss genomes and then placed on ice to prevent strand
renaturation.
Transfection of M13 Genomes into E. coli Cells by Electroporation
For each electrotransformation, 40 pL of cells were added to microfuge
tubes containing denatured genomes and this mixture was transferred to a
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cold Bio-Rad Gene Pulser cuvette. Cells were electroporated with a Bio-Rad
Gene Pulser electroporation system at 2.5 kV volts, 25 pF and 200 ohms with
an average time constant of 4.7 s (Dower et al., 1988). To assess the
effect of the electroporation conditions on the cells, aliquots of the
cells were plated before and after electroporation to determine cell
survival. Immediately after electroporation, one ml of SOC medium was
added to the transformation mixture and the samples were removed from the
cuvette to a sterile culture tube. Aliquots of the mixture were plated on
B broth, X-Gal, IPTG indicator plates with an M13 host E. coli GW5100 to
determine efficiency of transfection of the genomes. Survival of the
modified genomes was measured by enumerating infective centers that were
produced after plating an aliquot of the transfection. Progeny phage were
produced by incubating the transfection tube at 370C for 2 hr. After the
incubation, the sample was centrifuged to pellet the cells and aliquots of
the progeny phage from the supernatant were diluted in TE, plated and
enumerated. Progeny phage from the initial transfection were subsequently
analyzed for mutants using the selection protocols detailed in the
following section.
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Isolation and Selection of DNA Mutants
PstI Restriction Enzyme Selection
Several methods were used to isolate and enumerate mutant phage among
the original progeny phage. The first protocol that was used to select for
mutants was similar to that of Loechler et al. (1984), for a site-
specifically-modified genome containing 06-methylguanine. Since the ABP
adduct resides in a unique PstI restriction site, 5'-CTGCAG-3', in the
polylinker cloning region in the lacZ gene of the M13 genome, any missense
mutation (except one change, vide infra) at this site does not affect the
production of active p-galactosidase and hence there is no phenotypic
difference in the blue plaque color exhibited by the wild-type (wt) phage
compared to the mutant phage in this assay. Any mutation that does occur
at the PstI site, however, does inactivate the recognition site for the
PstI restriction enzyme and this was the rationale used to select for
mutant phage among the wild-type population.
After the transfection experiment, progeny phage were produced and the
M13 RF DNA was isolated from the phage-infected cells. Typically 5 x 105
phage were incubated with 2 x 107 cells in 5 mL of 2X YT medium and grown
in a culture tube at 37 *C for 4-5 hr. The RF DNA was isolated from the
phage-infected cells as described earlier. The RF DNA was first subjected
to restriction by PstI enzyme (25 units for 10 pg RF DNA) to linearize
wild-type RF DNA, and subsequently transformed into E. coli MM294A cells
made competent by the CaCl 2 method.
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This mutant selection protocol was based upon two assumptions: first,
the adduct in the PstI site rendered mutant progeny resistant to this
enzyme, and second, linear RF DNA transforms at a very low efficiency
(< X.0% compared to circular RF DNA). Rounds of mutant selection were
continued to amplify mutant phage with respect to wt phage until there was
no apparent further increase in the relative number of PstI resistant
phage. After the final transformation, putative mutant phage were selected
for sequence analysis at the PstI site. Small-scale preparations of RF DNA
were done as described above, 5-10 pL of the sample was then removed and
digested with PstI enzyme. If the sample was resistant to PstI cleavage,
phage DNA was isolated from the phage culture supernatant and sequenced to
determine the types of mutations induced at the PstI site. The mutation
frequency was determined by enumerating the number of blue mutant progeny
phage from the final transformation and dividing that by the total number
of phage from the initial transformation and using a colorless plaque
phenotype as an internal standard to correct for transformation efficiency.
In-Frame opal Mutation
One type of expected base substitution mutation was readily screened
for in the lacZa mutation assay. This is a G:C > T:A bp substitution in
the minus strand at position 6246 that will result in a TGA (opal stop)
codon in the reading frame of the p-galactosidase gene in the lacZ gene of
the M13 genome. These mutations can be detected as colorless plaques
against wild-type blue plaques if the phage are plated on an M13 plating
host E. coli GW5100, an amber suppressor strain. If, however, the same
colorless plaques are picked and plated on an opal suppressor strain, E.
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coli NR8044, the TGA stop codon will be suppressed by the host cell and the
mutant plaques will have a pale-blue phenotype. M13 phage DNA can be
isolated from these putative mutants and the mutation can be confirmed by
sequence analysis.
M13 Plaque Hybridization Protocol
A differential plaque hybridization technique was used as an
alternative method of mutant isolation to confirm the results obtained from
the PstI rounds selection method. After transfection, phage plaques
produced on a plate were transferred by stippling in a grid onto a new
plate that had an overlay of the opal suppressor host, E. coli strain
NR8044, grown for 2 hours. In a typical experiment, 10 plates each with
approximately 300 stippled plaques would be analyzed for each sample. The
plaques from the grid were lifted by overlaying a 137 mm dry nitrocellulose
filter (Schleicher and Schuell) onto the plate. After the filters were
air-dried, they were baked for 30 min on a vacuum gel dryer at 80 *C.
The filters were then screened with a 15-base 5'-[ 32 P]-end-labeled
oligonucleotide, 5'-CGCCCTGCAGGGCAA-3', that had a complementary sequence
to the wild-type phage DNA at the PstI restriction site. In a typical
reaction, 200 pmoles of the 15-mer was 5'-end-labeled with 500 pCi of
[y32P]ATP and 30 units of T4 polynucleotide kinase. The hybridization
conditions used for the plaque-lift assay were 6X SSPE, 10% dextran
sulfate, 0.5% sodium pyrophosphate, 0.1% SDS, 100 pg/mL sonicated calf
thymus DNA with a probe concentration of 8 ng/mL at 1 x 106 cpm/mL. Single
filters were placed in 150 mm petri dishes with 25 mL of hybridization
solution and incubated at 42 *C for 16-24 hr with slight agitation to
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decrease nonspecific binding. The filters were then washed in large Pyrex
crystallizing dishes with four changes of 200 mL of 6X SSPE, 0.1% SDS
solution equilibrated at 42 *C. After the final wash, the filters were
placed on a sheet of 3 MM paper which was covered in Saran wrap and exposed
under slight pressure to a phosphor screen for 24-72 hr. The phosphor
screen was scanned and hybridization analysis was performed on the
Molecular Dynamics phosphorimager. Using this method of hybridization
analysis, the putative mutant plaques were detected, and subsequently
plaque-purified and analyzed by DNA sequencing.
Characterization of Mutant DNAs
Putative mutant phage isolated from the mutant selection protocols were
plaque-purified by restreaking onto new plates and small-scale preparations
of single plaques were made. The purified M13 ss DNA was sequenced using
the dideoxynucleotide sequencing method of Sanger et al. (1977).
Alternatively, M13 RF DNA was isolated from phage-infected cells produced
from a single putative mutant plaque and restricted with PstI enzyme and
analyzed by gel electrophoresis. M13 ss DNAs from the samples that were
resistant to enzyme digestion were prepared for sequence analysis.
DNA sequence analysis of mutants
Sequencing reagents using [35S-ATP] and Sequenase T7 DNA Polymerase
enzyme were used to sequence the putative mutant DNAs. The primer used was
the "-40" M13 17-base sequencing primer that anneals at position 6278-6294,
just outside the polylinker region in the vector (the adduct was positioned
in the PstI site, at position 6245 or 6246 in the polylinker) (Figure 8).
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Sequences were analyzed on 10% acrylamide (19:1 acrylamide:bis acrylamide),
1X TBE, 7M urea sequencing gels, that were fixed, dried and exposed for 24
hrs to X-Ray film.
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IV. RESULTS
Genotoxicity and Mutagenicity of UV Light in E. coli
The UV toxicity and mutagenesis assays were conducted to determine the
optimal amount of UV required for induction of mutagenic SOS functions in
both excision repair proficient (uvr*) and excision repair deficient (uvr~)
bacterial strains. UV survival assays were carried out by direct UV
irradiation of E. coli cells and determining cell survival. The UV
genotoxicity and mutagenicity assays were performed by transfecting
UV-irradiated M13 DNA into cells that were UV-treated or not treated for
induction of SOS functions.
UV Toxicity Assays
The E. coli uvr* strains, DL7 and DL7/pGW16 (pGW16: mucAB), and the uvrC
strain, DL4, were irradiated with increasing doses of UV light to determine
cell survival after UV irradiation. The results of the UV cell survival
assays are shown in Figure 15. Two observations were made based on these
results: first, the uvr* strains, DL7 and DL7/pGW16, were more resistant to
the toxic effects of UV irradiation than the uvr~ DL4 cells; and second,
cells harboring the plasmid pGW16, DL7/pGW16, were more sensitive to UV
irradiation than DL7 cells without the plasmid.
The toxic effect of UV was clearly observed in the uvrA cells, which
were more sensitive to UV radiation at much lower doses than the uvr+
strains. The 37% survival, corresponding to one lethal hit, was attained
at approximately 45 J/m 2, 20 J/m2 and 5 J/m2 for the uvr*, uvr*/mucAB and
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Figure 15.
Genotoxicity of Ultraviolet Light in E. coli. UV survival assays were
performed by UV-irradiating E. coli with a range of UV doses and plating
aliquots of irradiated and unirradiated cells to determine cell survival.
- 122 -
100
0
DL040 D
0
00-
DL7/pGW16
4)
DL4
1.
10 20 30 40 50 60 70
UV fluence (J/m 2 )
- DL7 (uvr+)
A DL7/pGW16 (uvr*, mucAB+)
- DL4 (uvrC)
- 123 -
uvrA cells, respectively. The survival results confirm the involvement of
the uvr excision repair system on the survival of the cell after cellular
DNA damage by UV irradiation.
UV Mutagenesis Assays with UV-Irradiated M13 Genomes
These assays involved transfecting UV-irradiated M13 ss genomes into E.
coli cells irradiated with increasing doses of UV light. The results were
used to determine the optimum UV radiation dosage required to induce the
SOS mutagenic functions of the host cells. Either M13mplO or M13mpl8 ss
DNA UV irradiated at 72 J/m 2 was transfected in parallel with unirradiated
M13mplO or M13mpl8 ss DNA into E. coli cells made competent for DNA uptake
by the calcium chloride method. Transfectants were plated on indicator
plates and mutations in the lacZ gene represented as light-blue or
colorless plaques among wild-type blue plaques were enumerated. The
mutation frequency was determined by dividing the number of mutant plaques
by the total number of infective centers.
The results of the UV mutagenesis assays indicate a significant
increase in mutation frequency of UV-irradiated DNA in UV-irradiated host
cells compared to unirradiated cells (Table 2). At equivalent doses of UV
treatment to DL7 and DL7/pGW16 cells, there was a three-fold increase in
mutation frequency in UV-DNA replicated in cells containing pGW16 compared
to cells without the plasmid. Approximately equal mutation frequencies
were obtained for UV-DNA in both the uvr+ and the uvrA strains. The
results suggest that the amount of UV required to induce SOS functions at a
cell survival level of 10-40% was 45 J/m 2 and 7 J/m 2 for the uvr* and uvrA
strains, respectively.
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Table 2.
Mutagenesis by UV-irradiated M13 ss DNA MF = (x 104 )a
UV dose to cells (J/m2):
Cells 0 37 45 55
DNA
UV dose (Jim2)
DL7 0 2.9 2.5 <7.9 <6.6
(uvr) 60 n.d. 6.4 36 8.6
UV dose to cells (J/m 2):
Cells 0 9.6 50
DNA
UV dose (J/m 2)
DL7/pGW16 0 8.4 10 17
(uvrlmucAB) 60 44 46 102
UV dose to cells (J/m 2):
Cells 0 4.8 7.2 9.6
DNA
UV dose (J/m 2)
DL4 0 n.d. 2.5 <2.5 <2.5
(uvrA) 60 <3.1 4.7 28 6.1
aMF= x 10-4. Mutation frequency is the number of mutant plaques divided by
the total number of plaques (infective centers)
n.d. not determined
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The Mutational Spectrum of ABP in the M13 SS Genome
The first step towards generating a mutational spectrum for ABP in the
lacZ gene of M13 was to conduct forward mutation assays in E. coli with
globally ABP-modified bacteriophage genomes. The assay used to evaluate
the mutagenicity of ABP-DNA adducts in the lacZ gene detects many bp
substitutions as well as most insertions and deletions (Kunkel, 1984).
Analysis of ABP-Modified Ml3 Genomes
M13 ss and RF DNAs were adducted to various adduct levels with N-OAc-
TFAABP. Modification of DNA by this compound produces a similar adduct
profile to reaction of DNA with N-OH-ABP (Beland and Kadlubar, 1985; Lasko
et al., 1988). N-OAc-TFAABP reacted with M13 ss DNA more efficiently than
ds DNA; therefore, much less ABP reagent was required to achieve the same
number of adducts for ss DNA as for ds DNA. The adduct levels obtained
from the reaction were 0 (b.c.), 1 and 5 lesions per 7 kilobase (kb) ss
genome and 0 (b.c.), 45 and 93 adducts per 7 kbp RF genome. When the ABP-
modified genomes were characterized by gel electrophoresis, the M13 ss and
RF DNAs migrated on the gel with ss and RF DNA standards, suggesting that
the reaction conditions did not obviously affect the genomes. When the AP
site analysis was conducted, the RF genomes containing 93 ABP adducts were
estimated to contain less than 1 AP site per genome. Analysis of ABP-
modified ss genomes indicated that there were no significant differences
between alkali-treated b.c. DNA and ABP-modified DNA.
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Transfection of ABP-Modified DNAs into E. coli
The bacterial strains used for the transfection of M13 ABP-modified
DNAs were the E. coli strains, DL7 (uvr+), DL6 (uvrA), DL7/pGW16
(uvr+/mucAB) and DL6/pGW16 (uvrA/mucAB), induced.or not induced for SOS
functions by UV irradiation (Table 1). The modified DNAs were transfected
into cells made competent by the CaCl 2 method. Subsequently, transfectants
were plated on indicator medium plates and infective centers produced from
the transfection were enumerated for determining transfection efficiency
and mutation frequency (Figure 10). Mutant phage, detected as light-blue
or colorless plaques, were distinguished from the blue (wild-type) phage on
indicator plates as described above.
Genotoxicity of ABP-DNA Lesions in M13 Genomes
Survival of M13 RF ABP-Hodified DNA
The results indicate that survival of ABP-modified M13 RF genomes
decreased with increasing adduct levels; however, survival of ABP-adducted
ds DNA, especially at 93 adducts/genome, was enhanced by the excision
repair-proficiency of the host cell (Figure 16). In uvr+ DL7 cells induced
for SOS mutagenic processing, the survival of ds DNA (93 adducts/genome)
was two-fold higher than in cells not UV-irradiated and increased to 6-fold
higher in DL7 cells containing the plasmid pGW16. The transfection
efficiency of genomes containing 93 ABP lesions was much lower in DL6 uvrA
cells and this number was not significantly increased in UV-irradiated host
cells. The genotoxicity of ABP lesions was more profound in uvrA cells
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Figure 16.
Genotoxicity of 4-aminobiphenyl-DNA adducts in M13 Replicative form (RF)
DNA. M13 RF DNA was modified with N-OAc-TFAABP and replicated in both SOS-
induced and uninduced cells. Transfectants were plated on indicator plates
with M13 host cells. The number of transfectants, or infective centers,
was enumerated to determine tranfection efficiency of ABP-modified genomes
compared to unmodified genomes (buffer control conditions).
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than in uvr* cells. The results suggest that the uvr+ excision repair
system is active in the repair of ABP lesions in M13 RF DNA. The 37%
survival was attained at approximately 90, 45 and 25 ABP adducts per RF
genome in uvr+/mucAB, uvr+ and uvrA cells induced for SOS-mutagenic
processing.
Survival of M13 ABP-Modified SS DNA
In comparison, ABP lesions in M13 ss DNA were more genotoxic than ABP
adducts in ds DNA. Survival of ABP-adducted ss DNA was not enhanced in
excision repair-proficient cells compared to excision repair-deficient
cells; the low transfection efficiency of ABP-adducted genomes was not
enhanced by SOS-induction of host cells (Figure 17). In uvr+ cells induced
for SOS functions, two adducts/ss genome reduced genome survival to 37% of
control DNA. The results indicate that survival of the M13 ss genome
containing 5 adducts was reduced to approximately 5% of the b.c. treated
DNA sample in all cells assayed.
Mutagenicity of ABP-DNA Lesions in M13 Genomes
Mutagenesis of M13 ABP-Modified RF DNA
The mutation frequency of M13 ABP-modified DNA was evaluated with
genomes adducted with 0, 45 and 93 adducts/RF genome. There was a dose-
response effect with increasing adduct level in both the DL7 (uvr*) and the
DL6 (uvrA) cells induced for SOS functions by UV-irradiation (Figure 18).
The mutation frequency of ds DNA increased with dose level from 0 to 93
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Figure 17.
Genotoxicity of 4-aminobiphenyl-DNA adducts in M13mplO single-stranded (ss)
DNA.. M13 ss DNA was modified with N-OAc-TFAABP and replicated in both SOS-
induced and uninduced cells. Transfectants were plated on indicator plates
with M13 host cells. The number of transfectants, or infective centers,
was enumerated to determine tranfection efficiency of ABP-modified genomes
compared to unmodified genomes (buffer control conditions).
- 131 -
100
0
0
-
0
10
DL7+UV
DL7
(DU
DL7/p+UV
DL6/p+UV
1. -
0 1 2 3 4 5 6
Adducts / ss Genome
----- DL7
--- DL7+UV
-A-- DL7/pGW16+UV
- DL6/pGW16+UV
- 132 -
Figure 18.
Mutagenesis induced by 4-aminobiphenyl DNA adducts in M13 Replicative form
(RF) DNA. M13 RF DNA was modified with N-OAc-TFAABP and replicated in both
SOS-induced and uninduced cells. Transfectants were plated on indicator
plates with M13 host cells. The number of transfectants, or infective
centers, was enumerated to determine mutation frequency of ABP-modified
genomes compared to unmodified genomes. The mutation frequency (MF) is
calculated by dividing the mutant plaques over the total number of plaques.
The relative mutation frequency is expressed as the mutagenesis detected
above background (buffer control conditions).
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adducts/genome to 40-fold over background; (b.c. conditions, MF - 1.1 x
10-4) in UV-irradiated DL7 cells (Table 3). In DL7 cells without SOS-
induction there was no significant increase in mutagenesis above
background. The results clearly indicate that in DL7 cells, mutagenesis
induced by ABP lesions is dependent on the SOS mutagenic processing of the
adducts.
In DL7/pGW16 (uvr+/mucAB) cells, there was a 20-fold increase above
background (b.c.) for RF genomes with 93 ABP adducts per genome; this value
increased to 35-fold above background with SOS-induction of host cells. In
DL6 cells, the mutation frequency of ABP-modified RF DNA increased with
increasing number of ABP adducts, a significant increase in mutation
frequency was observed in uninduced cells and this value increased with SOS
induction of the host cell.
The mutation frequency of the "average" ABP adduct in the lacZ gene of
RF DNA was determined to be approximately 0.09% in SOS-induced DL7/pGW16
cells. This value was calculated as follows (from Lasko et al., 1988):
From Table 3, the relative mutation frequency induced by an RF genome with
93 adducts replicated in DL7/pGW16 cells (+UV), is 35 x 10~4. The M13mplO
RF genome is approximately 7244 bp; therefore, 93 adducts would be
distributed around the genome approximately every 78 bp. The M13 lacZ gene
target is approximately 300 bp (Figure 11); therefore, the mean number of
potential ABP adducts in the lacZ gene is approximately 4 adducts per
target. The mutation frequency of the genome (93/RF) in SOS-induced cells,
35 x 10~4, is divided by 4 adducts per target gene to yield, 8.8 x 10~4, or
a 0.09% mutation frequency for the average ABP lesion in the lacZ gene of
RF DNA.
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Table 3.
Mutagenesis by 4-aminobiphenyl in
in the lacZ gene of ABP-modified M1 3 RF (ds)
E. coli
DNA
Cells +/- UV DNA MFa infective centers Relative MFb Survival
adducts/genome (10-4 ) mutants/ (10-4) % control
totas
0 3.8 (317883) 0 100%
DL7 (uvr*) - UV 45 6.5 (4/6114) 2.7 26%
93 6.1 (2/3272) 2.3 7.0%
0 3.8 (2/5182) 0 100%
DL7 (uvr *) + UV 45 18 (10/5617) 14 35%
93 47 (25/5325) 43 17%
0 1.0 (2/20,080) 0 100%
DL7/pGW16 - UV 45 n.d. n.d. n.d.
(uvr *) 93 23 (25/10,750) 22 31%
0 1.3 (2/14,900) 0 100%
DL7 /pGW16 + UV 45 n.d n.d. n.d. n.d.
(uvr *) 93 36 (60/16630) 35 46%
0 0.7 (1/15001) 0 100%
DL6 (uvrA) - UV 45 7.6 (4/5294) 6.9 11%
93 28 (1/352) 27 0.2%
0 2.6 (4/15504) 0 100%
DL6 (uvrA) + UV 45 13 (10/7680) 10 17%
93 50 (3/598) 47 0.3%
aMutation frequency was determined by dividing the number of mutant plaques by the total
number of plaques (infective centers)
b Relative mutation frequency is the MF above background
n.d.. not determined
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Mutagenesis of M13 ABP-Modified SS DNA
ABP adducts in M13 ss DNA were observed to more mutagenic than in ds
DNA #nd the frequency of mutations increased with SOS induction of the host
cell (Figure 19). In DL7 cells that were not UV-irradiated there was only
a two-fold increase in mutation frequency above background. The mutation
frequency of modified ss DNA with 5 adducts per genome increased to about
4-fold above background (3.8 x 10-3) in SOS-induced DL7 cells (Table 4).
The greatest increase in mutation frequency was observed in UV treated DL7
cells containing the plasmid, pGW16. In SOS-induced DL7/pGW16 cells, the
mutation frequency increased to approximately 12-fold above background
(b.c. conditions). In DL6/pGW16 cells induced for SOS functions, the
increase in mutagenesis was 14-fold above background. Overall, the results
indicate a strong requirement for SOS mutagenesis gene functions in ABP-
induced mutagenesis.
The mutagenic efficiency of the "average" ABP adduct in the lacZ gene
was calculated to be approximately 6.2% in SOS-induced DL7/pGW16 cells.
This value was calculated as follows (Lasko et al., 1988). From Table 4,
the relative mutation frequency for an M13 ss genome with 5 adducts/ss
genome was 12.4 x 10-3 in SOS-induced DL7/pGW16 cells. An ss genome with 5
adducts would have a mean number of 0.2 adducts per 300 b of the lacZ gene
target. By dividing 12.4 x 10-3 by 0.2, I arrived at a mutation frequency
of 6.2 x 10-2, or approximately 6.2% for the average ABP lesion in ss DNA.
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Figure 19.
Mutagenesis induced by 4-aminobiphenyl DNA adducts in M13 single-stranded
(ss) DNA. M13 ss DNA was modified with N-OAc-TFAABP and replicated in both
SOS-induced and uninduced cells. Transfectants were plated on indicator
plates with M13 host cells. The number of transfectants, or infective
centers, was enumerated to determine mutation frequency of ABP-modified
genomes compared to unmodified genomes. The mutation frequency (MF) is
calculated by dividing the mutant plaques over the total number of plaques.
The relative mutation frequency is expressed as the mutagenesis detected
above background (buffer control conditions).
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Table 4.
Mutagenesis by 4-aminobiphenyl in E. coli
in the lacZ gene of ABP-modified M1 3 ss DNA
Cells +/- UV DNA MF a infective centers Relative MF b Survival
adducts/ (10-3) mutants/ (10-3) % control
genome total
0 2.5 (40/13990) 0 100%
DL7 (uvr *) - UV 1 3.4 (37/9269) 0.5 75%
5 4.2 (66/16489) 1.7 6.0%
0 3.8 (52/14263) 0 100%
DL7 (uvr *) + UV 1 6.0 (38/2988) 2.2 73%
5 8.0 (85/10590) 4.2 7.0%
0 8.6 (51/5950) 0 100%
DL7 /pGW16 + UV 1 15 (83/6084) 6.4 81%
(uvr */ mucAB) 5 21 (93/4344) 12.4 4.4%
0 7.0 (14/2022) 0 100%
DL6 /pGW16 + UV 1 12 (21/1739) 5.0 72%
(uvrA) 5 21 (20/958) 14 3.0%
a Mutation frequency (MF) is expressed as the number of mutant plaques divided by the total number
of plaques (infective centers)
b Relative mutation frequency (MF) is expressed as the MF above background
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Spectrum of Mutations Induced by ABP-DNA Adducts in the lacZa Gene of M13
SS DNA
Once the mutation frequencies were determined, independent mutants were
isolated and restreaked to confirm plaque phenotype. M13 ss DNA was
prepared from single plaques and sequenced to evaluate the types and
positions of the mutations in the lacZ gene. The sequencing data indicate
that in ss DNA, ABP induces a spectrum of mutational changes predominantly
base-substitution mutations at deoxyguanosine bases (Table 5). The
mutations induced in SOS-induced DL7 (uvr+) or DL7/pGW16 (uvr+/mucAB) cells
were similar to those found in uninduced DL7 cells, albeit at a higher
occurrence.
The partial mutational spectrum formulated for ABP in the lacZ gene of
M13 ss DNA revealed that ABP-induced mutations in ss DNA were similar to
those previously found in ds DNA (Lasko et al., 1988) with two common
hotspots of mutation for ss and ds DNA in the lacZ gene; over 50% of the
base-substitution mutations were found in these sequences (Figure 20). The
dG at the position 6310 in the sequence, 5'-TGA-3', was found to be the
site of mutation for approximately 25% of the observed base changes in ss
DNA. Among the base changes in ss DNA, 80% occurred at putative dG adducts
(we assume that mutagenesis is targeted to the site of the adduct, but we
have no substantiating evidence). In SOS-induced DL7 and DL7/pGW16 cells,
the primary mutation observed was the G -> T transversion; however, in
uninduced DL7 cells, both G -> T and G -> C mutations occurred with equal
frequency (Table 5).
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Table 5.
Partial mutational spectrum for 4-aminobiphenyl
in the lacZ gene of M13 ss ABP-DNA
Mutation Occurrences Location Sequence
-SOS G ->T 1 6295 TCGTT
G ->T 1 6310 GTGAC
G -> T 1 6371 CAGCT
G ->A 1 6310 GTGAC
G ->C 2 6315 TGGGA
G ->C 1 6377 GCGTA
C ->T 1 6353 AGCAC
C ->T 1 6355 CACAT
+SOS G -> T 1 6207 CAGGA
G -> T 3 6259 TAGAG
G ->T 1 6283 TGGCA
G ->T 3 6310 GTGAC
G ->T 1 6314 CTGGG
G->T 1 6371 CAGCT
G -> C 1 6308 TCGTG
G -> C 1 6310 GTGAC
G -> C 1 6367 TCGCC
G -> A 1 6316 GGGAA
A->T 1 6356 ACATC
C->T 1 6334 CCCAA
C -> T 1 6355 CACAT
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Figure 20.
Mutations induced by 4-aminobiphenyl in the lacz gene of M13mplO single-
stranded DNA. Base substitution mutations observed in the lacZ gene are
shown in the shaded boxes above the gene sequence.
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Site-Specific Mutagenesis Studies with Genomes Containing the Major ABP-DNA
Adduct
The initial site-specific mutagenesis studies that I conducted with M13
genomes were made with an ABP-adducted tetranucleotide, 5'-TG-(ABP)CA-3',
synthesized at NCTR. The synthesis and characterization of the
tetranucleotide used for my initial experiments was described by Lasko et
al. (1987). Throughout this section, I shall refer to the ABP-
tetranucleotide used in these initial studies as TG-(ABP)CA (NCTR).
A site-specifically modified genome was constructed by ligating either
the modified tetranucleotide, 5'-TG-(ABP)CA-3'(NCTR), or the corresponding
unmodified tetramer, 5'-TGCA-3' into a unique PstI site restriction enzyme
site in a M13 gapped heteroduplex DNA vector. After its construction, the
ABP-modified genome was characterized to map the location of the ABP-DNA
adduct in the vector. The results of the PstI restriction enzyme digestion
assay, used as a criterion to assess the purity of the ABP-modified genome,
indicated that the ABP-tetranucleotide may have undergone some degradation
since its synthesis at NCTR.
Subsequently, the ABP-genomes were digested with PstI enzyme prior to
transfection into E. coli, assuming the treatment would eliminate possible
contaminants present in the sample. Transfection assays with site-
specifically ABP-modified and unmodified genomes were carried out in DL7
cells and SOS-induced DL7 and DL7/pGW16 cells. Mutants were isolated and
the mutation frequency as well as the types of mutations induced by the ABP
lesion in M13 ss DNA were determined. Although, the mutagenesis results
and sequencing data obtained with the site-specifically modified genome
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were consistent with the data from the mutational spectrum observed in the
lacZ gene of globally ABP-modified ss genomes, it was important to confirm
the these experiments with a pure, freshly-prepared ABP-modified
tetranucleotide. Hence, a new ABP-adducted tetranucleotide, designated as
TG-(ABP)CA (MIT), was synthesized and characterized in our laboratory.
In the first section of the RESULTS chapter I will present the results
from studies conducted with the newly-synthesized, TG-(ABP)CA (MIT).
Subsequently, the analysis of site-specifically ABP-modified genomes
constructed with TG-(ABP)CA (MIT), the transfection of the modified and the
control genomes into E. coli cells, and the mutant selection protocols are
described in the following sections. Finally, in the last part of the
RESULTS chapter, I will describe the results of my initial mutagenesis
experiments conducted with M13 genomes made with the NCTR ABP-adducted
tetranucleotide.
I have presented the results from my experiments in this order because
I have the most confidence in the newly-synthesized and well-characterized
tetranucleotide, TG-(ABP)CA (MIT), and I am less confident in the purity of
the TG-(ABP)CA (NCTR) (based on HPLC analysis of TG-(ABPCA (NCTR) and
characterization of genomes containing this tetranucleotide). The
coincidence, however, between the type of mutations induced by the NCTR ABP
tetranucleotide and the predominant mutational event observed in the known
mutational spectrum of ABP, as established in our laboratory, may be
significant; therefore, I have included the results from my initial
mutagenesis assays in this dissertation.
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Synthesis, Purification and Characterization of the Deoxytetranucleotide,
5'-d[TpG-(ABP)pCpA]-3'(MIT), Containing the Major DNA Adduct of ABP
HPLC Analysis of the Synthesis and Purification of d[pTpG-(ABP)pCpA] (MIT)
The tetranucleotide 5'-d[TpGpCpA]-3' was synthesized and allowed to
react with N-acetoxy-4-aminobiphenyl (N-OAc-ABP), an electrophilic
derivative of ABP to produce 5'-d[TpG-(ABP)pCpA]-3' (MIT). Analysis of the
synthesis by reversed-phased HPLC indicated that the yield of d[TG-(ABP)CA]
(MIT) was approximately 30-40% from the reaction of TGCA with N-OAc-ABP
(Figure 21 a,b).
The unadducted and ABP-adducted oligonucleotides were purified by a
reversed-phase HPLC system and characterized by UV spectroscopy. The UV
spectrum of TG-(ABP)CA (MIT) was shown to be different from that of TGCA;
an absorbance shoulder was present at 310 nm in the spectrum, typical of
C8-arylamine-substituted nucleotides (Figure 22).
Characterization of d[pTpG-(ABP)pCpA] (MIT) by Mass Spectrometry
In collaboration with Dr. C. Costello (Chemistry department, MIT),
fast-atom bombardment (FAB) mass spectrometry was used to analyze the
structural characteristics of the TG-(ABP)CA (MIT) tetranucleotide. The
TG-(ABP)CA oligonucleotide was calculated to have a molecular weight of
1340; indeed the negative ion spectrum for TG-(ABP)CA showed the major [M -
H]~ ion to be at m/z 1339, the expected value.
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Figure 21.
a. HPLC analysis of the crude reaction mixture from the adduction of 5'-
TGCA'3' with N-acetoxy-4-aminobiphenyl (N-OAc-ABP), to produce
5'-TG-(ABP)CA-3'. b. HPLC analysis of the purified product, 5'-
TG-(ABP)CA-3'.
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Figure 22.
UV spectra of the tetranucleotides, TGCA and TG-(ABP)CA. An absorbance
shoulder at 310 nm in the spectrum for TG-(ABP)CA is observed, typical of
C8-arylamine-substituted nucleotides (Lasko et al., 1987).
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Nucleoside Composition Analysis of d[pTpG-(ABP)pCpA] (MIT)
The ABP-modified and unmodified tetramers were enzymatically digested
to their respective nucleosides, which were then analyzed by HPLC to
confirm the nucleoside composition. Digestions by nuclease P1 and snake
venom phosphodiesterase were conducted on the unmodified tetranucleotide,
d[TpGpCpA] and the ABP-modified tetramer d[TpG-(ABP)pCpA] (MIT) in
parallel. An analysis of the digestion products on reversed-phase HPLC
indicated that the enzymatic digestion had gone to completion (Figure 23a).
The four peaks that were observed for TGCA occurred in equimolar ratio and
corresponded to the nucleosides dC, dG, deoxythymidine (dT) and dA. The
chromatogram of the digested tetramer, dTG-(ABP)CA (MIT), exhibited no dG
peak but instead a prominent peak with a retention time identical to that
of an authentic dG-(ABP) standard (Figure 23b).
Electrophoretic Gel Analysis of d[pTpG-(ABP)pCpA] (MIT)
In separate reactions the ABP-modified and unmodified oligonucleotides
were subjected to the same heat denaturation conditions (100*C, 5 min) used
to produce the ss genomes used for the mutagenesis assays. Both
tetranucleotides appeared not to have undergone any chemical degradation
when analyzed by HPLC and UV spectroscopy. In addition, both the
unmodified and ABP-modified tetranucleotides were shown to be pure when
5'-end-labeled with [y32P]-ATP and analyzed on a 23% acrylamide denaturing
gel. After purification and characterization of TG-(ABP)CA (MIT) and TGCA,
the phosphorylated tetranucleotides were ligated into M13 gapped duplex
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Figure 23.
Nucleoside composition analysis of the tetranucleotides. a. HPLC analysis
of the digestion of TGCA with nuclease P1 and snake venom phosphodiesterase
produced four peaks, dT, dG, dC, and dA. b. HPLC analysis of the parallel
enzymatic digestion of TG-(ABP)CA, yielded four peaks, dT, dC, dA and
dG-C8-ABP.
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vectors to produce the site-specifically ABP-modified and unmodified
genomes, respectively.
Characterization of an M13 Genome Containing a Single ABP-DNA Lesion
A site-specifically modified M13 genome containing the dG-C8-ABP adduct
at a unique Pst I site, 5'-CTGCAG-3', was constructed and characterized
(the adduct was situated at the underscored base). According to the
protocol, genomes were produced containing the adduct in this palindromic
sequence in either the plus strand of the M13 genome at position 6245, or
in the minus strand at position 6246. The site-specifically modified
genome is designated as M13-TG-(ABP)CA (MIT) and the control, unmodified
genome as M13-TGCA (Figure 13).
Estimation of Ligation Efficiency of the ABP-Modified Genome
The efficiency of ligation of the adducted tetramer into the gapped
duplex genomes was calculated by determining the specific activity (in
cpm/pmol) of the tetramer and comparing it to the specific activity of the
ligated genomes after purification. Several calculations for ligation were
performed, after which it was determined that the ligation efficiency of
the adducted tetranucleotide into the gapped heteroduplex vector was
approximately 25% compared to a 50% ligation efficiency for the unmodified
genome, M13-TGCA. The lower ligation efficiency observed with M13-
TG-(ABP)CA (MIT) could be due to the presence of the bulky ABP lesion in a
tetranucleotide sequence. In comparison, ligation of a tetranucleotide
containing an a minor 06-methlyguanine adduct occurred with an efficiency
of 50% into an M13 vector at the PstI site (Green et al., 1984).
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Restriction Enzyme Analysis of the ABP-Hodified Genomes
Both of the ligated genomes, M13TG-(ABP)CA (MIT) and M13-TGCA, were
characterized by PstI restriction enzyme digestion to confirm the location
of the adduct in the genome as well as to observe if the presence of the
adduct rendered the genome refractory to cleavage by the PstI enzyme. The
adduct resided within the PstI site and hence failure of the modified
genome to cleave was used as a criterion to assess the purity of the
singly-adducted genome. The PstI enzyme restriction analysis of both the
ABP-modified and control genomes is shown in Figure 24. The
characterization experiments demonstrated that M13 genomes constructed with
the ABP-tetramer were resistant to enzymatic digestion by PstI. As
expected, the unmodified genome was linearized with restriction by PstI.
These results correlate with earlier studies in which the presence of an
ABP-DNA adduct at the PstI site in an M13 genome rendered the restriction
enzyme incapable of cleavage at that site (Lasko et al., 1987).
5' and 3' Ligation Analysis of the ABP-todified Genome
In addition to the PstI digestion analysis, it was important to
determine the actual percentage of constructed genomes in which ligation
had occurred on both the 5' and 3' ends of the tetranucleotide since the
nicked duplex genomes were to be denatured to ss DNA prior to transfection
in E. coli. Restriction enzymes that cleaved the genomes in the vicinity
of the PstI site were used to digest both the adducted and the unadducted
genomes. The results of the experiment indicated that greater than 95% of
the both the ABP-modified and the unmodified genomes were ligated at both
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Figure 24.
Restriction enzyme and gel analysis of the control genome, M13 TGCA (Lanes
1-3), and the site-specifically ABP-modified genome, M13 TG-(ABP)CA (Lanes
4-6). Ligated genomes were digested with PstI enzyme to assess the purity
of the genomes as well as to map the location of the adduct at the PstI
site. Undigested samples, buffer control (no enzyme), and PstI treated
samples were electrophoresed on 0.8% agarose gels containing ethidium
bromide. Due to the nick in the genome at the BglII site in one strand of
the genome, the uncut M13TGCA and the M13TG-(ABP)CA genomes migrate as RF
form II (nicked circular) DNA under these conditions (Lanes 1 and 4,
respectively). In addition, the buffer control samples also migrate as
uncut DNA (Lanes 2 and 5, respectively). The unmodified M13TGCA genome is
linearized with PstI digestion, and hence migrates as RF form III (RF
linear) DNA under these electrophoresis conditions (Lane 3). The presence
of the ABP adduct in the M13TG-(ABP)CA genome, however, inhibits cleavage
by PstI and thus the modified genomes still migrate as form II DNA after
enzyme treatment (Lane 6).
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the 5' and 3' sides of the tetranucleotide (Figure 25). This restriction
analysis also mapped the ABP lesion to an 18 base restriction fragment in
the M13 genome.
One important method of genome analysis was performed to estimate the
actual amount of viable ss circular DNA present in the ligated genomes.
When both the ABP-modified and the unmodified nicked duplex genomes were
denatured with heat at 100*C and analyzed in agarose gels, it was
determined that approximately 50% of the DNA was present as ss circular
genomes (Figure 26). Although the 5'- 3' ligation analysis indicated that
> 95% of the DNA was ligated at both ends of tetramer, the lower amount of
closed, circular ss DNA may be attributed to random nicks in other regions
of the duplex genome.
Genotoxicity and Mutagenicity of a Single ABP Lesion in an M13 SS Genome
Transfection of a Singly-Modified M13 Genome into E. coli
The site-specifically ABP-modified and control genomes used for the
mutagenesis experiments were constructed prior to each experiment as
described in the previous section. Both the genomes, M13-TG-(ABP)CA (MIT)
and M13-TGCA, were transfected by the method of electroporation into
E. coli DL7 (uvr*) cells or SOS-induced E. coli DL7/pGW16 (uvr+/mucAB)
cells (Figure 14). The method of electrotransformation was used to
transfect DNAs because it was important to obtain a large number of
transfectants for accurate mutant analysis. The electroporation protocol
could produce ~10 7 infective centers/pg of ss DNA compared to the standard
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Figure 25.
5' and 3' ligation analysis of the site-specifically ABP-modified, M13-
TG-(AB)CA (GAB), and the control, M13-TGCA (G) genomes. Ligated genomes
were digested with the enzymes, HindIII, EcoRI, and PstI, that cut within
the local region of the adduct site to assess the extent of ligation on
both the 5' and the 3' ends of the unmodified, TGCA, and the ABP-modified,
TG-(ABP)CA, tetranucleotides into the M13GHD vectors. Digestion reactions
were heat denatured and electrophoresed in 20% polyacrylamide, 7 M urea
gels. The uncut and the singly digested G and GA genomes are represented
in Lanes 1-4. Efficient (100%) 5'-3' ligation would produce an 18 b
fragment for a double digestion with HindIII and EcoRI under these
conditions (Lanes 5 and 6). 5' ligation, but not 3', would produce a 13 b
fragment. 3' ligation, but not 5', would yield a 9 b fragment. Addition of
PstI to the HindIII/EcoRl digestion reaction produces a 13 b fragment for
M13TGCA, but, as expected, does not cleave the M13 TG-(ABP)CA genome (Lanes
7 and 8).
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Figure 26.
Estimation of the amount of viable site-specifically ABP-modified single-
stranded genome and control single-stranded genome. ABP-modified, M13
TG-(ABP)CA, and control, M13 TGCA, genomes were heat denatured and analyzed
on 1.0% agarose gels to determine the percent of ss circular DNA in each
ligation sample. Uncut and buffer control M13TGCA and M13TG-(ABP)CA
genomes migrate as RF form II (RF nicked circular) under these conditions
(lanes 1, 6 and 2, 7, respectively). PstI treatment of M13TGCA linearizes
the genome to RF form III (RF linear) (lane 4); however, PstI treatment of
M13TG-(ABP)CA does not alter the migration of the genome (lane 9). After
heat denaturation of the genomes two DNA forms, ss circular and ss linear,
are visible for M13TGCA and M13TG-(ABP)CA (lanes 3 and 8, respectively).
Heat denaturated PstI digested M13TGCA and M13TG-(ABP)CA samples are shown
in Lanes 5 and 10, respectively.
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M13-TGCA
CaCl2 method of transformation, which produces only 10
4
-105
transfectants/pg of ss DNA.
After transfection of the genomes, an aliquot of the mixture was plated
on an M13 host strain, E. coli GW5100, to produce infective centers; these
were enumerated to determine survival of modified genomes. Subsequently,
progeny phage produced from the initial transfection (T 1 ) were plated and
enumerated to determine the number of progeny phage produced after T1 .
Protocol for Isolation of ABP-Induced Mutants by PstI Selection
The PstI selection protocol was the first method used to select for the
mutants among the progeny phage from the initial transfection (T1 ) of both
the ABP-modified and control genomes (Figure 27). Briefly, an aliquot of
the progeny phage from T, was used to infect fresh M13 host cells, and the
RF DNA was isolated from the phage-infected cells. The RF DNA was
subjected to restriction by PstI to cleave wild-type DNA, and subsequently
transformed into competent E. coli MM294A cells. Since the ABP adduct
resides in the unique PstI restriction site, 5'-CTGCAG-3', any mutations
within this site should inactivate the PstI recognition sequence. The
selection protocol was based upon two reasonable assumptions: first, the
adduct induced mutants in the PstI site were resistant to cleavage by this
enzyme; and second, that linear RF DNA transforms at a very low efficiency
(< 1.0% compared to circular RF DNA). The mutants were amplified by a
further three rounds of selection and transformation. Single plaques
obtained after the fourth round of transformation (T,) were isolated; their
ss DNA was prepared and then sequenced to determine the types of mutations
that occurred at the PstI site.
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Figure 27.
PstI Enzyme Mutant Selection Protocol. Mutations within the PstI
restriction site were selected as described.
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Determination of Mutation Frequency of ABP-Induced Mutants
The mutation frequency (MF) was determined by enumerating the number of
mutant phage from the final transformation as determined by DNA sequencing
and dividing that value by the number of total phage produced after the
initial transformation and multiplying this ratio by a correction factor
that normalized for variable transformation efficiency. The following
formula was used:
MF - (M/seq Bn) x (B./Cn) x (C/Tj)
where M represents the mutant blue phage obtained after the final
transformation and seq Bn is the number of blue plaques from the final
transformation that were sequenced; Bn equals the total blue phage after
the final transformation; C represents the number of colorless plaques in
the final transformation; C1 is the number of colorless plaques observed
from the first transfection and Ti is the total number of progeny phage
produced from the initial transfection. The number of colorless plaques
was used as an internal standard since this value was not expected to
change during the course of the PstI selection protocol.
A typical calculation of MF induced by the site-specifically ABP-
modified genome was performed as follows. To obtain the value for the
mutation frequency of the M13-TG-(ABP)CA genome replicated in DL7/pGW16
SOS-induced cells (MF presented in Table 6), an average of the induced MF
from two independent transfections was taken. To determine the MF the
following calculations were made using the mutant selection protocol
described in Figure 27. After the final or fourth transformation (T. or in
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this case, T4), 60 putative mutant ss DNAs were sequenced. Of this number,
24 were determined to be wild-type DNAs that may have escaped the PstI
selection protocol. From the remaining 36, 24 were sequenced to be
untargeted bp substitutions, insertions or deletions and the remaining 12
were sequenced to be targeted bp substitutions at either position 6245 or
6246 of the PstI site. To determine the targeted mutation frequency, I
used the formula above as follows:
MF - 12 (M after T4)/ 60 (seq B4) X 2 x 106 (B4)/ 9.5 x 107 (C4) X 1.7
x 106 (C1) / 6.0 x 107 (Tj) -
0.2 X 2.1 x 10-2 X 2.8 x 10-2, which yields an MF of 0.012% for the
M13-TG-(ABP)CA genome replicated in DL7/pGW16 (+SOS) cells (Table 6).
Transfection and Mutagenic Efficiency of the dG-C8-ABP Adduct at the PstI
Site in an M13 SS Genome
The results of two independent mutation assays using site-specifically
modified M13-TG-(ABP)CA, and the control genome, M13-TGCA, are presented in
Table 6. The combined results of both assays indicate that the
transfection efficiency of the ABP-adducted genome was not remarkedly lower
than the unmodified genome in uvr+ cells. This survival did not increase
in SOS-induced DL7 cells containing pGW16. This observation correlates
with the random mutagenesis studies in which neither SOS-induction of host
cells nor the presence of pGW16 led to an increase in the survival of
globally-ABP-modified M13 ss genomes.
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Table 6.
Site-specific Mutagenesis Assays
M13 dG-C8-ABP-modified (MIT) ss genomes
Expt 1:
Cells M13 genome Survival Mutation frequency (%)a
Transfection Efficiency Targeted Untargeted Total
DL7 M1 3 TGCA 1.2 x 1 03/ng < 0.007% 0.023% 0.023%
M13TG-(ABP)CA 3.4 x 103/ng < 0.002% 0.007% 0.007%
DL7/pGW16 M13TGCA: 6.7 x 102/ng < 0.015% 0.015% 0.015%
+ UV M13TG-(ABP)CA 1.3 x 103/ng 0.012% 0.024% 0.036%
a Mutation frequency = Percent of mutant phage among original progeny phage ( T1)
Expt 2:
Cells M13 genome Survival Mutation frequency (%)a
Transfecton Efficiency Targeted Untargeted Total
DL7 M13 TGCA 100%(7.2 x 102/ng) n.d. n.d. n.d
M13TG-(ABP)CA 53%(4.2 x 102/ng) n.d. n.d. n.d.
DL7/pGW16 M13TGCA: 100%(3.0 x 103/ng) < 0.011% 0.126% 0.126%
+ UV M13TG-(ABP)CA 21%(8.5 x 102/ng) 0.016% 0.240% 0.256%
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a Mutation frequency = Percent of mutant phage among original progeny phage (T1)
n.d. not determined
Using the PstI selection protocol for isolation of mutants, the total
mutation frequency for a singly-modified genome was 0.036% compared to
0.015% for the control genome in SOS-induced DL7/pGW16 cells; however, the
targeted mutation frequency in the modified sample was only 0.012% (Table
6). In the second experiment, the targeted mutation frequency of a single
ABP lesion was calculated to be 0.016%. This latter value, however, was
exceeded by a large number of nontargeted mutations with a mutation
frequency of 0.240%. These insertion mutations were also present in the
control samples.
Spectrum of Mutations Induced by the dG-C8-ABP Adduct
Among the mutations analyzed (from Expt 1, Table 6), only targeted
mutations were observed in the samples from the transfections with the M13-
TG-(ABP)CA genomes. An analysis of the targeted base substitution
mutations indicated that they were almost exclusively G -> C transversions
that occurred with equal frequency from adducts that could have originated
in either the plus strand or the minus strand (Table 7). In these site-
specific mutagenesis experiments, targeted mutations were not observed in
M13-TG-(ABP)CA genomes replicated in non-SOS-induced cells. The remainder
of the mutations were primarily large insertions and deletions, followed by
nontargeted base substitutions that occurred within the PstI recognition
site. The untargeted mutations were also present in the control samples
and probably resulted from the genetic engineering techniques used to
construct the genomes.
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Table 7.
Mutations observed in Site-specific Mutagenic Assays
M13 dG-C8-ABP modified (MIT) ss genomes
6245
TTG CC TGC AG
AACGG AC9 TC
6246
GCG
CGC
6259
AAT TCA
TTA AGT
Targeted Mutations:
Cells M13 genome Type Location Number MF
DL7/pGW16 TG-(ABP)CA G -> C 6245 4 0.012%
+UV (MIT) G ->C 6246 5
G ->T 6245 2
G->T 6246 1
G -> A 6245 1
Untargeted Mutations:
Cells M13 genome Type Location Number MF
DL7-UV TGCA C -> A 6243 1 0.023%
insertions 6244-6248 4
-21 deletion 6232-6252 2
DL7-UV TG-(ABP)CA A -> C 6247 1 0.007%
(MIT) insertions 6244-6248 6
DL7/pGW16 TGCA C -> A 6243 1 0.015%
+UV G -> T 6248 1
insertions 6244-6248 6
DL7/pGW16 TG-(ABP)CA T -> G 6244 1 0.024%
+UV (MIT) T -> C 6244 2
A -> G 6247 2
-21 deletion 6232-6252 7
A->T 6253
insertions 6244-6248 11
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M13 Plaque Hybridization Protocol for Selection of DNA Mutants at the PstI
Site
Although the mutagenesis results were obtained using the PstI mutant
selection protocol that was successfully employed in earlier studies
(Loechler et al., 1984), it was possible that in the current study, the
selection protocol used to isolate the mutant phage may have resulted in a
biased selection for the nontargeted mutants, specifically the insertion
and deletions, which could obscure the real or targeted mutations.
Therefore, a differential plaque hybridization technique was used as an
additional method for screening the phage population. This procedure
involved isolating mutant plaques among wild-type plaques by using
radiolabeled probes that would hybridize only to wild-type phage DNA. The
positive signal produced would permit the detection of mutant phage, which
would be represented as a negative signal when screened with the wild-type
probe.
The following tests were performed to confirm that all possible single-
base mismatches would be detected in the hybridization analysis of the
phage samples. A series of M13 phage DNAs mutated at a single position in
the PstI site, 5'-CTGCAG-3,' was used to test the efficacy of the
hybridization conditions. Briefly, wild-type phage plaques were stippled
onto a 10 x 10 grid on an E. coli NR8044 overlayed B Broth plate. Mutant
phage samples were then stippled at specific positions among the wild-type
phage in the grid. Filters were made of these grids and probed with a
5'-[ 32P]-ATP labeled 15-mer probe with a sequence that was complementary to
the wild-type phage DNA at the PstI restriction site. The hybridization
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and washing conditions were adjusted so that the wild-type probe hybridized
only to wild-type M13 plaque DNA but not to DNA sequences that had a single
base mutation (Figure 28).
This technique was used to analyze the phage from the transfection
experiments. After plating aliquots of the progeny phage from the first
transfection (T1 ), phage plaques produced on a plate were transferred by
stippling onto a bacterial lawn in a grid. Filters made from the plaque
grids were screened with the 5'-[ 32P]-ATP labeled wild-type probe.
Using the plaque hybridization protocol, phage plaques from the
transfection samples from Experiment 1 were screened with the wild-type
radiolabeled probe. The probe hybridized only to wild-type M13 plaque DNA
but not to DNA sequences that had a single base mutation at the PstI site.
In this manner, the putative mutant plaques were detected, subsequently
plaque-purified and analyzed by DNA sequencing. Using the hybridization
protocol, no mutant plaques were detected in 3 x 103 progeny phage plaques
produced from the initial transfection (T 1 ) of M13-TG-(ABP)CA genomes in
SOS-induced DL7/pGW16 cells. Subsequently, 3 x 103 phage plaques from the
progeny phage pool that was selected with PstI and amplified once were
analyzed for mutant phage. This analysis yielded 9 mutant plaques among
3000 total plaques. The targeted mutation frequency was calculated to be
0.007% in the progeny phage from the initial transfection, which correlates
reasonably well with the value of 0.012% obtained from mutant selection
using the PstI enzyme digestion and rounds of selection method vide supra.
The results of the hybridization analysis confirmed that the PstI protocol
was a reasonable method of mutant selection.
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Figure 28.
Experiment to establish conditions for the M13 plaque hybridization
protocol for mutant selection. M13 plaque grids were made on a B Broth
plate that had an overlay of the M13 opal suppressor host cells. A 10 x 10
grid of stippled wild type (at the PstI site) phage was made on the plate.
At certain positions within the grid, specifically positions, 5, 25, 50,
75, and 100, phage with known mutations at the PstI site were stippled to
be used as "negative" controls. Filters were then made of the different
grids and probed with a radiolabeled wild-type probe. Conditions were
adjusted to permit detection of mutant plaques among wild-type plaques.
Filter 1: no plaque control; Filter 2: all wild-type plaques; Filter 3: C
(-4 base deletion mutants at PstI site) mutant plaques stippled at
specified positions; Filter 4: T5 (G -> T at position 6245) mutant plaques
stippled at specified positions; Filter 5: T6 (G -> T at position 6246)
mutant plaques; Filter 6: A5 (G -> A at position 6245) mutant plaques;
Filter 7: A6 (G -> A at position 6246) mutant plaques; Filter 8: C5 (G -> C
at position 6245) mutant plaques; Filter 9: C6 (G -> C at position 6246)
mutant plaques.
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Detection of opal Mutations at the PstI Site
One type of expected base substitution mutation could be readily
screened in the lacZa mutation assay. This is a G:C -> T:A bp substitution
in the minus strand at position 6246. This mutation results in a TGA
(opal) stop codon in the reading frame of the #-galactosidase gene encoded
by the lacZa fragment of the M13 genome (Figure 29). These mutations were
detected as colorless plaques against a background of wild-type blue
plaques when the phage were plated on the M13 host E. coli GW5100 (an amber
suppressor strain). The plaques exhibited a light-blue phenotype, however,
when plated on an opal suppressor strain, E. coli NR8044. M13 phage DNA
was isolated from these putative mutants and the mutation was confirmed by
sequence analysis.
Using the plaque phenotype method of mutant selection, the frequency of
the G -> T transversions was determined to be approximately 0.01% for M13-
TG-(ABP)CA genomes assayed in Experiment 1. Many of the putative opal
mutants, which produced the light-blue phenotype, were sequenced to be
mutations at sites other than at the PstI site.
To summarize, the results of three independent methods of mutant
selection or screening have indicated that the mutation frequency of a
single ABP lesion situated at the PstI site in an M13 single-stranded
genome is approximately 0.01% in our experimental system.
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Figure 29.
Protocol for detection of in-frame opal mutants. The normal gene sequence
and the mutant gene sequence are depicted.
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Normal M13mp19+ sequence
Amino acid sequence: Ser Leu Pro Cys Arg Ala Asn Ser
+ strand:
- strand:
AGC
TCG
TTG
AAC
CCC
GGG
6245
T6 C AGG
AC9 TCC
6246
GCG
CGC
AAT
TTA
TCA
AGT
Sequence after G -> T transversion at position 6246
Amino acid sequence: Ser Leu Pro STOP
+ strand:
- strand:
AGC
TCG
TTG
AAC
CCC
GGG
TGA AGG
ACT TCC
6246
GCG
CGC
AAT
TTA
TCA
AGT
Protocol:
Original phage population after transfection 1 (Ti):
mutants plus nonspecific mutants (colorless)
Screen for mutants by plating on opal suppressor strain:
mutants (light blue)
Mutation frequency: mutant phage after Tn
mutant phage after T1
clear phage after T1
X clear phage after Tn
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Initial Site-Specific Mutagenesis Studies Conducted with M13 Singly ABP-
Adducted (NCTR) Genomes in E. colil
This section describes the results from the initial site-specific
mutagenesis studies conducted with M13 genomes made with the ABP-adducted
tetranucleotide, 5'-TG-(ABP)CA-3' (NCTR). The synthesis and
characterization of the NCTR tetranucleotide used in the initial
experiments, described herein, was reported by Lasko et al. (1987).
Throughout this section, I shall refer to the ABP-tetranucleotide used in
these initial experiments as TG-(ABP)CA (NCTR).
A site-specifically modified genome was constructed by ligating either
the modified tetranucleotide, 5'-TG-(ABP)CA-3'(NCTR), or the corresponding
unmodified tetramer, 5'-TGCA-3' into a unique PstI site restriction enzyme
site in a M13 gapped heteroduplex DNA vector. After its construction, the
ABP-modified genome was characterized to map the location of the ABP-DNA
adduct in the vector. The results of the PstI restriction enzyme digestion
assay, used as a criterion to assess the purity of the ABP-modified genome,
indicated that the ABP-tetranucleotide may have undergone some degradation
since its synthesis at NCTR. Aware of the technical problems, I proceeded
to conduct mutagenesis experiments with the ABP-modified genome (NCTR),
taking some precautions prior to transfection into cells. The initial
mutagenesis results and sequencing data were encouraging and were
consistent with the mutational spectrum obtained from globally ABP-modified
ss genomes.
Although these initial results were encouraging, I have repeated the
site-specific mutagenesis experiments with a freshly-made tetranucleotide,
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5'-TG-(ABP)CA-3' (MIT). The results of these experiments conducted with
MIT-modified tetranucleotide indicated that the dG-C8-ABP adduct was not
significantly mutagenic at the PstI site in the M13 ss genome. The results
of the initial site-specific experiment, however, indicated that the dG-C8-
ABP was mutagenic, albeit at a low level (9-fold above background), in SOS-
induced cells. The analysis of TG-(ABP)CA (NCTR), the characterization of
M13 genomes constructed with TG-(ABP)CA (NCTR), and the results from the
initial site-specific mutagenesis experiments are described in the
following sections.
Characterization of the Tetranucleotide, d[pTpG-(ABP)pCpA] (NCTR)
Analysis of the ABP-adducted tetranucleotide, TG-(ABP)CA (NCTR), by
nucleoside digestion and HPLC analysis indicated that some contaminants, at
a level of -10%, may be present in the TG-(ABP)CA (NCTR) sample (Figure 30)
compared to the analysis of TG-(ABP)CA (MIT) (Figure 21b). In addition,
FAB mass analysis of the TG-(ABP)CA (NCTR) oligonucleotide indicated that
the [M - H]~ ion was at m/z 1340; however, there was also a significant
peak at m/z 1339. The molecular weight of the TG-(ABP)CA (NCTR) after its
initial synthesis at NCTR was inferred to be 1340 from earlier mass
spectrometry analysis (Lasko et al., 1987). In comparison, analysis by
mass spectrometry of TG-(ABP)CA (MIT) indicated that the major [M - H]~ ion
was at m/z 1339, which correlates with a accurate molecular weight of 1340
for TG-(ABP)CA (MIT).
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Figure 30.
Analysis of the tetranucleotide, 5'-TG-(ABP)CA-3'. a. HPLC analysis of the
tetranucleotide, 5'-TG-(ABP)CA-3' (NCTR). b. Nucleoside composition
analysis of TG-(ABP)CA (NCTR) by nuclease P1 and snake venom
phosphodiesterase digestion.
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Construction and Characterization of Singly-ABP-Modified Genomes
A site-specifically modified genome was constructed by ligating either
the modified tetranucleotide, 5'-TG-(ABP)CA-3'(NCTR), or the corresponding
unmodified tetramer, 5'-TGCA-3' into a unique PstI site restriction enzyme
site in a M13 gapped heteroduplex DNA vector. The site-specifically
modified genome, denoted as M13-TG-(ABP)CA (NCTR), together with the
control genome, M13-TGCA, were characterized with restriction enzyme
digestions followed by gel analysis as described above. The PstI
restriction assay was used as a criterion to assess the purity of the
genome as well as to confirm the location of the ABP-DNA adduct in the
vector. Restriction analysis of the genome, M13-TG-(ABP)CA (NCTR) resulted
in a significant fraction of the genomes being sensitive to digestion by
PstI (Figure 31). These results are in contrast to the results obtained
for the PstI digestion assay for the genome M13-TG-(ABP)CA (MIT) (Figure
24). These earlier results suggested that the ABP-tetranucleotide used for
the construction of M13-TG-(ABP)CA (NCTR) may have undergone some
degradation since its initial synthesis at NCTR.
Transfection Assays with the Singly-ABP-Hodified Genome
Although the purity of the M13-TG-(ABP)CA (NCTR) genome was in
question, I treated this ABP-genome with the PstI enzyme prior to any
mutagenesis experiments, reasoning that the treatment would possibly
eliminate contaminants present in the sample. The linear DNA generated
from the PstI digestion would become biologically inviable when the genomes
were heat denatured prior to transfection into E. coli.
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Figure 31.
Restriction enzyme analysis of the site-specifically modifed genome, M13-
TG-(.ABP)CA (NCTR), and the control genome, M13-TGCA. The uncut M13TGCA and
M13TG-(ABP)CA genomes migrate as RF form II (nicked circular) DNA (Lanes 1
and 2, respectively). Both the ligated M13TGCA and M13TG-(ABP)CA genomes
were digested with the enzymes, PstI, ClaI, and FokI to map the position of
the ABP adduct in the M13TG-(ABP)CA genome and to determine if the PstI
digestion was inhibited by the ABP adduct at the PstI site. PstI digestion
of the M13TGCA genome linearizes the nicked circular genome, from RF form
II DNA, to RF form III DNA (Lane 3). PstI digestion of the ABP-modified
genome indicates that a significant proportion of the genomes are
linearized by PstI from form II to form III (Lane 4). Digestion of the
M13TGCA and the M13TG-(ABP)CA genomes with either ClaI (Lanes 5 and 6,
respectively) and FokI (Lanes 7 and 8, respectively) yield the expected
sized fragments.
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The control genome, M13-TGCA, and the adducted genome, M13-TG-(ABP)CA
(NCTR), were denatured to produce ss genomes and then transfected into SOS-
induced DL7 (uvr*) cells, SOS-induced DL7/pGW16 (uvr*/(mucAB)) or uninduced
DL7 (uvr+) cells using the electrotransformation protocol (Figure 14).
After transformation, an aliquot of the transfection mixture was plated to
determine transfection efficiency of the modified genome and compare it to
the value obtained for the control genome. Subsequently, progeny phage
produced from the initial transfection (Tj) were plated and enumerated as
the first step in determining mutation frequency.
Mutation Frequency of the Singly ABP-Modified Genome
To isolate mutant phage, rounds of mutant selection were performed to
amplify mutant phage with respect to wild-type phage with the PstI
selection protocol as detailed above (Figure 27). Transfection efficiency
and mutation frequency of M13-TG-(ABP)CA (NCTR) compared to M13-TGCA were
determined.
The results of one site-specific mutagenesis experiment are presented
in Table 8. In this study, a decrease in transfection efficiency was
observed between ABP-modified genomes and control genomes; however, the
survival of ABP-modified genomes did not increase with SOS-induction of DL7
or DL7/pGW16 host cells. The mutagenesis data from this experiment
indicate that the dG-C8-ABP was mutagenic, albeit at a low level (9-fold
above background), in SOS-induced DL7/pGW16 cells. The average adduct-
induced mutation frequency was determined to be 0.09% for the M13-
TG-(ABP)CA (NCTR) genome replicated in these cells.
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Table 8.
Site-specific Mutagenesis Assays
M13 dG-C8-ABP-modified (NCTR) ss genomes
Cells M13 genome Survival Mutation Frequency(%)a
Transfection Efficiency Targeted Untargeted Total
DL7 M13 TGCA 100% (2.8 x 104/ng) <0.01% 0.06% 0.06%
M13TG-(ABP)CA 53% (1.5 x 104/ng) 0.01% 0.01% 0.02%
DL7 +UV M13TGCA 100% (2.8 x 103/ng) < 0.02% 0.02% 0.02%
M13TG-(ABP)CA 43% (1.2 x 103/ng) 0.06% <0.01% 0.06%
DL7/pGW16 M13TGCA 100% (1.3 x 104/ng) <0.01% 0.05% 0.05%
+UV M13TG-(ABP)CA 21% (2.8 x 103/ng) 0.09% 0.05% 0.14%
a Mutation frequency= percent of mutant phage among original progeny phage after T1
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Two conclusions were made based on these results: first, survival of
the ABP-adducted genome was not enhanced by SOS-induction of host cells;
and second, the ABP-modified genome exhibited a higher mutation frequency
in DL7/pGW16 cells compared to DL7 cells. The results are consistent with
the survival of globally ABP-adducted ss genomes in E. coli (Figure 17 and
Table 4). The mutagenesis results also suggest that the mucAB mutagenic
genes, which are present on plasmid pGW16, are required to observe high
mutation frequencies with ABP-DNA adducts, especially in ss DNA.
As an alternative selection protocol, the progeny phage from the first
transfection (Tj) of this experiment were analyzed by the hybridization
screening protocol. Using this method of analysis, a targeted mutation
frequency of 0.07% was determined; this result concurred with the mutation
frequency of 0.09% obtained by the PstI selection protocol described above.
The results of the hybridization analysis confirmed that the PstI protocol
was a reasonable method of mutant selection.
Spectrum of Mutations Induced by the dG-C8-ABP Lesion at the PstI Site
. An analysis of the mutations induced by the ABP lesion in ss DNA
revealed that they were almost exclusively G -> T and G -> A changes
targeted to site of the adduct (Table 9). These data are consistent with
the mutation spectrum from globally-modified ss genomes in which the
primary mutation was the G -> T transversion. A large number of untargeted
mutations were observed in the SOS-induced DL7/pGW16 cells; some of these,
especially the -21 deletion, which has been observed in the recent
experiments (Table 6), may be due to the nature of the sequence context at
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Table 9.
Mutations observed in Site-specific Mutagenic Assays
M13 dG-C8-ABP-modified (NCTR) ss genomes
Sequence:
6232
ACG CCA AGC
TGC GGT TCG
6245
TTG C C TGC AG
AACGG ACQ TCAACG 6M2
6246
6259
GCG AAT TCA
CGC TTA AGT
Targeted Mutations:
Cells M13 genome Type Location Number MFa
DL7 -UV TG-(ABP)CA G -> T 6245 2 0.01%
(NCTR) G ->A 6246 1
DL7 +UV TG-(ABP)CA G -> T 6245 6 0.06%
(NCTR) G ->A 6246 1
DL7/pGW16 TG-(ABP)CA G -> T 6245 5 0.09%
+UV (NCTR) G ->A 6245 7
G ->A 6246 2
G ->C 6245 2
a Mutation frequencies are from Table 8. (% mutant phage among T1)
Untargeted Mutations:
Cells M13 genome Type Location Number MFa
DL7-UV TGCA -21 deletion 6232-6252 2 0.06%
G -> T 6248 2
TG-(ABP)CA -21 deletion 6232-6252 2 0.01%
DL7/pGW1 6 TGCA -21 deletion 6232-6252 5 0.05%
+UV T ->A 6244 4
TG-(ABP)CA T -> A 6244 8 0.05%
A->T 6247 1
A->G 6247 1
a Mutation frequencies are from Table 8. (% mutant phage among T1)
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the PstI site. The untargeted bp substitution mutations which appeared in
both the control and the ABP-modified samples probably were the result of
genetic engineering techniques used to construct the genomes.
The mutational changes observed in this experiment were consistent with
the ABP mutational spectrum, but they were not consistent with the
mutations induced by the genomes made with the chemically-pure TG-(ABP)CA
(MIT). Some contaminants, present at a level of -10%, were observed in the
HPLC analysis of the NCTR ABP-modified tetranucleotide (Figure 30). It is
possible, but not certain, that these contaminants or putative breakdown
products of TG-(ABPCA (NCTR) may be the components responsible for the
different types of mutations in my initial experiments with the M13-
TG-(ABP)CA (NCTR) genomes. As stated above, in studies conducted with
genomes made with the newly synthesized, pure MIT ABP-adducted tetramer, I
observed far less mutagenesis and, importantly, a different mutation
specificity for the dG-C8-ABP adduct.
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V. DISCUSSION
In this section, I shall discuss the results from both my lacZ gene
random ABP mutagenesis studies and the site-specific dG-C8-ABP mutagenesis
experiments. I shall also relate my results to previous studies
investigating mutagenesis induced by ABP and related aromatic amines such
as AF.
The results of an earlier study conducted in our laboratory had
indicated that a single dG-C8-ABP adduct when present in only one strand of
a ds M13 genome causes a low or undetectable mutation frequency in E. coli
(Lasko et al., 1988). A bias against replication of the ABP-adducted
strand of the singly-modified vector was suggested as one explanation for
this observation. In addition, other studies carried out in our laboratory
had shown that a single chemical-DNA adduct, including 06-methylguanine,
thymine glycol, and the major GAG adduct of cis-platin, when present in ss
DNA was more mutagenic than the same lesion situated in ds DNA (Essigmann
et al., 1986; Basu et al., 1988; Bradley, 1991).
To address the question of whether a single ABP-DNA adduct in M13 ss
DNA could induce mutations, three studies were undertaken. First, the UV
genotoxicity assays were carried out to be used as a model system in E.
coli cells in which to study the toxicity and the mutagenesis by DNA
adducts of ABP; second, the lacZ gene random mutagenesis assays were
performed to determine which of the known DNA adducts of ABP were mutagenic
in the M13 ss genome and to compare the mutational spectrum in ss DNA with
the results previously observed in ds DNA (Lasko et al., 1988); and third,
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the site-specific mutagenesis experiments were conducted to determine the
genotoxic and mutagenic effects of the major ABP-DNA adduct in M13 ss DNA.
UV Genotoxicity Assays
The results from the preliminary UV assays provided information about
the toxicity of bulky or helix-distorting DNA lesions such as those formed
by UV radiation in bacterial strains of different repair and mutagenic
backgrounds. The combined results from the UV assays indicated that the
uvr excision repair system protects the host cell from the damaging effects
of UV irradiation and the mucAB gene products enhance mutagenesis induced
by UV lesions in ss DNA. The results also correlate with the previous
results obtained with UV-irradiated M13 ss DNA replicated in uvr+ and uvr~
cells (Lasko, 1986). From these assays it was demonstrated that DL7/pGW16
(uvr~/mucAB)) induced for SOS functions were the optimum cells in which to
study mutagenesis induced by single ABP lesions.
Mutagenesis Studies in the lacZ Gene of Globally ABP-Modified M13 Genomes
The results from the random mutagenesis experiments demonstrate that
ABP lesions are both genotoxic and mutagenic in M13 bacteriophage genomes
replicated in E. coli. ABP adducts in M13 ss DNA are 50-fold more
genotoxic than in M13 ds DNA (Figure 17). In contrast to the results found
with ds DNA, excision repair proficiency of the host cell did not enhance
the survival of ABP-modified ss DNA. Hence, ABP lesions in ds DNA are
likely removed by the excision repair enzymes of the host cell but the
same lesions in ss DNA apparently cannot be effectively repaired. My
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results additionally indicate that SOS-induction of the host cells leads to
an increase in the survival of ABP-modified RF DNA (Figure 16). A large
number of ABP lesions (e.g. 93, adducts/genome) can be lethal to the M13
genome if the host enzymes cannot repair the lesions. In addition, the
persistence of these unrepaired adducts can result in mutations when the
DNA is replicated. This was evidenced in the high toxicity and the
increase in mutation frequency of ABP lesions observed in uvrA cells.
The data from assays with both ABP-modified ss and ds genomes indicate
a dose-dependence of the number of ABP adducts per genome with an increase
in mutation frequency in both SOS-induced uvr+ and uvrA cells. SOS-
induction of host cells substantially increases the mutagenic impact of ABP
lesions in M13 ds DNA (Figure 18). In assays with M13 ss DNA, ABP lesions
were found to be more mutagenic when the host cells contained the plasmid
pGW16, which carries the mucAB mutagenic processing genes (Figure 19).
The mutation frequency of the average ABP adduct in the lacZ gene of
duplex RF DNA was determined to be 0.09% (calculated in RESULTS chapter) in
SOS-induced DL7/pGW16 cells whereas the mutagenic efficiency of the average
ABP lesion in the same mutational target of ss DNA was calculated to be
approximately 6.2% (see RESULTS chapter) in SOS-induced DL7/pGW16 cells.
These results clearly indicate that adducts in ss DNA are approximately 70-
fold more mutagenic than in ds DNA, underscoring the importance of an
unmodified DNA strand complementary to the adducted strand; the former
serves as a template for repair.
The mutagenesis results obtained with the M13 ABP-modified RF genomes
correlate with previous results obtained in our laboratory with randomly
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ABP-modified ds genomes replicated in SOS-induced cells as reported in our
earlier study (Lasko et al., 1988). The value of 0.09% for the mutagenic
efficiency of a single ABP lesion in the lacZ gene target of an RF genome
with 93 adducts in my studies correlates with the mutation frequency of
0.14% obtained for average ABP lesion in an RF genome containing 140 ABP
adducts (Lasko et al., 1988).
It was possible to estimate the number of abasic sites formed in vitro
in the ABP-modified DNA and, on the basis of this analysis, I determined
that the mutagenesis observed was predominantly due to the ABP lesions. It
is possible, however, that AP sites could have formed inside the cell
through some as yet unknown ABP repair system. These intracellularly
formed AP sites may have contributed to the increase in mutagenesis
observed in my experiments. It was important to perform the AP site
analysis, because the predominant mutation observed for ABP lesions (the G
-> T transversion) matches the primary mutation from AP sites. Hence, it
was essential to rule out the possibility that our observation was an
artifact of chemical depurination of ABP-adducted DNA. The results of
previous analysis of ABP-modified DNA also demonstrated that AP sites were
not formed in significant levels after reaction of activated ABP compounds
with M13 DNA (Lasko et al., 1988).
The results presented in this dissertation also correlate with another
mutagenesis study with the structurally related carcinogen, AF (Gupta et
al., 1988). This study investigated the genotoxic and mutagenic effects of
AF lesions in M13 ss and ds DNA. The results from this study also suggest
- 194 -
that AF adducts in ss DNA were more toxic and more mutagenic than adducts
in ds DNA. A mutation frequency of 2.5 x 10-3 in SOS-induced cells was
observed for an M13 ss genome containing 5 AF adducts. This correlates
with my studies in which I observed a mutation frequency of 4.2 x 10-3 for
M13 ss genome with 5 ABP adducts replicated in SOS-induced cells (Table 4).
These investigators also reported mutagenesis results for AF-modified M13
RF DNA that were similar to the results that I had obtained for ABP-
modified M13 RF DNA.
The mutation data also agree with studies conducted in the laboratory
of Fuchs and coworkers with plasmid DNA modified with N-OH-AF (Bichara and
Fuchs, 1985). This study demonstrated that AF-DNA adducts were
significantly mutagenic in plasmid DNA only under SOS-induction of host
cells. It appears, therefore, that the much studied carcinogen, AF, which
differs from ABP only by a methylene bridge, is probably a good model for
ABP mutagenesis. The toxicological importance of this conclusion stems
from the fact that AF is a compound of relatively minor human health
significance, as compared to ABP, but there is a wealth of information in
the literature on its biological effects.
The mutation data indicate that ABP is a versatile mutagen, inducing a
variety of mutational changes in both SOS-induced and uninduced cells. In
uninduced (uvr*) cells, ABP induces both G -> T and G -> C transversions.
In SOS-induced cells, however, the G -> T transversion was the predominant
mutation observed (Table 5). The mutation data suggest that both the dG
adducts of ABP, dG-C8-ABP and dG-N 2-ABP, could have contributed to the
mutational spectrum. The mutational spectrum for ABP in the lacZ gene of
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M13 ss DNA was similar to the mutational spectrum for ABP in ds DNA as
established in our labortory by Lasko et al. (1988). The predominant
changes in the lacZ gene of M13 ds DNA were G -> T and G -> A
substitutions.
The mutation data also correlated with studies conducted by Gupta et
al. (1988), in which AF was found to be a versatile mutagen; the mutational
changes induced by AF included all three possible bp substitutions at
putative dG-C8-AF adducts. The results also agree with the results
obtained in AF-modified plasmid DNA, in which the primary mutation observed
was the G -> T transversion (Bichara and Fuchs, 1985). Since N-OH-AF
predominantly forms the dG-C8-AF adduct after reaction with DNA, it can be
speculated that that the mutational change caused by the dG-C8-AF lesion is
the G -> T transversion. Site-specific mutagenesis studies with the dG-C8-
AF adduct in M13 ds DNA have not entirely resolved this speculation but
recent results indicate that this adduct induces a G -> T mutation when
situated in an M13 duplex genome containing uracil residues in the strand
opposite that in which the dG-C8-AF adduct was situated (Reid et al.,
1990).
The mutagenesis results from my experiments conducted with ABP-modified
ss DNA provide strong evidence that adducts in ss DNA were more toxic and
more mutagenic than adducts in ds DNA. From the results of both the UV
genotoxicity and the random ABP mutagenesis assays, it appears that the
DL7/pGW16, (uvr~/mucAB) cells induced for SOS functions are the optimum
cells in which to study mutagenesis induced by single ABP lesions. The
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mutation data and the correlation of my work with previous results suggest
that perhaps the major dG-C8-ABP adduct formed by ABP is responsible for
the majority of the ABP-induced mutations in the mutational spectrum.
Site-Specific Mutagenesis Studies by the Major DNA Adduct of ABP
The results of the random mutagenesis studies confirmed that the M13 ss
genome would be the most useful vector in which to study site-specific
mutagenesis by the major DNA adduct of ABP, dG-C8-ABP. Subsequent to
obtaining the mutational spectrum for ABP in M13 ss DNA, a site-
specifically ABP-modified genome was constructed and replicated in vivo to
study mutagenesis induced by a single ABP lesion in the same cells used to
conduct the random mutagenesis experiments.
The findings from my site-specific mutagenesis experiments are
summarized as follows. Three independent methods of mutant
selection/screening have indicated that the targeted mutation frequency of
a single dG-C8-ABP lesion in an M13 ss genome is approximately 0.01% in the
experimental system used to assay this genome (Table 6). The results of
these site-specific mutagenesis experiments have clearly shown that the dG-
C8-ABP adduct was not very mutagenic, if indeed it is mutagenic at all,
under the conditions of my experiment (adduct located in the PstI site in
the M13 ss genome). The low level of mutagenesis observed in these studies
was surprising considering that the mutagenic efficiency of a single ABP
lesion in the lacZ gene of M13 ss DNA was calculated from the random
mutagenesis experiments to be approximately 6.2% (in RESULTS chapter).
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Analysis of the targeted mutations in the site-specific mutagenesis
Experiment 1 was complicated by the low frequency at which ABP induces
mutations (Table 6). This made the mutants difficult to detect against the
unavoidable background of nontargeted or genetic engineering induced
mutations and made it necessary for me to develop, during the course of
this work, a mutation analysis system that is an order of magnitude more
sensitive than any previously used in our laboratory. In Experiment 2, the
frequency of untargeted mutations, specifically the large deletions and
insertions, exceeded the frequency of the targeted mutations. It was first
believed that the large sequence alterations were the result of the
selection protocol used to isolate mutants; however, when the progeny phage
from the second round of transformation after one PstI selection were
screened for mutants by the plaque hybridization protocol, it appeared that
the large insertion and deletion mutants were already present in the phage
population. The frequent large deletion mutation (-21) that I have
observed throughout these experiments may be due to the nature of the
sequence of the genome itself and some hairpin structure formation that
becomes deleted when the genomes are replicated in vivo.
There may be at least two explanations for the low level of mutagenesis
observed in the site-specific mutagenesis experiments; first, the major dG-
C8-ABP adduct may not be responsible for the mutagenesis observed in the
mutational spectrum studies; and second, the dG-C8-ABP adduct may have been
situated in a site not susceptible to ABP-induced mutagenesis (i.e., not a
mutational hot-spot sequence). For a sequence to be considered a mutation-
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prone sequence, the presence of an adduct at this site may induce a change
in the conformation of the DNA such that the lesion becomes a target for
the proteins involved in the processing of that lesion into a mutation
(Bichara and Fuchs, 1985). If the site were not considered to be a hot-
spot sequence, then it is possible that bypass of the ABP lesion in vivo
may have resulted in the low level of mutations observed in these
experiments. Recent studies have demonstrated that the dG-C8-AF adduct
when situated in a random DNA sequence was bypassed in vivo with accurate
translesion synthesis by DNA polymerase I (Michaels et al., 1991). A
combination of in vitro replication assays and in vivo mutagenesis studies
with DNA adducts of ABP situated in hot-spot sequences, as deduced from the
mutational spectrum, may provide insights into the effect of DNA sequence
context on the mutagenic processing of ABP-DNA lesions.
The major mutational change induced, albeit at a low frequency, by the
dG-C8-ABP adduct at the PstI site in SOS-induced cells, was the G -> C
transversion (Table 7). This bp mutation represented less than 20% of the
changes observed in the mutational spectrum for ABP in SOS-induced cells.
Although the predominant mutation observed in the lacZ mutational spectrum
was the G -> T transversion, and not the G -> C transversion, it is
possible that at the PstI site, the dG-C8-ABP induces a G -> C mutational
change. The mutagenic processing of ABP-DNA adducts in different sequences
might result in different mutagenic consequences (E. Loechler, manuscript
in preparation).
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Studies conducted by Reid et al. (1990) have shown that in SOS-induced
cells, the dG-C8-AF adduct induces predominantly G -> T transversions when
situated in a duplex genome with uracil residues in the strand opposite
that containing the adduct. The mutational spectrum for N-OH-AF (a
compound that predominantly forms the dG-C8-AF adduct), revealed that AF
induces G -> T, G -> C and G -> A mutations with similar frequencies in the
lacz gene of AF-modified genomes replicated in SOS-induced host cells
(Gupta et al., 1988).
Molecular mechanisms giving rise to the types of mutation induced by
ABP have been suggested in an earlier report from our laboratory (Lasko et
al., 1988). It is possible that at the PstI site, 5'-CTGCAG-3', the dG-C8-
ABP adduct induces a syn conformation about the N-glycosidic bond in DNA;
in this local architecture, the adducted base may mispair with dG and hence
lead to G -> C mutations. Alternatively, in other DNA sequences, the dG-
C8-ABP adduct in a syn conformation could mispair with the imino form of
dA, which could result in the G -> T transversion (Figure 32).
Verification of these models awaits the development of synthetic procedures
that will permit preparation of sufficient amounts of ABP-adducted
oligonucleotides for analysis by the appropriate spectroscopic techniques.
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Figure 32.
Biochemical models for hypothesized mechanisms for mutagenesis by ABP-DNA
adducts. The normal G:C base-pair is depicted in the top panel.
Mechanisms by which G -> C and G -> T mutations could arise from dG-C8-ABP
lesions are shown in the middle and lower panels, respectively.
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VI. SUMMARY AND CONCLUSIONS
The objective of my research was to determine if the major DNA adduct
of ABP, dG-C8-ABP, could cause mutations when situated in the single-
stranded M13 bacteriophage genome replicated in E. coli.
To address the question of whether ABP lesions in M13 ss DNA could
induce mutations, two studies were undertaken. In the first study, ABP
mutagenesis assays in the lacz gene of globally ABP-modified M13 DNA were
performed to determine which of the known DNA adducts of ABP were likely to
be mutagenic in the M13 ss genome and to compare the mutational spectrum in
ss DNA with the results observed in our laboratory with ABP-modified ds
DNA. In the second study, site-specific mutagenesis experiments were
conducted with an M13 ss genome containing a single dG-C8-ABP to determine
the genotoxic and mutagenic effects of the major ABP-DNA adduct in M13 ss
DNA.
Forward mutation assays were conducted with ABP-modified M13 ss and RF
genomes in SOS-induced and uninduced E. coli to assess repair and
mutagenesis induced by ABP. The results indicated that ABP-DNA adducts are
50-fold more genotoxic and 70-fold more mutagenic in ss DNA than in RF (ds)
DNA. Approximately 2 ABP-DNA lesions per ss genome reduced genome survival
to 37%, representing a lethal hit, whereas in ds DNA, 37% survival of the
genome was attained at approximately 100 adducts/ds genome. The mutation
frequency of an "average" ABP-DNA lesion in the lacz gene of ss DNA was
determined to be approximately 6.2%, whereas the mutation frequency of a
single ABP-DNA adduct in the lacZ gene of a ds genome was calculated to be
0.09%.
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A partial mutational spectrum for ABP in the lacZ gene of ss DNA was
determined. ABP lesions in ss DNA induced a variety of mutations at
putative deoxyguanosine adducts. Over 50% of the mutations observed in ss
DNA were found in two regions of the lacZ gene. The dG in the sequence 5'-
TGA-3', was found to be the site for mutation for approximately 25% (6/26)
of the observed base changes. The spectrum of mutations in ss DNA included
G -> T, G -> A, and G -> C bp substitutions; these changes represented 80%
of the mutations found in ss DNA.
A deoxytetranucleotide containing a single dG-C8-ABP adduct was
synthesized, characterized and incorporated into an M13 single-stranded
genome at a unique PstI restriction site. The site-specifically ABP-
modified was characterized to confirm the position of the ABP lesion within
the genome. The ABP-modified genome and a control unmodified genome were
then replicated, in parallel, in SOS-induced and uninduced cells. Mutants
were selected and isolated to determine the mutation frequency and the
mutational specificity of the major ABP-DNA adduct. To summarize the
findings from the site-specific mutagenesis experiments, the results of
three methods of mutant selection have indicated that the targeted mutation
frequency of a single dG-C8-ABP lesion, situated at the PstI site in an M13
ss genome, was approximately 0.01%.
The major mutational change observed at the site of the adduct was the
G -> C transversion. This mutation occurred with equal frequency from
adducts that were positioned in either the plus or the minus strand of the
genome. From the mutational spectrum of ABP in the lacZ gene, the G -> C
mutation represented approximately 20% of the bp changes in ss DNA.
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VII. SUGGESTIONS FOR FUTURE RESEARCH
My recommendations for future studies are based upon the results
presented in this study which, investigated the mutagenesis and the repair
of DNA adducts of ABP in E. colil.
Further research in this area should investigate the mutagenic effects
of the three DNA adducts of ABP situated in different DNA sequence
contexts. These investigations can be accomplished by two methods to assess
which sequences are mutation-prone sequences for ABP. The first method
would utilize in vitro DNA replication assays with E. coli DNA polymerases
on a series of DNA templates containing single ABP-DNA adducts to determine
which ABP-DNA adducts are a block to DNA replication and which adducts are
bypassed during in vitro synthesis. The results from these assays could
also determine the effect of DNA sequence on the mutations induced in vitro
by ABP-DNA lesions as well as determine the frequency of in vitro bypass of
an ABP lesion in a particular sequence. In addition, by comparing the two
dG adducts of ABP, dG-C8-ABP and dG-N2-ABP, in the same assay system, it
may be possible to determine which of these lesions is responsible for the
mutational specificity of ABP. The in vitro assays would provide some
information on the effect of DNA sequence on mutagenesis, which would be
valuable prior to embarking on in vivo site-specific mutagenesis
experiments.
The second method could investigate the in vivo mutagenic effects of
the major dG-C8-ABP adduct or the minor dG-N 2 -ABP adduct in a hot-spot
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sequence as deduced from the mutational spectrum. One site that was found
to be a hotspot for mutagenesis by putative dG adducts in both ss and ds
DNA was the sequence 5'-CGT GAC TGG GAA-3' at position 6307-6318 in the
lacZ gene. In ss DNA, 11 out of 26 mutations occurred at this sequence and
4 out 14 mutational changes at G:C bps occurred at this site in ds DNA. By
testing the individual dG adducts of ABP in this sequence, it may be
possible to determine which of the two dG-ABP lesions was responsible for
the mutations observed in this sequence.
In addition, it is important to investigate the mutagenic specificity
of the minor dA-C8-ABP lesion and assess the contribution of this adduct to
the mutational spectrum. Previous studies conducted in our laboratory have
revealed a hotspot sequence, 5'-GGGGGA-3', for ABP-mutagenesis in the
mutational spectrum at a putative adenine lesion. It would be interesting
to conduct site-specific mutagenesis studies investigating the mutagenic
specficity of this lesion compared to the major deoxyguanosine adduct in
the same experimental system.
Once ABP studies in E. coli have been accomplished, the next logical
step would be to study mutagenesis by ABP and related compounds in
mammalian cell culture assays. ABP is known to be a human bladder
carcinogen, and the presence of ABP in our environment has been documented;
thus exposure to ABP could have significant implications for many
indivduals, particularly smokers. In addition, the related heterocyclic
amines, such as the imidazo-quinolines, are known mutagens present in
cooked and fried foods. These compounds should also be investigated in
both bacterial and mammalian systems.
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